[
    {
        "file_name": "2020.03.022.en.txt",
        "en": "The patient, a 51-year-old male, contacted the Scottish telehealth service for advice on day +1 with a 24-hour history of fever and cough having returned to Scotland from northern Italy on day -2. His symptoms were in keeping with a possible case of COVID-19 according to the national case definition at the time. Community SARS-CoV-2 testing was arranged for day +2. The patient had travelled to Italy on day -9 to watch a rugby match in Rome. He travelled with his partner and two friends in a private rental vehicle through Lombardy, Veneto and Tuscany, staying in private rental accommodation, before flying back to Scotland from Milan on day -2. He was not aware of any contact with cases of COVID-19. On day 0 he developed fever, myalgia, malaise and sinusitis. This progressed to a cough productive of green sputum on day +1. His fever had subsided by day +2. The patient remained in self isolation in the community whilst awaiting the results of SARS-CoV-2 PCR which was performed in the West of Scotland Specialist Virology Centre on a combined nose/throat swab. This sample tested positive for SARS-CoV-2 on day +3 with a threshold cycle (Ct) value of 36. An urgent teleconference was held between virology, public health, Scottish ambulance service and the receiving regional High Consequence Infectious Diseases (HCID) unit. The patient was subsequently transferred by Special Operations Response Team (SORT) ambulance to the HCID unit. The patient was escorted from the ambulance to a laminar flow room (with antechamber) on the first floor of the unit by medical staff in appropriate personal protective equipment (PPE). The patient was wearing a surgical face mask throughout transit. The ambulance staff returned to their base for doffing of PPE. He was a lifelong non-smoker. His medical history consisted only of hypertension. He had no known underlying lung disease. He took an ACE-inhibitor and self-medicated with paracetamol and non-steroidal anti-inflammatory drugs during his illness. On admission, the patient was afebrile with a mild non-productive cough. He had no limitation in exercise tolerance during this acute illness and continued to exercise in his home whilst self-isolating. On assessment, lung fields were clear on auscultation and bilateral scleral injection was noted. Admission vital signs were: heart rate 79 beats per minute, blood pressure 171/105mmHg, respiratory rate 18, pulse oximetry 96% on air and temperature 36.5. By day three of admission the patient had lymphocytopenia, which was found in 80.4% of patients with laboratory-confirmed non-severe COVID-19 in mainland China3. Chest radiography was not clinically indicated. PCR testing for other respiratory viruses, Mycoplasma pneumoniae and Chlamydia pneumoniae on the throat swab was negative. Nose and throat samples for SARS-CoV-2 PCR were obtained daily to monitor viral shedding. SARS-CoV-2 PCR on urine, faeces and EDTA blood was negative. The patient was clinically well throughout the admission; no supportive care was required. He was discharged after 8 days, following two sequential nose and throat swabs negative for SARS-CoV-2 by PCR. The initial viral sample was sequenced by the MRC-University of Glasgow Centre for Virus Research, mapped against the Wuhan-Hu-1 reference genome and aligned with a collection of global SARS-CoV-2 sequences, with the resulting analysis released open access. Phylogenetic analysis demonstrated that Scotland/CVR01/2020 belonged to a clade of isolates all acquired in northern Italy4.",
        "es": "El paciente, un hombre de 51 a\u00f1os, se puso en contacto con el servicio de teleasistencia sanitaria para pedir asesoramiento el d\u00eda +1, con fiebre y tos de un d\u00eda de evoluci\u00f3n; hab\u00eda regresado a Escocia procedente del norte de Italia el d\u00eda -2. Sus s\u00edntomas coincid\u00edan con un posible caso de COVID-19 de acuerdo con la definici\u00f3n nacional de casos en ese momento. Se acord\u00f3 una prueba extrahospitalaria de SARS-CoV-2 para el d\u00eda +2. El paciente hab\u00eda viajado a Italia el d\u00eda -9 para asistir a un partido de rugby en Roma; luego, hab\u00eda viajado con su pareja y dos amigos por la Lombard\u00eda, el V\u00e9neto y la Toscana, desplaz\u00e1ndose en un coche de alquiler y haciendo estancia en casas privadas de alquiler, antes de regresar a Escocia desde Mil\u00e1n el d\u00eda -2. No ten\u00eda constancia de ning\u00fan contacto con casos de COVID-19. El d\u00eda 0 comenz\u00f3 a tener fiebre, mialgia, malestar general y sinusitis. El d\u00eda +1 estos s\u00edntomas evolucionaron a tos productiva con expectoraci\u00f3n verde. La fiebre hab\u00eda desaparecido el d\u00eda +2. El paciente permaneci\u00f3 autoconfinado en su vecindario esperando los resultados de la PCR de SARS-CoV-2, que se realiz\u00f3 en el West of Scotland Specialist Virology Centre a partir de un frotis nasofar\u00edngeo. La muestra dio positivo para SARS-CoV-2 el d\u00eda +3, con ciclo liminar (Ct) de 36. Se celebr\u00f3 una teleconferencia urgente con los servicios de virolog\u00eda, salud p\u00fablica, ambulancias de Escocia y la unidad receptora regional de enfermedades infecciosas de gran relevancia (HCID, High Consequence Infectious Diseases). El paciente fue trasladado a la unidad HCID mediante una ambulancia de operaciones especializadas (SORT, Special Operations Response Team). Se llev\u00f3 al paciente de la ambulancia a una sala de flujo laminar (con antec\u00e1mara) en la primera planta de la unidad, acompa\u00f1ado de personal m\u00e9dico con equipos adecuados de protecci\u00f3n individual (EPI). El paciente llev\u00f3 una mascarilla quir\u00fargica durante todo el traslado. El personal de ambulancia regres\u00f3 a su sede para quitarse los EPI. El paciente gozaba de buena salud y hac\u00eda ejercicio con regularidad. Nunca hab\u00eda sido fumador. Sus antecedentes m\u00e9dicos eran de hipertensi\u00f3n. No ten\u00eda ninguna neumopat\u00eda preexistente. Tomaba un inhibidor de la ECA y se automedic\u00f3 con paracetamol y antinflamatorios no esteroideos durante su afecci\u00f3n. Al ingreso, el paciente estaba afebril, con una tos leve no productiva. No not\u00f3 ning\u00fan l\u00edmite de tolerancia al ejercicio durante su afecci\u00f3n aguda y sigui\u00f3 practicando ejercicio en el hogar durante su autoconfinamiento. Los campos pulmonares eran claros a la auscultaci\u00f3n y se apreci\u00f3 congesti\u00f3n conjuntival. Las constantes vitales al ingreso eran: pulso de 79 l.p.m., presi\u00f3n arterial de 171/105 mmHg, frecuencia respiratoria de 18 r.p.m., pulsioximetr\u00eda de 96% en aire ambiental y temperatura de 36,5 \u00baC. El d\u00eda tres del ingreso el paciente mostr\u00f3 linfocitopenia, manifestaci\u00f3n que se ha hallado en el 80,4% de pacientes con COVID-19 no grave confirmada anal\u00edticamente en China. La radiograf\u00eda tor\u00e1cica no estaba cl\u00ednicamente indicada. Las pruebas mediante PCR de otros virus respiratorios a partir de frotis far\u00edngeos, Mycoplasma pneumoniae y Chlamydia pneumoniae, fueron negativas. Se obten\u00edan diariamente muestras nasofar\u00edngeas para las PCR de SARS-CoV-2, con el objetivo de hacer un seguimiento de la carga v\u00edrica. Los resultados de PCR para SARS-CoV-2 en orina, heces y sangre EDTA fueron negativos. El paciente estuvo cl\u00ednicamente estable durante toda la hospitalizaci\u00f3n y no se necesit\u00f3 tratamiento sintom\u00e1tico. Fue dado de alta despu\u00e9s de 8 d\u00edas, tras dos frotis nasofar\u00edngeos consecutivos negativos para SARS-CoV-2, analizados mediante PCR. La muestra v\u00edrica inicial fue secuenciada por el Centro de Investigaci\u00f3n V\u00edrica de la Universidad de Glasgow-Medical Research Council y se compar\u00f3 con el genoma de referencia Wuhan-Hu-1 y con un conjunto de secuencias globales de SARS-CoV-2; los resultados del an\u00e1lisis est\u00e1n disponibles en acceso libre. Los an\u00e1lisis filogen\u00e9ticos demostraron que Scotland/CVR01/2020 forma parte de un subtipo de cepas aisladas contra\u00eddas todas en el norte de Italia."
    },
    {
        "file_name": "2020.03.300.en.txt",
        "en": "A 42-year-old male recently diagnosed with metastatic sarcomatoid clear cell renal cell carcinoma, had been hospitalized for fever, symptomatic bone metastases pain management and first-line systemic treatment decisions. The patient had no other significant medical history. He presented initially with isolated fever of 39.0C on March 12th, 2020 for which he received ceftriaxone outside our center. On Day 6, he developed mild cough and fever (38.3C) prompting SARS-Cov-2 real time polymerase chain reaction test, which was positive. The patient was admitted to the Covid-19 ward of our hospital and closely monitored. Chest computerized tomography (CT) scan revealed bilateral patchy ground glass opacities related to Covid-19 (Figure 1). Antiviral therapy lopinavir-ritonavir use (400mg-100mg orally) was begun at D7 and maintained for 5 days, according to local guidelines. On day 8, sudden dyspnea and saturation drop required oxygen supplementation increase to 6 l/min, without the need for artificial ventilation. He received two doses of tocilizumab, at 8 mg/kg intravenously for each dose, 8 hours apart, with a good tolerability. Thereafter, he experienced clinical improvement, rapidly afebrile and with gradually decreased oxygen consumption. This was fully discontinued on day 12 (Figure 1). Chest CT on day 12 confirmed improvement by showing partial regression of the pulmonary infiltrates and ground glass appearance (Figure 1). Creactive protein in blood, a surrogate marker of cytokine storm, decreased from 225 mg/L to 33 mg/L in 4 days (Figure 1). No major change was observed in circulating lymphocytic subpopulations after tocilizumab, and the percentage of CD4 + CD25 + lymphocytes was found high, before and after tocilizumab. The Patient ultimately clinically fully recovered from Covid-19 symptoms.",
        "es": "Se hospitaliz\u00f3 un hombre de 42 a\u00f1os, al que se le hab\u00eda diagnosticado recientemente un carcinoma renal sarcomatoide de c\u00e9lulas claras metast\u00e1sico, con fiebre, manejo del dolor por met\u00e1stasis \u00f3seas sintom\u00e1ticas y para decisiones de tratamiento sist\u00e9mico de primera l\u00ednea. El paciente no ten\u00eda otros antecedentes. Inicialmente present\u00f3 fiebre de 39,0 \u00b0C el 12 de marzo de 2020, para la cual recibi\u00f3 ceftriaxona fuera de nuestro centro. El d\u00eda 6, present\u00f3 tos leve y fiebre (38,3\u00b0C), lo que llev\u00f3 a realizar una prueba de PCR en tiempo real para SARS-CoV-2; el resultado fue positivo. El paciente fue ingresado en la sala de COVID-19 de nuestro hospital y se monitoriz\u00f3 estrechamente. La TAC tor\u00e1cica mostr\u00f3 opacidades de vidrio esmerilado bilaterales parcheadas, asociadas al COVID-19 (figura 1). El D7 se le empez\u00f3 a administrar terapia antiv\u00edrica con lopinavir y ritonavir (400mg/100mg por v\u00eda oral), que se mantuvo durante 5 d\u00edas, seg\u00fan las directrices locales. El d\u00eda 8, una disnea s\u00fabita y una ca\u00edda de la saturaci\u00f3n obligaron a aumentar el ox\u00edgeno a 6 l/min, sin necesidad de ventilaci\u00f3n mec\u00e1nica. Se le administraron dos dosis de tocilizumab, con 8 mg/kg i.v. en cada dosis, separadas 8 horas, con buena tolerancia. Despu\u00e9s mostr\u00f3 una mejora cl\u00ednica, pasando a afebril r\u00e1pidamente y con un consumo de ox\u00edgeno decreciente, que fue retirado por completo el d\u00eda 12. Una TAC tor\u00e1cica del d\u00eda 12 confirm\u00f3 la mejora mostrando regresi\u00f3n parcial de los infiltrados pulmonares y de las opacidades de vidrio esmerilado. La prote\u00edna C-reactiva, un marcador indirecto de liberaci\u00f3n de citocinas, disminuy\u00f3 de 225 mg/L a 33 mg/L en 4 d\u00edas (figura 1). Tras la administraci\u00f3n de tocilizumab no se observaron cambios relevantes en las subpoblaciones linfoc\u00edticas circulantes y el porcentaje de CD4 + CD25 + linfocitos era alto, antes y despu\u00e9s del tocilizumab. Finalmente, el paciente se recuper\u00f3 totalmente de los s\u00edntomas de la COVID-19."
    },
    {
        "file_name": "32073161.en.txt",
        "en": "A 47\u2010year\u2010old man came to the People's Hospital in Wuwei with a 7\u2010day history of unexplained fever, cough and bosom frowsty on 21 January 2020. The patient had a chief complaint that he had a fever (up to a maximum of 39.3\u00b0C), cough productive of white phlegm, stuffy and runny noses, vertigo, fatigue, chest tightness, and nausea, while he had no chest pain, sore throat or breathing problems. He disclosed that he had returned to Wuwei city on January 18 from Wuhan city by car. The patient with a history of hypertension grade 2 and type 2 diabetes has been smoking since he was 27 years old and reported no alcohol abuse. Nasopharyngeal swab specimens were collected on January 23, 29, and 30 according to the CDC guidelines. After putting nasopharynx swab into the nasal cavity, twist it on the nasopharynx mucosa, keep it for 10 to 15\u2009seconds, and then remove it, and finally, insert it into a sterile tube containing viral transport medium. The specimens were examined by RT\u2010PCR. Three gene targets including RdRP, E and N genes were detected. The positive expression (CT value \u2264\u200943) of the three genes, or RdRP and E genes, or RdRP and N genes indicates SARS\u2010CoV\u20102 is positive. Other examinations were also performed as well. The study was approved by the Ethics Review Committee of the First Affiliated Hospital of Wanan Medical College, and adhered to the tenets of the Declaration of Helsinki. Written informed consent was obtained from the patient for using clinical records in this study. Based on his primary laboratory report, chest radiograph, clinical and epidemiologic information, the patient received the treatment of interferon\u2010alpha and methylprednisolone. However, he was transferred to the First Affiliated Hospital of Wannan Medical College, Wuhu, China on January 23, because of acute exacerbation of clinical symptoms including expiratory dyspnea, poor diet, and lethargy. The laboratory tests were shown in Table 1 (day 0). The results indicated the patient with stable vital signs, significantly decreased lymphocytes and increased c\u2010reactive protein but slightly elevated fibrinogen, neutrophil, lactic dehydrogenase, and fibrinogen. A computed tomography (CT) lung imaging was reported as showing the multiple patchy high\u2010density shadows scattered mainly in the border regions of lungs which were solid changes in which the air bronchogram sign was seen or ground\u2010glass opacifications changes, as well as slightly thickened pleura (Figure S1a). Combination therapy was initiated with lopinavir and ritonavir tablets (800/200\u2009mg daily), methylprednisolone (40\u2009mg daily), recombinant human interferon alfa\u20102b (10 million IU daily), ambroxol hydrochloride (60\u2009mg daily) and moxifloxacin hydrochloride (0.4\u2009g daily), to inhibit the virus replication, relieve asthma, resolve phlegm, and implement the empirical antibiotic treatment. In addition, the high flow humidification oxygen inhalation therapy was used for preventing acute hypoxic respiratory failure. The treatment of blood glucose, blood pressure, and rehydration therapy was performed. On the second day of treatment, the patient's temperature had low\u2010grade intermittent fevers (range from 36.0\u00b0C to 37.2\u00b0C). With the exception of occasional chest tightness and shortness of breath, the other symptoms including cough productive of white phlegm, stuffy and runny noses, vertigo, and fatigue were improved. On day 3 of treatment, methylprednisolone was reduced to 20\u2009mg daily and withdraw on day 5. In addition, the high flow humidification oxygen inhalation therapy was removed until the 8th day of treatment, based on the markedly improved respiratory function. According to the persistent negative results of SARS\u2010CoV\u20102 on days 6 and 7, as well as the lung lesions partially absorbed (Figure S1b), the patient was discharged on day 10. During treatment, the patient's body temperature, pulse, and respiratory rate had slight fluctuation (Figure S1c), and the laboratory results got better improvement, especially lymphocyte count.",
        "es": "El 21 de enero de 2020, ingres\u00f3 en el Hospital Popular de Wuwei un hombre de 47 a\u00f1os con fiebre sin foco y tos de 7 d\u00edas de evoluci\u00f3n. El paciente refiri\u00f3 que hab\u00eda tenido fiebre (hasta un m\u00e1ximo de 39,3 \u00b0C), tos productiva con esputo blanco, congesti\u00f3n nasal, rinorrea, mareo, fatiga, opresi\u00f3n tor\u00e1cica y n\u00e1useas, pero sin dolor tor\u00e1cico, irritaci\u00f3n de garganta ni problemas respiratorios. Inform\u00f3 que hab\u00eda llegado a la ciudad de Wuwei en coche el 18 de enero, procedente de Wuhan. El paciente ten\u00eda antecedentes de hipertensi\u00f3n de grado 2 y diabetes de tipo 2 y era fumador desde los 27 a\u00f1os; no refiri\u00f3 antecedentes de alcoholismo. El 23, 29 y 30 de enero se tomaron frotis nasofar\u00edngeos, de acuerdo con las directrices del CDC. Tras introducir un frotis nasofar\u00edngeo en las fosas nasales, se gira sobre la mucosa nasofar\u00edngea, de 10 a 15 segundos y, luego, se retira; finalmente se inserta en un tubo est\u00e9ril con un medio de transporte v\u00edrico. Las muestras se analizaron mediante RT-PCR. Se detectaron tres genes objetivo: RdRP, E y N. La expresi\u00f3n positiva (valor CT \u2264\u200943) de los tres genes, de los genes RdRP y E o de los genes RdRP y N identifica el SARS-CoV-2 de modo concluyente. Tambi\u00e9n se realizaron otras pruebas. El estudio fue autorizado por el comit\u00e9 de \u00e9tica del Primer Hospital Asociado de la facultad de medicina de Wanan, observando los principios de la Declaraci\u00f3n de Helsinki. Se obtuvo el consentimiento informado del paciente para usar su historia cl\u00ednica en este estudio. A partir de las pruebas anal\u00edticas, radiograf\u00eda tor\u00e1cica y la informaci\u00f3n cl\u00ednica y epidemiol\u00f3gica, se trat\u00f3 al paciente con interfer\u00f3n \u03b1 y metilprednisolona. No obstante, a causa del agravamiento s\u00fabito de los s\u00edntomas cl\u00ednicos, como disnea espiratoria, deficiencia alimentaria y letargia, el 23 de enero se transfiri\u00f3 el paciente al Primer Hospital Asociado de la facultad de medicina de Wanan (Wuhu, China). Las pruebas anal\u00edticas se muestran en la tabla 1 (d\u00eda 0). Los resultados indicaron que el paciente ten\u00eda constantes vitales estables, valores reducidos de linfocitos, valores altos de prote\u00edna C-reactiva y valores moderadamente altos de fibrin\u00f3geno, neutr\u00f3filos y deshidrogenasa l\u00e1ctica. Una TAC pulmonar mostr\u00f3 varias sombras dispersas de alta densidad repartidas principalmente en los m\u00e1rgenes de los pulmones, cambios consistentes con la observaci\u00f3n de broncograma o de cambios de opacidad en vidrio esmerilado, adem\u00e1s de un ligero engrosamiento pleural. Se inici\u00f3 politerapia con comprimidos de lopinavir y ritonavir (800/200 mg por d\u00eda), metilprednisolona (40 mg por d\u00eda), interfer\u00f3n humano recombinante \u03b1-2b (10 millones IU por d\u00eda), clorhidrato de ambroxol (60 mg por d\u00eda) y clorhidrato de moxifloxacino (0,4 g por d\u00eda) para inhibir la proliferaci\u00f3n del virus, aliviar el asma, eliminar la flema y aplicar el tratamiento antibi\u00f3tico emp\u00edrico. Adem\u00e1s, se us\u00f3 terapia de inhalaci\u00f3n de ox\u00edgeno de alto flujo con humidificaci\u00f3n para evitar la insuficiencia respiratoria aguda. Tambi\u00e9n se aplic\u00f3 tratamiento para el control de la glucemia y presi\u00f3n arterial y terapia de rehidrataci\u00f3n. El segundo d\u00eda de tratamiento, el paciente present\u00f3 febr\u00edcula intermitente (intervalo entre 36,0 \u00b0C y 37,2 \u00b0C). Con la excepci\u00f3n de una ocasional opresi\u00f3n tor\u00e1cica y disnea, se observ\u00f3 una mejora de los otros s\u00edntomas, como tos productiva con esputo blanco, congesti\u00f3n nasal, rinorrea, mareo y fatiga. El tercer d\u00eda de tratamiento se redujo la metilprednisolona a 20 mg por d\u00eda y el quinto d\u00eda se retir\u00f3 por completo. Adem\u00e1s, el octavo d\u00eda de tratamiento, se retir\u00f3 la oxigenoterapia, gracias a la clara mejora de la capacidad respiratoria. A partir de los resultados negativos persistentes de SARS-CoV-2 los d\u00edas 6 y 7, as\u00ed como la eliminaci\u00f3n parcial de las lesiones pulmonares (figura S1b), el paciente fue dado de alta el d\u00eda 10. Durante el tratamiento, la temperatura, el pulso y la frecuencia respiratoria del paciente presentaron fluctuaciones leves (figura S1c) y las pruebas anal\u00edticas mostraron una mejora, sobre todo en la cifra de linfocitos."
    },
    {
        "file_name": "32161941.en.txt",
        "en": "The mother of the neonatal patient is a 34-year-old pregnant woman who lives near the Huanan Seafood Wholesale Market (about 1.2 km walking distance) in Wuhan. She has not been to the market during pregnancy and her family has no confirmed or suspected cases of COVID-19, but > 15 people had been diagnosed in the same community she lives in. She had a history of hypothyroidism for 4 years and has been treated with oral drugs, with no history of hypertension, diabetes, or heart disease. She had a termination of pregnancy in 2016 due to chromosomal abnormalities. She is allergic to penicillin and first-generation cephalosporins (positive in skin test). At 8:00 pm on 1 February 2020, the pregnant woman (at 40 weeks\u2019 gestation) developed a small amount of vaginal bleeding and lower abdominal pain. Two hours later, she developed a fever (37.8\u00b0C) and presented to the Wuhan women and children\u2019s medical care center for medical advice. As she was febrile, she was referred to the fever clinic of Wuhan Tongji Hospital the next morning. Thoracic computed tomography (CT) scan showed ground-glass opacities in the left upper and lower lobes, indicating the possibility of viral pneumonia. Chest computed tomography of the mother, obtained on 2 February 2020, showing signs of infection in the left upper and lower lobe, indicating the possibility of viral pneumonia, with limited emphysema in the right lower lobe and a little cord focus in the right middle lobe. Blood tests revealed lymphopenia (0.97 \u00d7 109 cells/L [normal, 1.1\u20133.2 \u00d7 109 cells/L]), neutrophilia (9.97 \u00d7 109 cells/L [normal, 1.8\u20136.3 \u00d7 109 cells/L]), and elevated high-sensitivity C-reactive protein level (11.5 mg/L [normal, < 1 mg/L]). On admission, her body temperature was 37.8\u00b0C and her blood pressure was 131/89 mm Hg, with a respiratory rate of 20 breaths per minute and heart rate of 96 beats per minute. She had no cough or sputum. Fetal heart rate was 136 bpm and fetal heart monitoring showed no abnormality. Emergency cesarean delivery was performed. At 8:45 am, she delivered a baby boy weighing 3205 g. Apgar scores at 1 and 5 minutes were 8 and 9, respectively. The infant had no moaning or spitting after birth. The skin was ruddy and the crying was loud. The mother had been wearing an N95 mask throughout the operation, and the baby had no contact with the mother after birth. The infant was transferred to the neonatology department 10 minutes after birth for close observation and the mother was transferred to the fever ward for isolation after surgery. Half an hour after birth, the infant vomited once after feeding with formula, which we considered to be swallowing syndrome. After gastric lavage, the infant could be fed normally. Blood tests of the neonate revealed lymphopenia (2.43 \u00d7 109 cells/L [normal, 3\u20138 \u00d7 109 cells/L]), deranged liver function tests (aspartate aminotransferase 143 U/L [normal, \u2264\u200941 U/L]; total bilirubin 33.0 \u03bcmol/L [normal, \u226426 \u03bcmol/L]; indirect bilirubin 26.0 \u03bcmol/L [normal, \u2264\u200916.8 \u03bcmol/L]) and elevated creatine kinase level (479 U/L [normal, \u2264\u200941 U/L]). Intravenous penicillin G (150 000 U once daily, intravenous bolus) and vitamin K1 (1 mg once daily, intravenously) were given as antibiotic prophylaxis and to prevent coagulopathy, respectively. The mother was well and afebrile during the immediate postoperative period. She had no cough or any other discomfort such as diarrhea, nausea, or vomiting. Her vital signs were stable with blood oxygen saturation of 99%. Antiviral treatment, including 40 \u03bcg of recombinant human interferon \u03b11b atomized inhalation with 2 mL of sterilization injection water twice daily and ganciclovir (0.25 g every 12 hours, intravenously), was administered. Abipenem (0.3 g every 12 hours, intravenously) and moxifloxacin (0.4 g once daily, intravenously) were used for anti-infection. The mother had intermittent fever on the first postoperative day with the highest temperature up to 38.3\u00b0C. She was given methylprednisolone (20 mg intravenously). Her pharyngeal swab sampled for SARS-CoV-2 reported back as positive later that day. A pharyngeal swab specimen was collected immediately from the infant (36 hours after birth), along with the breast milk of the mother. We recommended the mother not to breastfeed and to empty the breast milk to avoid mastitis. The mental response of the newborn was acceptable the first day after birth and his blood oxygen saturation stayed > 92% without supplemental oxygen. The laboratory results of the infant returned negative including Legionella pneumophila, Chlamydia pneumoniae, Mycoplasma pneumoniae, Q fever (Rickettsia), adenovirus, respiratory syncytial virus, influenza A virus, influenza B virus, and parainfluenza virus 1\u20133. n 4 February, the second day after the surgery, the mother\u2019s vitals were stable and she was given methylprednisolone (40 mg once daily, intravenously). The neonate was well and his blood gas analysis showed pH 7.476\u2191, partial pressure of carbon dioxide 28.2 mm Hg\u2193, partial pressure of oxygen 116.0 mm Hg\u2191, bicarbonate 20.6 mmol/L\u2193, base excess 1.30 mmol/L, and peripheral oxygen saturation 98.4%. A complete set of pediatric virus results of the infant reported back as negative, including cytomegalovirus, rubella virus, Toxoplasma gondii, herpes simplex virus types 1 and 2, echovirus, parvovirus B19, Epstein-Barr virus, coxsackievirus A16, coxsackievirus B, measles virus, varicella zoster virus. The neonatal chest radiograph showed thickened lung texture with no abnormalities in heart and palate. Chest radiograph of the newborn, obtained on 4 February 2020, showing thickened lung texture with no abnormalities in the heart and palate. The infant was given formula 25 mL every 3 hours and closely monitored. On 5 February, the newborn\u2019s vital signs were stable with the blood oxygen saturation maintained > 90%, with no discomfort such as apnea or vomiting. The result of pharyngeal swab for SARS-CoV-2 was positive at 36 hours after birth. Combining all of the laboratory results with full discussion, we made a diagnosis that the infant was confirmed with SARS-CoV-2 infection. Since the neonatal department of Tongji Hospital did not have the isolation conditions for the diagnosed newborn, he was transferred to Wuhan Children\u2019s Hospital for further isolation later that day. After finding evidence of neonatal infection, we performed nucleic acid tests for SARS-CoV-2 on cord blood and placental specimens that we retained during the operation, and the results were negative. The mother\u2019s breast milk sample was negative for SARS-CoV-2 as well. We followed up the newborn\u2019s condition after he was transferred to Wuhan Children\u2019s Hospital. He was well and afebrile with no cough or vomiting. He was closely monitored in isolation and no special treatment was given. Chest CT on 6 February showed high-density nodular shadow under the pleura of the posterior segment of the upper lobe of the right lung. Chest CT on 12 February showed that the upper lobe and lower lobe of the right lung were scattered with small pieces of patchy shadow. Chest CT on 17 February showed a few small pieces of patchy shadow in the upper lobe of the right lung, which were absorbed compared with the previous ones. On 17 February 2020, the nucleic acid tests of the pharyngeal and anal swabs for SARS-CoV-2 were negative. The newborn was discharged on 18 February 2020.",
        "es": "La madre del paciente neonatal es una mujer embarazada de 34 a\u00f1os que vive cerca del mercado mayorista de marisco de Huanan (a unos 1,2 km de distancia), en Wuhan. No ha visitado el mercado durante su embarazo y su familia no tiene casos confirmados ni presuntos de COVID-19, pero en la misma comunidad en la que vive se han diagnosticado m\u00e1s de 15 personas. Tiene antecedentes de hipotiroidismo de 4 a\u00f1os de evoluci\u00f3n y se ha tratado con f\u00e1rmacos por v\u00eda oral; no tiene antecedentes de hipertensi\u00f3n, diabetes ni cardiopat\u00edas. Tuvo un aborto en 2016 a causa de alteraciones cromos\u00f3micas. Es al\u00e9rgica a la penicilina y a las cefalosporinas de primera generaci\u00f3n (positivo en pruebas cut\u00e1neas). A las 20:00 h del 1 de febrero de 2020, la mujer, de 40 semanas de gestaci\u00f3n, present\u00f3 una peque\u00f1a hemorragia vaginal y dolor en la regi\u00f3n abdominal inferior. Dos horas despu\u00e9s, present\u00f3 fiebre (37,8 \u00b0C) y acudi\u00f3 al centro de asistencia maternoinfantil de Wuhan. Como ten\u00eda fiebre, fue derivada al consultorio de enfermedades infecciosas del hospital Tongji de Wuhan a la ma\u00f1ana siguiente. Una TAC tor\u00e1cica mostr\u00f3 opacidades de vidrio esmerilado en los l\u00f3bulos superior e inferior izquierdos, lo que indicaba la posibilidad de neumon\u00eda v\u00edrica. TAC tor\u00e1cica de la madre, obtenida el 2 de febrero de 2020, que muestra signos de infecci\u00f3n en los l\u00f3bulos inferior y superior izquierdos e indica la posibilidad de neumon\u00eda v\u00edrica, con enfisema reducido en el l\u00f3bulo inferior derecho y una peque\u00f1a afectaci\u00f3n en el l\u00f3bulo medio derecho. Los an\u00e1lisis de sangre mostraron linfocitopenia (0,97 \u00d7 109 c\u00e9lulas/L [normal: 1,1\u20133,2 \u00d7 109 c\u00e9lulas/L]), neutrofilia (9,97 \u00d7 109 c\u00e9lulas/L [normal: 1,8\u20136,3 \u00d7 109 c\u00e9lulas/L]) y concentraciones altas de prote\u00edna C-reactiva (11,5 mg/L [normal: < 1 mg/L]). Se decidi\u00f3 hospitalizarla por presunta neumon\u00eda v\u00edrica. Al ingreso, su temperatura era de 37,8 \u00b0C, la presi\u00f3n arterial de 131/89 mmHg, la frecuencia respiratoria de 20 r.p.m. No presentaba tos ni expectoraci\u00f3n. El pulso fetal era de 136 l.p.m. y su registro no mostr\u00f3 anomal\u00edas. Se realiz\u00f3 una ces\u00e1rea de urgencia. Intraoperatoriamente se observ\u00f3 l\u00edquido amni\u00f3tico con meconio. A las 8:45 la paciente dio a luz un ni\u00f1o con un peso de 3025 g. Los \u00edndices de Apgar a 1 y 5 minutos fueron de 8 y 9, respectivamente. El ni\u00f1o no regurgit\u00f3 tras el parto. La piel era rojiza y el lloro, alto. La madre llev\u00f3 una mascarilla N95 durante la intervenci\u00f3n y, tras el alumbramiento, el ni\u00f1o no tuvo contacto con la madre. El ni\u00f1o se transfiri\u00f3 a la planta de neonatolog\u00eda 10 minutos despu\u00e9s del parto para estrecha vigilancia; la madre se transfiri\u00f3 a la planta de enfermedades infecciosas para su aislamiento tras la intervenci\u00f3n. Media hora despu\u00e9s del parto, el ni\u00f1o vomit\u00f3 una vez tras ser alimentado con leche artificial, y se consider\u00f3 que ten\u00eda disfagia. Tras un lavado g\u00e1strico, el ni\u00f1o pudo ser alimentado sin complicaciones. Los an\u00e1lisis de sangre del reci\u00e9n nacido mostraron linfocitopenia (2,43 \u00d7 109 c\u00e9lulas/L [normal: 3\u20138 \u00d7 109 c\u00e9lulas/L]), pruebas funcionales hep\u00e1ticas alteradas (aspartato-aminotransferasa 143 U/L [normal: \u2264\u2009 41 U/L]; bilirrubina total 33,0 \u03bcmol/L [normal: \u2264 26 \u03bcmol/L]; bilirrubina indirecta 26,0 \u03bcmol/L [normal: \u2264\u200916,8 \u03bcmol/L]) y alta concentraci\u00f3n de creatina-cinasa (479 U/L [normal: \u2264\u2009 41 U/L]). Se administr\u00f3 penicilina G (150.000 U una vez por d\u00eda, bolo intravenoso) y vitamina K1 (1 mg una vez por d\u00eda, i.v.) como profilaxis antibi\u00f3tica y para evitar coagulopat\u00edas, respectivamente. La madre permaneci\u00f3 en buen estado y afebril durante el periodo posoperatorio inmediato. No present\u00f3 tos ni ninguna otra molestia, como diarrea, n\u00e1useas o v\u00f3mitos. Sus constantes vitales fueron estables, con una saturaci\u00f3n de ox\u00edgeno del 99%. Se le administr\u00f3 un tratamiento antiv\u00edrico, con 40 \u03bcg de interfer\u00f3n \u03b11b humano recombinante atomizado por v\u00eda inhalatoria con 2 mL de soluci\u00f3n de esterilizaci\u00f3n dos veces por d\u00eda y ganciclovir (0,25 g cada 12 horas, i.v.). Tambi\u00e9n se le administr\u00f3 abipenem (0,3 g cada 12 horas, i.v.) y moxifloxacina (0,4 g una vez por d\u00eda, i.v.) La madre tuvo fiebre intermitente durante el primer d\u00eda del posoperatorio, llegando a 38,3 \u00b0C; se le administr\u00f3 metilprednisolona (20 mg i.v.). Su frotis far\u00edngeo para detecci\u00f3n del SARS-CoV-2 result\u00f3 positivo ese mismo d\u00eda. Inmediatamente, se obtuvo un frotis far\u00edngeo del reci\u00e9n nacido (36 horas tras el parto) junto con leche de la madre. Recomendamos a la madre no amamantar al ni\u00f1o y extraerse leche para evitar mastitis. La respuesta neurol\u00f3gica del reci\u00e9n nacido result\u00f3 aceptable durante el primer d\u00eda despu\u00e9s del parto y su saturaci\u00f3n de ox\u00edgeno se mantuvo > 92% sin oxigenoterapia. Las pruebas anal\u00edticas del ni\u00f1o fueron negativas para Legionella pneumophila, Chlamydia pneumoniae, Mycoplasma pneumoniae, Rickettsia, adenovirus, virus respiratorio sincicial, virus de la gripe A virus de la gripe B y virus paragripal 1\u20133. El 4 de febrero, el segundo d\u00eda posoperatorio, las constantes vitales de la madre eran estables y se le administr\u00f3 prednisolona (40 mg una vez por d\u00eda i.v.). El reci\u00e9n nacido se mantuvo sano y su gasometr\u00eda mostr\u00f3 pH de 7,476\u2191, presi\u00f3n parcial de di\u00f3xido de carbono de 28,2 mm Hg\u2193, presi\u00f3n parcial de ox\u00edgeno de 116,0 mm Hg\u2191, bicarbonato de 20,6 mmol/L\u2193, exceso de base de 1,30 mmol/L y saturaci\u00f3n de ox\u00edgeno perif\u00e9rico de 98,4%. Las pruebas para un conjunto de virus pedi\u00e1tricos resultaron negativas para citomegalovirus, virus de la rub\u00e9ola, Toxoplasma gondii, virus del herpes com\u00fan tipos 1 y 2, ecovirus, parvovirus B19, virus de Epstein-Barr, virus de Coxsackie A16, virus de Coxsackie B, virus del sarampi\u00f3n y virus de la varicela z\u00f3ster. La TAC tor\u00e1cica del reci\u00e9n nacido mostr\u00f3 un engrosamiento de la textura de los pulmones sin anormalidades card\u00edacas. TAC tor\u00e1cica del reci\u00e9n nacido, obtenida el 4 de febrero de 2020, que muestra un engrosamiento de la textura de los pulmones sin anormalidades card\u00edacas. Se aliment\u00f3 al ni\u00f1o con leche artificial, 25 mL cada 3 horas, y se supervis\u00f3 estrechamente. El 5 de febrero, las constantes vitales del reci\u00e9n nacido eran estables, con una saturaci\u00f3n de ox\u00edgeno por encima del 90% y sin molestias como apnea o v\u00f3mitos. El resultado del frotis far\u00edngeo para detecci\u00f3n del SARS-CoV-2 fue positivo a las 36 horas despu\u00e9s del parto. Combinando todas las pruebas anal\u00edticas y un intercambio exhaustivo de ideas, diagnosticamos que el ni\u00f1o presentaba infecci\u00f3n por SARS-CoV-2. Como el departamento neonatal del Hospital Tingji no dispone de las condiciones de aislamiento para el reci\u00e9n nacido, se transfiri\u00f3 al Hospital Maternoinfantil de Wuhan ese mismo d\u00eda, para un mejor aislamiento. Tras hallar las pruebas de la infecci\u00f3n neonatal, efectuamos pruebas de \u00e1cido nucleico del SARS-CoV-2 en la sangre del cord\u00f3n umbilical y muestras de la placenta que hab\u00edamos conservado durante la intervenci\u00f3n; los resultados fueron negativos. La muestra de la leche materna tambi\u00e9n fue negativa para SARS-CoV-2. Hicimos un seguimiento del estado del reci\u00e9n nacido despu\u00e9s de ser transferido al Hospital Maternoinfantil de Wuhan. Su estado era bueno y afebril, sin tos ni v\u00f3mitos. Fue supervisado estrechamente en condiciones de aislamiento y no se le administr\u00f3 ning\u00fan tratamiento especial. Una TAC tor\u00e1cica el 6 de febrero mostr\u00f3 sombras nodulares de alta densidad bajo la pleura del segmento posterior del l\u00f3bulo superior del pulm\u00f3n derecho. En una TAC tor\u00e1cica del 12 de febrero se observaron peque\u00f1os n\u00facleos de sombras parcheadas en los l\u00f3bulos inferior y superior del pulm\u00f3n derecho. En una TAC tor\u00e1cica del 17 de febrero se observaron unos pocos y peque\u00f1os n\u00facleos de sombras parcheadas en los l\u00f3bulos inferior y superior del pulm\u00f3n derecho, absorbidas en comparaci\u00f3n con las anteriores. El 17 de febrero de 2020, las pruebas de \u00e1cido nucleico de frotis far\u00edngeos y anales para detecci\u00f3n del SARS-CoV-2 resultaron negativas. El reci\u00e9n nacido fue dado de alta el 18 de febrero de 2020."
    },
    {
        "file_name": "32201125.en.txt",
        "en": "A previously healthy 64-year-old female was admitted to our hospital with a two-day history of high fever, fatigue, and dry cough. She had a history of recent travel from Wuhan, China, the center of an outbreak of 2019 novel coronavirus (2019-nCoV), to Shanghai one day before admission. On physical examination, she was febrile and tachypneic. Coarse breath sounds in both lungs were heard during inspiration and expiration. Laboratory data showed a white blood cell (WBC) count of 4.6\u202f\u00d7\u202f109/L with 87.4% neutrophils and 10.0% lymphocytes. Inflammatory marker levels were elevated with erythrocyte sedimentation rate (ESR) of 67\u202fmm/h and C-reactive protein (CRP) of 57.7\u202fmg/L. A computed tomography (CT) scan of the chest showed multiple ground-glass opacities in both lungs. Real-time reverse transcription polymerase chain reaction assay of the material collected form patient\u2019s throat was positive for the 2019-nCoV nucleic acid. Subsequently, the patient was transferred to Shanghai public health clinical center (SHPHCC), the designated hospital, for further treatment. She had a satisfactory response to the medical treatment and was discharged upon recovery two weeks after the onset of illness.",
        "es": "Una mujer de 64 a\u00f1os, por lo dem\u00e1s sana, fue ingresada en nuestro hospital con hipertermia, cansancio y tos seca con una evoluci\u00f3n de dos d\u00edas. La paciente inform\u00f3 que hab\u00eda viajado recientemente a Wuhan, el foco del brote del nuevo coronavirus de 2019 (2019-nCoV), a Shangh\u00e1i un d\u00eda antes del ingreso. A la exploraci\u00f3n f\u00edsica, se observ\u00f3 fiebre y taquipnea. Se auscultaron estertores gruesos durante la inspiraci\u00f3n y la espiraci\u00f3n. Las pruebas anal\u00edticas mostraron una f\u00f3rmula leucocitaria de 4,6 \u00d7 109/L con 87,4% de neutr\u00f3filos y 10,0% de linfocitos. Los valores de marcadores de inflamaci\u00f3n eran altos, con una velocidad de sedimentaci\u00f3n globular (VSG) de 67 mm/h y una prote\u00edna C-reactiva de 57,7 mg/L. Una TAC tor\u00e1cica mostr\u00f3 m\u00faltiples opacidades de vidrio esmerilado en ambos pulmones. La RT-PCR en tiempo real de un frotis far\u00edngeo de la paciente result\u00f3 positiva para \u00e1cido nucleico del 2019-nCoV. Posteriormente, la paciente fue transferida al centro cl\u00ednico de salud p\u00fablica de Shangh\u00e1i para su tratamiento posterior. Mostr\u00f3 una respuesta satisfactoria al tratamiento m\u00e9dico y fue dada de alta dos semanas despu\u00e9s del inicio de la enfermedad."
    },
    {
        "file_name": "32208010.en.txt",
        "en": "A  59-year-old  woman  from  Wuhan  was  admitted  to  our  hospital  after  experiencing  4  days  of  recurrent  fever. Her  highest  body  temperature  was  38.8\u00b0C  before  admission,  and this was accompanied by headache, diz-ziness, nausea, and vomiting, without chills, cough, or muscle soreness. She had lived in Wuhan for many years and had a contact history of exposure to a patient infected with SARS-CoV-2. Our  patient  also  had  a  his-tory  of  chronic  gastritis. Before  admission,  the laboratory at the Guangzhou Centers for Disease  Control  and  Prevention  confirmed that  the  patient  was  infected  with  SARS-CoV-2 using the real-time reverse transcrip-tion\u2013polymerase   chain   reaction   test. The   initial  laboratory  examination  also  revealed  decreased  WBC  count  (3.06  \u00d7  109/L;  nor-mal range, 3.50\u20139.50 \u00d7 109/L) and decreased lymphocyte  count  (0.68  \u00d7  109/L;  normal  range, 1.10\u20133.20 \u00d7 109/L). Chest CT showed bilateral  ground-glass  opacities  that  were  considered   to   represent   viral   pneumonia. The  patient  was  diagnosed  with  COVID-19 pneumonia using both the history and laboratory examination. After admission, the patient had recurrent fever  with  a  high  temperature  of  38.6\u00b0C  ac-companied  by  chills,  cough  with  minimal  white  sputum,  nasal  congestion,  chest  distress,  and  shortness  of  breath  after  activ-ity. A laboratory test showed that C-reactive protein   (CRP)   level   elevated   gradually,   and  WBC  count  and  lymphocyte  count  de-creased. Initially, the patient received antivi-ral and antiinfective treatment. At 6 days after admission, the patient had marked shortness of breath, her blood oxygen saturation had dropped, and her oxygenation index was 169 (< 300). Chest CT showed mul-tiple bilateral subsegmental peripheral patchy and   ground-glass   opacities   with   obscure   boundaries  and  mainly  subpleural  distribu-tion. The  SARS-CoV-2  nucleic  acid test results were negative and CT showed diffuse consolidations in both lungs. Neither pleural  effusions  nor  enlarged  mediastinal  lymph  nodes  were  found. The  bilateral  lung  lesions  showed  obvious  progression  and  en-larged  scope. The  diagnosis  was  changed  to  severe COVID-19 pneumonia, and the patient was  transferred  to  the  ICU. Treatment  was  changed  to  high-frequency  ventilation  and  administration   of   human   immunoglobulin   and teicoplanin immediately. After 9\u201311 days, the patient\u2019s temperature went  back  to  normal,  but  the  patient  had  an  aggravated  cough  and  blood-tinged  sputum. However, the CRP level had decreased, WBC count and lymphocyte count increased gradu-ally, and moreover, the SARS-CoV-2 test was found to be negative. CT showed an enlarged lesion  with  increased  attenuation. Some  of  the  ground-glass  opacities  had  turned  into  consolidations. The patient\u2019s symp-toms  were  improving,  whereas  the  imaging  presentation  worsened. The  physician  sus-pected a delay in change in imaging. With  a  series  of  effective  treatments,  on  days  12,  17,  and  21  after  admission,  detec-tion of SARS-CoV-2 by nucleic acid test from throat swabs was negative. Chest CT showed obvious  absorption  of  the  lesions  and  a  sub-pleural line. The patient\u2019s symptoms improved, and the nucleic acid test was repeat-edly negative for SARS-CoV-2, so the patient was released from quarantine and discharged. In  this  case,  we  observed  on  chest  CT  the  dynamic  changes  of  severe  COVID-19  pneumonia. At  the  early  stage  of  disease,  CT showed multiple patchy or ground-glass opacities   with   subpleural   distribution   in multiple bilateral lobes, which are the char-acteristic  CT  findings  of  COVID-19  pneu-monia. As  pneumonia  progressed,  CT  showed that the areas of lesions in the lungs enlarged  and  developed  into  diffuse  con-solidations in both lungs within a few days. Even  when  SARS-CoV-2  nucleic  acid  test  results  become  negative  and  the  patient\u2019s  symptoms  abated,  there  was  a  delay  in  the  changes  on  CT  and  evidence  of  lesion  ab-sorption. During the absorption period, the patchy  lung  consolidations  gradually  ab-sorbed  and  shrank,  but  the  subpleural  line  was still present. A dynamic chest CT scan plays a very important role in the diagnosis and prognosis of SARS-CoV-2 infection.",
        "es": "Una mujer de 59 a\u00f1os de Wuhan ingres\u00f3 en nuestro hospital tras 4 d\u00edas de fiebre recurrente. Su m\u00e1xima temperatura hab\u00eda sido de 38,8 \u00b0C antes del ingreso, acompa\u00f1ada de cefalea, mareo, n\u00e1useas y v\u00f3mitos; no report\u00f3 escalofr\u00edos, tos ni dolor muscular. Hab\u00eda residido en Wuhan durante muchos a\u00f1os y ten\u00eda antecedentes de contactos con un paciente infectado de SARS-CoV-2. La paciente tambi\u00e9n ten\u00eda antecedentes de gastritis cr\u00f3nica. Antes del ingreso, el laboratorio de los Centros de Control y Prevenci\u00f3n de Enfermedades de Guangzhou confirm\u00f3, mediante RT-PCR, que la paciente estaba infectada por SARS-CoV-2. Las pruebas anal\u00edticas iniciales tambi\u00e9n mostraron una f\u00f3rmula leucocitaria baja (3,06 \u00d7 109/L; intervalo normal: 3,50-9,50 \u00d7 109/L) y linfocitopenia (0,68 \u00d7 109/L; intervalo normal: 1,10-3,20 \u00d7 109/L). Una TAC tor\u00e1cica mostr\u00f3 opacidades de vidrio esmerilado bilaterales, que se consideraron indicativas de neumon\u00eda v\u00edrica. A partir de los antecedentes y las pruebas, la paciente fue diagnosticada con neumon\u00eda por COVID-19. Tras el ingreso, la paciente mostr\u00f3 fiebre recurrente, de hasta 38,6 \u00b0C que curs\u00f3 con escalofr\u00edos, tos con poca expectoraci\u00f3n blanca, congesti\u00f3n nasal, malestar tor\u00e1cico y disnea de esfuerzo. Las pruebas anal\u00edticas mostraron que los valores de prote\u00edna C-reactiva aumentaron gradualmente, mientras que la f\u00f3rmula leucocitaria y la cifra de linfocitos disminuyeron. Inicialmente, a la paciente se le administr\u00f3 un tratamiento antiv\u00edrico y antiinfeccioso. A los seis d\u00edas del ingreso, la paciente mostr\u00f3 una acusada disnea, su saturaci\u00f3n de ox\u00edgeno disminuy\u00f3 y su oxigenaci\u00f3n era de 169 (< 300). Una TAC tor\u00e1cica mostr\u00f3 m\u00faltiples opacidades de vidrio esmerilado y parcheadas bilaterales, con l\u00edmites imprecisos y distribuci\u00f3n b\u00e1sicamente subpleural. Las pruebas de \u00e1cido nucleico del SARS-CoV-2 resultaron negativas y la TAC mostr\u00f3 consolidaciones difusas en ambos pulmones. No se observ\u00f3 derrame pleural ni adenopat\u00edas mediast\u00ednicas. Las lesiones pulmonares mostraron un claro empeoramiento y aumento de tama\u00f1o. Se cambi\u00f3 el diagn\u00f3stico a neumon\u00eda grave por COVID-19 y la paciente se transfiri\u00f3 a la UCI. El tratamiento se cambi\u00f3 inmediatamente a ventilaci\u00f3n de alta frecuencia y administraci\u00f3n de inmunoglobulina humana y teicoplanina. Tras 9-11 d\u00edas, la temperatura de la paciente volvi\u00f3 a valores normales pero se agrav\u00f3 la tos y la expectoraci\u00f3n hemoptoica. Sin embargo, los valores de prote\u00edna C-reactiva disminuyeron, mientras que la f\u00f3rmula leucocitaria y la cifra de linfocitos aumentaron gradualmente; adem\u00e1s, la prueba de SARS-CoV-2 result\u00f3 negativa. La TAC mostr\u00f3 un agrandamiento de las lesiones con mayor atenuaci\u00f3n. Algunas opacidades de vidrio esmerilado hab\u00edan evolucionado a consolidaciones. Los s\u00edntomas de la paciente mejoraban, pero las pruebas de diagn\u00f3stico por imagen mostraban un empeoramiento. El m\u00e9dico sospech\u00f3 un retraso en la presentaci\u00f3n de los cambios en las pruebas por imagen. Con un conjunto de tratamientos efectivos en los d\u00edas 12, 17 y 21 tras el ingreso, la detecci\u00f3n del SARS-CoV-2 mediante pruebas de \u00e1cido nucleico de frotis far\u00edngeos result\u00f3 negativa. Las TAC tor\u00e1cicas mostraron una clara absorci\u00f3n de las lesiones y una l\u00ednea subpleural. Los s\u00edntomas de la paciente mejoraron y las pruebas de \u00e1cido nucleico continuaron siendo negativas para SARS-CoV-2, de modo que sali\u00f3 de la cuarentena y se le dio de alta. En este caso, en las TAC tor\u00e1cicas observamos los cambios din\u00e1micos de neumon\u00eda grave por COVID-19. En la fase temprana de la enfermedad, la TAC mostr\u00f3 m\u00faltiples opacidades de vidrio esmerilado o parcheadas con distribuci\u00f3n subpleural en varios l\u00f3bulos bilaterales, caracter\u00edstica de los signos de la neumon\u00eda por COVID-19 en una TAC. A medida que progresaba la neumon\u00eda, la TAC mostr\u00f3 que, en pocos d\u00edas, las \u00e1reas de las lesiones en los pulmones aumentaban de tama\u00f1o y pasaban a consolidaciones difusas en ambos pulmones. Incluso cuando las pruebas de \u00e1cido nucleico del SARS-CoV-2 dieron resultados negativos y los s\u00edntomas de la paciente menguaron, hubo un retraso en los cambios en las TAC y en las evidencias de absorci\u00f3n de las lesiones. Durante el per\u00edodo de absorci\u00f3n, las consolidaciones pulmonares parcheadas disminuyeron y se fueron absorbiendo gradualmente, pero la l\u00ednea subpleural segu\u00eda presente. La TAC tor\u00e1cica din\u00e1mica tiene un papel muy relevante en el diagn\u00f3stico y el pron\u00f3stico de la infecci\u00f3n por SARS-CoV-2."
    },
    {
        "file_name": "32247642.en.txt",
        "en": "A 42-year-old male recently diagnosed with metastatic sarcomatoid clear cell renal cell carcinoma, had been hospitalized for fever, symptomatic bone metastases pain management and first-line systemic treatment decisions. The patient had no other significant medical history. He presented initially with isolated fever of 39.0\u00b0C on March 12th, 2020 for which he received ceftriaxone outside our center. On Day 6, he developed mild cough and fever (38.3\u00b0C) prompting SARS-Cov-2 real time polymerase chain reaction test, which was positive. The patient was admitted to the Covid-19 ward of our hospital and closely monitored. Chest computerized tomography (CT) scan revealed bilateral patchy ground glass opacities related to Covid-19 (Figure 1). Antiviral therapy lopinavir-ritonavir use (400mg-100mg orally) was begun at D7 and maintained for 5 days, according to local guidelines. On day 8, sudden dyspnea and saturation drop required oxygen supplementation increase to 6 l/min, without the need for artificial ventilation. He received two doses of tocilizumab, at 8 mg/kg intravenously for each dose, 8 hours apart, with a good tolerability. Thereafter, he experienced clinical improvement, rapidly afebrile and with gradually decreased oxygen consumption. This was fully discontinued on day 12 (Figure 1). Chest CT on day 12 confirmed improvement by showing partial regression of the pulmonary infiltrates and ground glass appearance (Figure 1). Creactive protein in blood, a surrogate marker of cytokine storm, decreased from 225 mg/L to 33 mg/L in 4 days (Figure 1). No major change was observed in circulating lymphocytic subpopulations after tocilizumab, and the percentage of CD4 + CD25 + lymphocytes was found high, before and after tocilizumab. The Patient ultimately clinically fully recovered from Covid-19 symptoms.",
        "es": "Se hospitaliz\u00f3 un hombre de 42 a\u00f1os, al que se le hab\u00eda diagnosticado recientemente un carcinoma renal sarcomatoide de c\u00e9lulas claras metast\u00e1sico, con fiebre, manejo del dolor por met\u00e1stasis \u00f3seas sintom\u00e1ticas y para decisiones de tratamiento sist\u00e9mico de primera l\u00ednea. El paciente no ten\u00eda otros antecedentes. Inicialmente present\u00f3 fiebre de 39,0 \u00b0C el 12 de marzo de 2020, para la cual recibi\u00f3 ceftriaxona fuera de nuestro centro. El d\u00eda 6, present\u00f3 tos leve y fiebre (38,3\u00b0C), lo que llev\u00f3 a realizar una prueba de PCR en tiempo real para SARS-CoV-2; el resultado fue positivo. El paciente fue ingresado en la sala de COVID-19 de nuestro hospital y se monitoriz\u00f3 estrechamente. La TAC tor\u00e1cica mostr\u00f3 opacidades de vidrio esmerilado bilaterales parcheadas, asociadas al COVID-19 (figura 1). El D7 se le empez\u00f3 a administrar terapia antiv\u00edrica con lopinavir y ritonavir (400mg/100mg por v\u00eda oral), que se mantuvo durante 5 d\u00edas, seg\u00fan las directrices locales. El d\u00eda 8, una disnea s\u00fabita y una ca\u00edda de la saturaci\u00f3n obligaron a aumentar el ox\u00edgeno a 6 l/min, sin necesidad de ventilaci\u00f3n mec\u00e1nica. Se le administraron dos dosis de tocilizumab, con 8 mg/kg i.v. en cada dosis, separadas 8 horas, con buena tolerancia. Despu\u00e9s mostr\u00f3 una mejora cl\u00ednica, pasando a afebril r\u00e1pidamente y con un consumo de ox\u00edgeno decreciente, que fue retirado por completo el d\u00eda 12. Una TAC tor\u00e1cica del d\u00eda 12 confirm\u00f3 la mejora mostrando regresi\u00f3n parcial de los infiltrados pulmonares y de las opacidades de vidrio esmerilado. La prote\u00edna C-reactiva, un marcador indirecto de liberaci\u00f3n de citocinas, disminuy\u00f3 de 225 mg/L a 33 mg/L en 4 d\u00edas (figura 1). Tras la administraci\u00f3n de tocilizumab no se observaron cambios relevantes en las subpoblaciones linfoc\u00edticas circulantes y el porcentaje de CD4 + CD25 + linfocitos era alto, antes y despu\u00e9s del tocilizumab. Finalmente, el paciente se recuper\u00f3 totalmente de los s\u00edntomas de la COVID-19."
    },
    {
        "file_name": "32269194.en.txt",
        "en": "A 46-year-old previously healthy man from Wuhan, China, presented to our emergency department with a 9-day history of persistent fever. He had been in his usual state of health until 9 days prior to admission (PTA), when he developed a fever of 38.3\u2103 without any respiratory symptoms, including runny nose, nasal congestion, sore throat, cough, sputum and dyspnea. He had traveled to Japan 3 days PTA and presented to our hospital. On arrival, his vital signs were as follows: body temperature, 37.1\u2103; blood pressure, 120/82 mmHg; pulse rate, 80/min; respiratory rate, 18 breaths/min; and oxygen saturation, 95% on ambient air. On physical examination, no crackles were heard. A rapid antigen test for influenza was negative. Chest CT revealed bilateral ground glass opacities. PCR for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was positive.",
        "es": "Un hombre de 46 a\u00f1os de Wuhan (China), por lo dem\u00e1s sano, acudi\u00f3 a nuestro servicio de urgencias con fiebre persistente de 9 d\u00edas de evoluci\u00f3n. Se hab\u00eda encontrado bien hasta 9 d\u00edas antes del ingreso, cuando present\u00f3 fiebre de 38,3 \u00b0C sin s\u00edntomas respiratorios como rinorrea, congesti\u00f3n nasal, dolor de garganta, tos, expectoraci\u00f3n o disnea. Hab\u00eda viajado a Jap\u00f3n 3 d\u00edas antes del ingreso y acudi\u00f3 a nuestro hospital. Al ingreso, sus constantes vitales eran las siguientes: temperatura de 37,1 \u00b0C; presi\u00f3n arterial de 120/82 mmHg; pulso de 80 l.p.m. ; frecuencia respiratoria de 18 r.p.m. A la exploraci\u00f3n f\u00edsica no se apreciaron crepitantes. Una prueba r\u00e1pida de ant\u00edgenos para gripe result\u00f3 negativa. Una TAC tor\u00e1cica revel\u00f3 opacidades de vidrio esmerilado bilaterales. La prueba de PCR para el coronavirus del s\u00edndrome respiratorio agudo grave (SARS-CoV-2) fue positiva."
    },
    {
        "file_name": "32278585.en.txt",
        "en": "A 64-year-old man without significant clinical history initially presented with syncope. His vital signs were within the normal ranges. Ear temperature was 38\u00a0\u00b0C and oxygen saturation was 99% on room air. Chest X-Rays showed mild linear densities in the lower and middle left lung fields. Laboratory investigations showed increased white blood cell count (10.900 per \u03bcL), elevated serum lactate level (250 U/L) and elevated reactive C protein (RCP) (89\u00a0mg/dL). The other blood tests showed normal results. COVID-19 was detected in a throat swab sample by RT-PCR. Due to the worsening of the blood tests on the day 2 (white blood cell count, 15.270 per \u03bcL; serum lactate level, 341 U/L; serum CRP level, 285\u00a0mg/dL), the patient was admitted to a dedicated ward. On day 6, the patient developed dyspnea; decreased of oxygen saturation (90%) and further increase of CRP was observed (336\u00a0mg/dL); white blood cell count was 10.800 per \u03bcL; interleukin-6 was 80\u00a0ng/L (normal value\u00a0<\u00a06\u00a0ng/dL). On day 7, unenhanced chest CT showed the presence of diffused bilateral air space opacities, including ground glass opacities and consolidation, with prevalent posterior distribution, linear opacities, mainly peripheral, mild bilateral pleural effusion, and mediastinal lymphadenopathy. Assisted ventilation was started. The patient received 2 doses of tocilizumab (8\u00a0mg/kg), 12\u00a0hours apart, on day 7 and 8. On day 9, CRP dropped to 96\u00a0mg/dL and white blood cell count to 2.360 per \u03bcL. Patient clinical condition progressively improved and ventilatory support was gradually weaned. On day 14, repeat chest CT showed mark improvement of CT findings, with size reduction of air cells opacities, density reduction of consolidations, with evidence of some ground glass opacities, peripheral reticular opacities, reduction of pleural effusion and mediastinal lymphadenopathy.",
        "es": "Se present\u00f3 un hombre de 64 a\u00f1os por s\u00edncope, sin antecedentes relevantes. Sus constantes vitales se hallaban dentro de los intervalos normales. La temperatura en el o\u00eddo era de 38\u00b0C y la saturaci\u00f3n de ox\u00edgeno era de 99% en aire ambiental. La radiograf\u00eda tor\u00e1cica revel\u00f3 densidades lineales leves en los campos pulmonares izquierdo medio e inferior. Las pruebas anal\u00edticas mostraron un aumento de la cifra de leucocitos (10,900 por ?L), alta concentraci\u00f3n de lactato s\u00e9rico (250 (U/L) y valores altos de prote\u00edna C-reactiva (89 mg/dL). El resto de las pruebas hem\u00e1ticas dieron resultados normales. Se detect\u00f3 COVID-19 en una muestra de frotis far\u00edngeo, mediante RT-PCR. A causa del empeoramiento de las pruebas anal\u00edticas el d\u00eda 2 (cifra de leucocitos 15.270 por ?L; lactato s\u00e9rico 341 U/L, prote\u00edna C-reactiva s\u00e9rica 285 mg/dL), se ingres\u00f3 al paciente en una planta especializada. El d\u00eda 6, el paciente present\u00f3 disnea, disminuci\u00f3n de la saturaci\u00f3n de ox\u00edgeno y un aumento adicional de la prote\u00edna C-reactiva (336 mg/dL); la cifra de leucocitos era de 10.800 por ?L y la interleucina 6 era de 80 ng/L (valor normal < 6 ng/dL). El d\u00eda 7, una TAC tor\u00e1cica sin contraste mostr\u00f3 la presencia de opacidades alveolares bilaterales, incluyendo opacidades de vidrio esmerilado y consolidaci\u00f3n, con una distribuci\u00f3n posterior prevalente, opacidades lineales, b\u00e1sicamente perif\u00e9ricas, derrame pleural bilateral leve y linfoadenopat\u00eda mediast\u00ednica. Se inici\u00f3 ventilaci\u00f3n asistida. El paciente recibi\u00f3 dos dosis de tocilizumab (8 mg/kg), a intervalos de 12 horas, los d\u00edas 7 y 8. El d\u00eda 9, la prote\u00edna C-reactiva baj\u00f3 a 96 mg/dL y la cifra de leucocitos a 2.360 por ?L. El estado cl\u00ednico del paciente mejor\u00f3 progresivamente y se le retir\u00f3 gradualmente la respiraci\u00f3n asistida. El d\u00eda 14, nuevas TAC tor\u00e1cicas revelaron una clara mejora de los resultados radiol\u00f3gicos, con reducci\u00f3n de las opacidades alveolares, reducci\u00f3n de la densidad de las consolidaciones, con evidencia de algunas opacidades de vidrio esmerilado, opacidades reticulares perif\u00e9ricas, y reducci\u00f3n del derrame pleural y de la linfoadenopat\u00eda mediast\u00ednica."
    },
    {
        "file_name": "32282027.en.txt",
        "en": "A 21-year-old female patient visited our hospital for febrile sensation, coughing, sputum, diarrhoea, and shortness of breath during the coronavirus disease 2019 (COVID-19) outbreak in Daegu, South Korea. Nasopharyngeal swab was positive for COVID-19. Troponin I level was 1.26 ng/mL (<0.3 ng/mL) and NT-proBNP was 1929 pg/mL (<125 pg/mL). The chest radiograph revealed a multifocal consolidation on both lung fields and cardiomegaly. Electrocardiography showed non-specific intraventricular conduction delay and multiple premature ventricular complexes. Echocardiography showed severe left ventricular (LV) systolic dysfunction). A chest computed tomography (CT) revealed a multifocal consolidation and ground-glass opacification in both lungs in the lower lobe and a peripheral dominant distribution. On the cardiac CT, the coronary arteries were normal, and the myocardium was hypertrophied due to oedema combined with a subendocardial perfusion defect on the lateral left ventricle. Cardiac magnetic resonance imaging (MRI) revealed a diffuse high signal intensity (SI) in the LV myocardium on T2 short tau inversion recovery image (SI ratio of myocardium over skeletal muscle = 2.2), and myocardial wall thickening (LV mass index: 111.3 g/m2), which suggests myocardial wall oedema. On mapping sequence, native T1 (mid-septum, 1431 ms; lateral wall, 1453 ms, reference value \u223c1150 ms) and extracellular volume (mid-septum, 29.7%; lateral wall, 61%; reference value \u223c25%) values were diffusely increased. Extensive transmural late gadolinium enhancement was noted. Myocarditis combined with COVID-19 was confirmed by multimodality imaging.",
        "es": "Una mujer de 21 a\u00f1os acudi\u00f3 a nuestro hospital con sensaci\u00f3n fiebre, tos, expectoraci\u00f3n, diarrea y disnea durante el brote de coronavirus (COVID-19) en Daegu (Corea del Sur). El frotis nasofar\u00edngeo fue positivo para COVID-19. El valor de troponina I era de 1,26 ng/mL (< 0,3 ng/mL) y el de prohormona N-terminal del p\u00e9ptido natriur\u00e9tico cerebral era de 1929 pg/mL (< 125 pg/mL). La radiograf\u00eda tor\u00e1cica revel\u00f3 una consolidaci\u00f3n multifocal en ambos campos pulmonares y cardiomegalia. El electrocardiograma mostr\u00f3 una demora de la conducci\u00f3n intraventricular inespec\u00edfica y varios complejos ventriculares prematuros. La ecocardiograf\u00eda mostr\u00f3 una grave alteraci\u00f3n sist\u00f3lica del ventr\u00edculo izquierdo (VI). Una TAC tor\u00e1cica revel\u00f3 consolidaci\u00f3n multifocal y opacidades de vidrio esmerilado en ambos pulmones, en el l\u00f3bulo inferior y con distribuci\u00f3n dominante perif\u00e9rica. En la TAC card\u00edaca, las arterias coronarias eran normales y el miocardio mostraba hipertrofia a causa de un edema combinado con anomal\u00eda de perfusi\u00f3n endoc\u00e1rdica en el ventr\u00edculo izquierdo lateral. La resonancia magn\u00e9tica nuclear (RMN) mostr\u00f3 una alta intensidad de la se\u00f1al (IS) difusa en el miocardio del VI evaluada en la secuencia STIR (cociente de la IS del miocardio respecto al m\u00fasculo esquel\u00e9tico = 2,2) y un engrosamiento de la pared mioc\u00e1rdica (\u00edndice de masa del VI: 111,3 g/m2), lo que sugiere edema parietal mioc\u00e1rdico. En la secuencia de im\u00e1genes, la T1 nativa (tabique medio 1431 ms; pared lateral 1453 ms; valor de referencia \u223c1150 ms) y el volumen extracelular (tabique medio 29,7%; pared lateral 61%; valor de referencia \u223c25%) mostraban un aumento difuso. Se realiz\u00f3 una detecci\u00f3n extensa transparietal de realce tard\u00edo con gadolinio. La miocarditis combinada con COVID-19 qued\u00f3 confirmada mediante obtenci\u00f3n de im\u00e1genes multimodal."
    },
    {
        "file_name": "32282871.en.txt",
        "en": "The patient was a 65-year-old man whose wife had COVID-19. He presented with a 4-day history of dry cough, anorexia, and fever (maximum temperature, 38.6 \u00b0C). On admission, computed tomography of the chest showed bilateral pneumonia. He had a C-reactive protein level of 13.5 mg/L and a leukocyte count of 3.0 \u00d7 109 cells/L with 27.4% lymphocytes. Tests processed by the Beijing Centers for Disease Control confirmed that he had COVID-19. We initiated supportive therapy and administered moxifloxacin to prevent secondary infection. On day 15 of the illness, he required invasive ventilatory support. We changed his antibiotics to vancomycin and imipenem for suspected sepsis and administered intravenous methylprednisolone and immune globulin to attenuate systemic inflammation. On day 16, he had a C-reactive protein level of 244.4 mg/L, leukocyte count of 10.1 \u00d7 109 cells/L with 1.6% lymphocytes, and blood lactic acid level of 3.13 mmol/L. He developed septic shock and died on day 21 of the illness.",
        "es": "Hombre de 65 a\u00f1os cuya mujer ten\u00eda COVID-19. Se present\u00f3 con tos seca, anorexia y fiebre (temperatura m\u00e1xima de 38,6 \u00b0C) de 4 d\u00edas de evoluci\u00f3n. Al ingreso, una TAC tor\u00e1cica mostr\u00f3 neumon\u00eda bilateral. Ten\u00eda unos valores de prote\u00edna C-reactiva de 13,5 mg/L y una cifra de leucocitos de 3,0 \u00d7 109 c\u00e9lulas/L, con un 27,4% de linfocitos. Las pruebas procesadas por los Centros para el Control de Enfermedades de Pek\u00edn confirmaron la COVID-19. Iniciamos un tratamiento sintom\u00e1tico y se le administr\u00f3 moxifloxacino para evitar sobreinfecciones. El d\u00eda 15 de enfermedad necesit\u00f3 respiraci\u00f3n asistida invasiva. Cambiamos sus antibi\u00f3ticos a vancomicina e imipenem a causa de una posible sepsis y le administramos inmunoglobulina y metilprednisolona por v\u00eda intravenosa para atenuar la inflamaci\u00f3n general. El d\u00eda 16 ten\u00eda unos valores de prote\u00edna C-reactiva de 244,4 mg/L, una cifra de leucocitos de 10,1 \u00d7 109 c\u00e9lulas/L, con un 1,6% de linfocitos, y un valor de \u00e1cido l\u00e1ctico de 3,13 mmol/L. El d\u00eda 21 de enfermedad sufri\u00f3 un choque s\u00e9ptico y falleci\u00f3."
    },
    {
        "file_name": "32292053.en.txt",
        "en": "A 2-month 21-day Chinese boy, born on November 13, 2019, was admitted to the Pediatric Intensive Care Unit (PICU) of Maternal and Child Health Hospital of Hubei Province (Women and Childrens Hospital of Hubei Province), Wuhan, in China, on February 3, 2020. He presented cough and wheeze for 3 days, symptom with dyspnea in the past 12 hours, but not any other discomfort such as diarrhea, nausea, and vomiting. He was brought to the emergency room by his mother. The boys father, who had fever and cough since 3 days ago, was treated at another designated hospital for suspected COVID-19. Furthermore, the chest computed tomography (CT) scan report of his father, detected in another designated hospital, showed ground glass opacities in his lung, indicating the possibility of viral pneumonia. The boys mother had no fever and cough, and there was no other family members living with them. In addition, the patients family community is about 15 km away from the Huanan Seafood Wholesale Market in Wuhan, and there was no family history of contact with the Huanan Seafood Wholesale Market. However, 5 people in the community where the patient lived were diagnosed with COVID-19. The boy was born at term, and Bacillus Calmette-Gurin vaccination had been performed on the first day. In addition, the patient had no asthma relevant family history. On the first day of admission (Day 1), a physical examination revealed the following: his temperature was 37C; respiratory rate was 52 beats per minute; heart rate was 170 beats per minute; blood pressure was 89/46 mm Hg; his peripheral capillary oxygen saturation (SpO2) was 89%; and his body weight was 6.4 kg. The cardiac examination was normal, but the sign of dyspnea was obvious and the sputum sound and wheezing rales could be heard by stethoscope. His abdomen was soft, splenomegaly was not palpated, but hepatomegaly 2 cm below costal margins was palpated. The initial blood test showed the following: white blood cell (WBC) count 8.81 (normal range = 4-10)  109/L; lymphocyte 6.14  109/L (normal range = 1-3); neutrophil 1.41  109/L (normal range = 2-6); eosinophils 0.23  109/L (normal range = 0.02-0.52); platelet 603  109/L (normal range = 100-300); and hemoglobin 108 g/L (normal range = 110-120). Serum immunoglobulin (Ig) profile and complement was as follows: IgG 3.9 g/L (normal range = 2.6-6.9); IgM 0.37 g/L (normal range = 0.26-1); and IgA 0.11 g/L (normal range = 0.08-0.57); C3 0.96 g/L (normal range = 0.65-1.52); and C4 0.13 g/L (normal range = 0.16-0.38). The peripheral lymphocyte subsets analysis, assessed by flow cytometry, revealed the following: the total T-cells 66.2% (normal range = 55% to 78%); helper T-cells (CD3+CD4+) 32.7% (normal range = 27% to 53%); suppressor T-cells (CD3+CD8+) 27.4% (normal range = 19% to 34%); B-cells (CD3?CD19+) 28.5% (normal range = 10% to 31%); and natural killer cells 4.2% (normal range = 4% to 26%). In addition, procalcitonin was 2.0 ng/mL (normal range <0.5). Liver function tests were basically normal. The laboratory results of respiratory virus detection, tested by enzyme-linked immunosorbent assay (ELISA), including adenovirus, influenza A virus, influenza B virus, parainfluenza virus 1/2/3, were negative, but RSV virus was positive. A chest CT scan revealed bilateral lung infection and consolidation in part of the lower lobe of the left lung. An arterial blood gas analysis showed the following: pH 7.33, partial pressure of oxygen (PaO2) 65 mm Hg, PaCO2 38 mm Hg, oxygen saturation (SaO2) 91%, BE ?5.5 mmol/L, HCO3 ?20 mmol/L, glucose 5.3 mmol/L, and blood lactate 5.4 mmol/L. Thus, severe pneumonia was diagnosed, and noninvasive continuous positive airway pressure (CPAP) ventilation was immediately performed at admission. Antibiotic treatment with ceftizoxime (50 mg/kg, intravenous [IV] Bid [twice a day]) was started as bacterial pneumonia was suspected. Before the antibacterial therapy, both the venous blood sample of the patient and the sputum were sent for culturing, but another 5 days later, the reports were negative. In addition, he was treated with intravenous ?-globulins (IVIG; 2 g/kg body weight, divided in 2 doses) and methylprednisolone (2 g/kg, Bid, for 3 days). Though result of pharyngeal swab, via quantitative real-time polymerase chain reaction (qRT-PCR) assay, for SARS-CoV-2 was negative at 36 hours after admission, the ?-interferon atomization inhalation was performed (0.5 million U/kg, in sterile injection water, Bid). On day 5, because of the improved conditions, noninvasive CPAP was withdrawn and he began absorbing oxygen via nasal tube. In addition, the blood test was reviewed: WBC 4.60  109/L; lymphocyte 3.27  109/L; neutrophil 1.05  109/L; eosinophils 0.01  109/L; platelet 416  109/L; and hemoglobin 80 g/L. Moreover, we obtained the message, by phone interviews, that his parents results of pharyngeal swabs tested by qRT-PCR assay, which was detected in another designated hospital, were negative, and a chest CT scan of his mother was normal. On day 10, the patient had a slight cough, no sputum, no fever, and the signs of lungs was improved. However, pharyngeal swab sample via qRT-PCR assay for SARS-CoV-2 was reviewed, and the result was positive. Then, the patient continued to the supportive treatment. On day 17, the patient had no fever, no cough, the signs of lungs was normal, and he stopped absorbing oxygen. Then, pharyngeal swab sample via qRT-PCR assay for SARS-CoV-2 was reviewed, and the result was negative. On day 19, pharyngeal swab sample via qRT-PCR assay for SARS-CoV-2 was reviewed, and the result was negative. On day 20, the repeat chest CT scan showed that the lung infection was basically absorbed. Thus, he was discharged from the hospital and continued to be isolated with his mother for 2 weeks at home.",
        "es": "El 3 de febrero de 2020, un ni\u00f1o de 2 meses y 21 d\u00edas, nacido el 13 de noviembre de 2019, fue ingresado en una unidad de cuidados intensivos pedi\u00e1tricos en el Hospital Maternoinfantil de la provincia de Hubei (Wuhan China). Presentaba tos y sibilancias de tres d\u00edas de evoluci\u00f3n, con disnea en las \u00faltimas 12 horas, pero sin otros s\u00edntomas como diarrea, n\u00e1useas o v\u00f3mitos. Su madre lo llev\u00f3 al servicio de urgencias. El padre, que ten\u00eda fiebre y tos desde hac\u00eda tres d\u00edas, fue tratado en otro hospital por posible COVID-19. Adem\u00e1s, la TAC tor\u00e1cica del padre, realizada en otro hospital, mostr\u00f3 opacidades de vidrio esmerilado en el pulm\u00f3n, lo que indicaba la posibilidad de neumon\u00eda v\u00edrica. La madre no ten\u00eda fiebre ni tos, y no conviv\u00edan con otros miembros de la familia. El barrio de la familia del paciente se halla a unos 15 km del mercado mayorista de marisco de Huanan, en Wuhan, y no constan antecedentes familiares de contactos con dicho mercado. Sin embargo, a 5 personas del vecindario en que reside el paciente se les hab\u00eda diagnosticado COVID-19. El ni\u00f1o naci\u00f3 a t\u00e9rmino y el primer d\u00eda se le administr\u00f3 la vacuna antituberculosa (BCG). El paciente no ten\u00eda antecedentes familiares relevantes de asma. El primer d\u00eda de ingreso (d\u00eda 1), la exploraci\u00f3n f\u00edsica revel\u00f3 los datos siguientes: temperatura de 37 \u00b0C, frecuencia respiratoria de 52 r.p.m., pulso de 170 l.p.m., presi\u00f3n arterial de 89/46 mmHg, saturaci\u00f3n de ox\u00edgeno en sangre perif\u00e9rica (SpO2) de 89%, peso de 6,4 kg. La exploraci\u00f3n cardiaca fue normal, pero los signos de disnea eran evidentes y se apreciaron sibilancias y ruidos de expectoraci\u00f3n con el fonendoscopio. El abdomen era blando y depresible y no se detect\u00f3 esplenomegalia a la palpaci\u00f3n pero s\u00ed se detect\u00f3 hepatomegalia a la palpaci\u00f3n 2 cm por debajo del reborde costal. Las pruebas anal\u00edticas iniciales dieron los resultados siguientes: cifra de leucocitos 8,81 (intervalo normal = 4-10) \u00d7 109/L; linfocitos 6,14 \u00d7 109/L (intervalo normal = 1-3); neutr\u00f3filos 1,41 \u00d7 109/L (intervalo normal = 2-6); eosin\u00f3filos 0,23 \u00d7 109/L (intervalo normal = 0,02-0,52); trombocitos 603 \u00d7 109/L (intervalo normal = 100-300) y hemoglobina 108 g/L (intervalo normal = 110-120). El perfil de inmunoglobulina s\u00e9rica (Ig) fue como sigue: IgG 3,9 g/L (intervalo normal = 2,6-6,9); IgM 0,37 g/L (intervalo normal = 0,26-1) e IgA 0,11 g/L (intervalo normal = 0,08-0,57); C3 0,96 g/L (intervalo normal = 0,65-1,52) y C4 0,13 g/L (intervalo normal = 0,16-0,38). Los an\u00e1lisis de subpoblaciones de linfocitos perif\u00e9ricos, evaluadas mediante citometr\u00eda de flujo, dieron los resultados siguientes: linfocitos T totales 66,2% (intervalo normal = 55% a 78%); linfocitos T cooperadores (CD3+CD4+) 32,7% (intervalo normal = 27% a 53%); linfocitos T supresores (CD3+CD8+) 27,4% (intervalo normal = 19% a 34%); linfocitos B (CD3?CD19+) 28,5% (intervalo normal = 10% a 31%); linfoc\u00edticos citol\u00edticos naturales 4,2% (intervalo normal = 4% a 26%). Adem\u00e1s, el valor de procalcitonina era 2,0 ng/mL (valor normal < 0,5). Las pruebas funcionales hep\u00e1ticas dieron resultados normales. Las pruebas anal\u00edticas de la detecci\u00f3n de virus respiratorios, mediante ensayo de inmunoadsorci\u00f3n enzim\u00e1tica (ELISA), que inclu\u00edan adenovirus, virus de la gripe A, virus de la gripe B y virus paragripal 1/2/3 fueron negativas, pero positivas para virus respiratorio sincicial. Una TAC tor\u00e1cica revel\u00f3 infecci\u00f3n pulmonar bilateral y consolidaci\u00f3n en parte del l\u00f3bulo inferior del pulm\u00f3n izquierdo. La gasometr\u00eda arterial dio los resultados siguientes: pH 7,33, presi\u00f3n parcial de ox\u00edgeno (PaO2) 65 mm Hg, PaCO2 38 mm Hg, saturaci\u00f3n de ox\u00edgeno (SaO2) 91%, EB ?5,5 mmol/L, HCO3 ?20 mmol/L, glucosa 5,3 mmol/L, lactato 5,4 mmol/L. En consecuencia, se diagnostic\u00f3 neumon\u00eda grave y al ingreso se aplic\u00f3 inmediatamente ventilaci\u00f3n mec\u00e1nica positiva continua (PPC) no invasiva. Se inici\u00f3 un tratamiento antibi\u00f3tico con ceftizoxima (50 mg/kg, i.v. dos veces al d\u00eda) ya que se sospech\u00f3 neumon\u00eda bacteriana. Antes del tratamiento antibacteriano, se enviaron muestras de sangre venosa y de esputo para su cultivo, pero 5 d\u00edas despu\u00e9s, los resultados eran negativos. Adem\u00e1s, fue tratado con gammaglobulina i.v. (IgIV, 2 g/kg de peso, en 2 dosis) y metilprednisolona (2 g/kg, dos veces al d\u00eda durante 3 d\u00edas). Aunque el resultado del ensayo mediante qRT-PCR del frotis far\u00edngeo para SARS-CoV-2 fue negativo 26 horas despu\u00e9s del ingreso, se le aplic\u00f3 interfer\u00f3n por v\u00eda inhalatoria (0,5 millones U/kg, en soluci\u00f3n est\u00e9ril, dos veces al d\u00eda). El d\u00eda 5, a causa de la mejora en el estado del paciente, se retir\u00f3 la PPC no invasiva y se pas\u00f3 a oxigenoterapia mediante c\u00e1nula nasal. Adem\u00e1s, se repitieron los an\u00e1lisis de sangre: leucocitos 4,60 \u00d7 109/L; linfocitos 3,27 \u00d7 109/L; neutr\u00f3filos 1,05 \u00d7 109/L; eosin\u00f3filos 0,01 \u00d7 109/L; trombocitos 416 \u00d7 109/L; hemoglobina 80 g/L. Mediante comunicaci\u00f3n telef\u00f3nica obtuvimos la informaci\u00f3n de que las pruebas de los frotis far\u00edngeos de los padres del paciente mediante qRT-PCR, obtenidos en otro hospital, eran negativos y que la TAC tor\u00e1cica de la madre era normal. El d\u00eda 10, el paciente ten\u00eda tos leve, sin fiebre y sin expectoraci\u00f3n, y los signos pulmonares hab\u00edan mejorado. Sin embargo, se efectu\u00f3 una prueba de frotis far\u00edngeo mediante qRT-PCR para SARS-CoV-2, con resultado positivo. El paciente sigui\u00f3 con tratamiento sintom\u00e1tico. El d\u00eda 17, el paciente no mostr\u00f3 fiebre ni tos, los signos pulmonares eran normales y se retir\u00f3 la oxigenoterapia. Luego, se efectu\u00f3 una prueba de frotis far\u00edngeo mediante qRT-PCR para SARS-CoV-2, con resultado negativo. El d\u00eda 19 se repiti\u00f3 la prueba de frotis far\u00edngeo mediante qRT-PCR para SARS-CoV-2, con resultado negativo. El d\u00eda 20, una TAC tor\u00e1cica de seguimiento mostr\u00f3 que la infecci\u00f3n pulmonar se hab\u00eda absorbido casi por completo. En consecuencia, fue dado de alta del hospital y sigui\u00f3 en asilamiento domiciliario con su madre durante dos semanas."
    },
    {
        "file_name": "32292054.en.txt",
        "en": "A 2-week-old Caucasian male infant born to a 32-year-old G3P2012 GBS-positive mother at 39 weeks gestation via elective cesarean section presented to the emergency center with 1 day of fever, measured 38.0C temporally. During the 3 days prior to admission, mother noted a progressively worsening erythema of the right thumb and fourth digit. Additionally, the patient had been having increased somnolence over the past day and decreased breast milk feeds, prompting mother to bring infant to the emergency center for evaluation. Pertinent negatives in review of systems include no nasal congestion, cough, increased work of breathing, vomiting, nor diarrhea. Mother endorsed feelings of congestion and cough for the past several days and sibling sick with viral symptoms. There is a maternal history of recurrent oral herpetic lesions. Physical examination revealed a well-appearing 2-week-old infant who was alert and able to breastfeed with mother in the emergency center. Patient had a nonfocal physical examination except for small erosions of the right thumb and right fourth finger with thin rim of erythema without subcutaneous fluctuance or drainage. During the emergency department visit, patient developed a temperature of 38C, rectally. Initial laboratory studies included a complete blood count with differential: white blood count 9.2 bil/L, hemoglobin 17.7 g/dL, platelets 244 bil/L, neutrophils 0.3 bil/L, lymphocytes 5.0 bil/L, monocytes 3.7 bil/L, and immature granulocytes 0.06 bil/L. Comprehensive metabolic panel was notable only for aspartate aminotransferase 64 U/L and alanine aminotransferase 40 U/L. Cerebrospinal fluid (CSF) studies showed glucose 51 mg/dL, protein 45 mg/dL, white blood count 6/L, and red blood cell count 360/L. Patient was started on empiric antibiotic therapy as well as acyclovir, given his elevated liver enzymes and suspicious finger lesions. Shortly after lumbar puncture, patient became hypoxic to 85% while resting in mothers arms which improved with stimulation and supplemental oxygen. Chest radiograph was notable for bilateral perihilar streaking without focal consolidation. Patient was admitted to the pediatric intensive care unit given hypoxic respiratory failure. Prior to transport, patient was nasopharyngeal swabbed for SARS-CoV-2. Patient required modest nasal cannula oxygen support over the first 24 hours of admission but was progressively weaned to room air without need for escalation of therapy. On day 1 of admission, SARS-CoV-2 polymerase chain reaction returned positive. Additional workup included herpes simplex virus surface cultures and wound cultures from right hand that ultimately returned positive for methicillin-sensitive Staphylococcus aureus. Blood and CSF cultures yielded no growth, and CSF meningitis/encephalitis panel returned negative. Respiratory viral panel was obtained and was negative. Serial complete blood count revealed improving neutropenia from 0.3 bil/L to 0.7 bil/L. Given patients improving clinical status, neither hydroxychloroquine nor azithromycin was initiated. On hospital day 4, patient discharged home with oral antibiotic therapy for soft tissue infection.",
        "es": "Un ni\u00f1o cauc\u00e1sico de 2 semanas, hijo de una mujer de 32 a\u00f1os (3 embarazos, 2 partos, 1 aborto, 2 hijos vivos), positiva para EGB y en la semana 39 de gestaci\u00f3n, con parto por ces\u00e1rea voluntaria, llev\u00f3 al beb\u00e9 al servicio de urgencias con fiebre de 38,0 \u00b0C de un d\u00eda de evoluci\u00f3n. En los tres d\u00edas antes del ingreso, la madre not\u00f3 un eritema que empeoraba progresivamente en el pulgar y en el cuarto dedo de la mano. Adem\u00e1s, el paciente hab\u00eda tenido somnolencia creciente durante el \u00faltimo d\u00eda y hab\u00eda disminuido su toma de leche, lo que convenci\u00f3 a su madre de llevarlo a urgencias para su evaluaci\u00f3n. La anamnesis sistem\u00e1tica no revel\u00f3 congesti\u00f3n nasal, tos, dificultad respiratoria, v\u00f3mitos ni diarrea. La madre refiri\u00f3 sensaci\u00f3n de congesti\u00f3n y tos durante los \u00faltimos d\u00edas y un hermano con s\u00edntomas v\u00edricos. La madre tiene antecedentes de lesiones herp\u00e9ticas orales recurrentes. La exploraci\u00f3n f\u00edsica mostr\u00f3 un ni\u00f1o de 2 semanas en buen estado de salud, consciente y capaz de tomar el pecho de la madre en el servicio de urgencias. La exploraci\u00f3n f\u00edsica del paciente fue irrelevante excepto por peque\u00f1as erosiones en el pulgar y el cuarto dedo derechos, con un fino borde eritematoso sin fluctuaci\u00f3n ni secreci\u00f3n. Durante la visita a urgencias, el paciente present\u00f3 una temperatura de 38 \u00b0C, medida rectalmente. Las pruebas anal\u00edticas iniciales con un hemograma completo y f\u00f3rmula leucocitaria dieron los resultados siguientes: cifra de leucocitos 9,2 bil/L, hemoglobina 17,7 g/dL, trombocitos 244 bil/L, neutr\u00f3filos 0,3 bil/L, linfocitos 5,0 bil/L, monocitos 3,7 bil/L, granulocitos inmaduros 0,06 bil/L. Un perfil metab\u00f3lico completo fue relevante solo por una aspartato-aminotransferasa de 64 U/L y una alanina-aminotransferasa de 40 U/L. Las pruebas de l\u00edquido cefalorraqu\u00eddeo (LCR) dieron una glucorraquia de 51 mg/dL, proteinorraquia de 45 mg/dL, cifra de leucocitos de 6/\u00b5L y cifra de eritrocitos de 360/\u00b5L. Se inici\u00f3 un tratamiento provisional con antibi\u00f3ticos y aciclovir, teniendo en cuenta sus altos valores de enzimas hep\u00e1ticas y posibles lesiones en los dedos. Poco despu\u00e9s de una punci\u00f3n lumbar, el paciente sufri\u00f3 hipoxia al 85%, mientras estaba en brazos de la madre, que mejor\u00f3 mediante estimulaci\u00f3n y oxigenoterapia. La radiograf\u00eda tor\u00e1cica mostr\u00f3 l\u00edneas perihilares bilaterales sin consolidaci\u00f3n focal. El paciente fue ingresado en la unidad de cuidados intensivos pedi\u00e1tricos a causa de la insuficiencia respiratoria hip\u00f3xica. Antes del traslado, se le hizo un frotis nasofar\u00edngeo para las pruebas de SARS-CoV-2. El paciente requiri\u00f3 ligera oxigenoterapia mediante c\u00e1nula nasal en las primeras 24 horas del ingreso, pero se retir\u00f3 progresivamente a aire ambiental sin necesidad de aumentar la terapia. El d\u00eda 1 de ingreso, las pruebas mediante PCR de SARS-CoV-2 dieron resultado positivo. Se hicieron pruebas adicionales de cultivos superficiales del virus del herpes simple y cultivos de las lesiones de la mano derecha que dieron positivo para Staphylococcus aureus resistente a la meticilina. Los cultivos de sangre y de LCR no mostraron crecimiento y las pruebas para meningitis y encefalitis del LCR fueron negativas. Las pruebas v\u00edricas respiratorias tambi\u00e9n fueron negativas. El hemograma completo revel\u00f3 una mejora de la neutrocitopenia, de 0,3 bil/L a 0,7 bil/L. Dada la mejora del estado cl\u00ednico del paciente, no se administr\u00f3 ni hidroxicloroquina no azitromicina. El d\u00eda 4 de hospitalizaci\u00f3n se le dio de alta con antibi\u00f3ticos orales para la infecci\u00f3n de las partes blandas."
    },
    {
        "file_name": "32292867.en.txt",
        "en": "A 44-year-old African American woman presented to the emergency department complaining of fever, vomiting, worsening cough, and flank pain. She was found to have acute kidney injury with a serum creatinine of 4.0 mg/dl superimposed on known chronic kidney disease. Urinalysis on presentation was positive for blood and protein with a spot urine protein/creatinine ratio of 3.9 g/g. Her baseline serum creatinine, measured 6 months before presentation, was1.4 mg/dl. Baseline urinalysis before presentation showed 2\u00fe protein with no spot urine protein/creatinine ratio collection result available. Her medical history included poorly controlled diabetes mellitus type 2, essential hypertension, dyslipidemia, and chronic kidney disease attributed to diabetes. Her past surgical history included cesarean delivery and cholecystectomy. She has never smoked. She denied drinking alcohol or illicit drugs. Physical examination showed the patient\u2019s temperature was 102 F (38.9 C), blood pressure of 140/90 mm Hg, heartrate of 107 beats per minute, and a respiratory rate of 18 breaths per minute. She was breathing ambient air. She appeared ill but alert and conversational. She had no sinus tenderness, but notable pharyngeal erythema, without cervical lymphadenopathy. Both lungs were clear to auscultation. Her heart sounds were normal, and there was no murmur. Her abdomen was soft, with mild costovertebral angle tenderness and active bowel sounds. There was no erythema, tenderness, or effusion in the joints, and no skin rash was seen. Capillary fill time was 2 seconds to all digits. Extremities showed no pitting edema. She had stable and congruent mood and affect. The patient was anemic and had electrolyte abnormalities. In addition, serologic testing for hepatitis B, hepatitis C, and HIV were negative. Serum complement testing for C3 and C4 were normal. A chest X-ray showed right subsegmental atelectasis and small right-sided pleural effusion. Renal ultrasound showed normal-sized kidneys with no evidence of obstructive uropathy. The differential diagnosis at the time of admission was sepsis, acute pyelonephritis, and COVID-19. She was started on i.v. fluid support as well as ceftriaxone and vancomycin. Full acute kidney injury workup was ordered. The patient was admitted to the medical floor for further evaluation and management. Over the course of 5 days, the patient developed confusion and worsening respiratory distress, requiring supplemental oxygen. She was able to maintain saturation with 2 to 3 l/min of nasal cannula. Repeat chest X-ray showed new-onset bilateral diffuse patchy opacities. Antibiotic therapy was changed from ceftriaxone to cefepime. The patient\u2019s renal function declined over the same period, and she was placed on dialysis on hospital day 8 with a serum creatinine of 11.4 mg/dl despite good urine output (>1 l/d). A spot urine protein/creatinine ratio at the time of dialysis initiation was 25 g/g. An autoimmune workup was positive for Sj\u00f6gren-syndrome\u2013related antigen A and antinuclear antibodies. Evaluation by rheumatology showed no clinical signs of Sj\u00f6gren syndrome. Serum antineutrophil cytoplasmic antibodies was negative and tests for serum complements C3 and C4 were normal. All urine and blood cultures were negative and the COVID-19 polymerase chain reaction assay was pending. A renal biopsy was performed to evaluate the etiology of the patient\u2019s renal disease. Shortly after the biopsy was ordered, the COVID-19 polymerase chain reaction assay returned as positive. The patient\u2019s clinical status markedly improved with dialysis. Her confusion resolved and she no longer required oxygen support. She continued to have good urine output, albeit without proper clearance, mandating further hemodialysis on an outpatient basis.",
        "es": "Una mujer afroamericana de 44 a\u00f1os acudi\u00f3 al servicio de urgencias aquejada de fiebre, v\u00f3mitos, tos y dolor en fosa lumbar. Ten\u00eda una lesi\u00f3n renal aguda, con creatinina s\u00e9rica de 4,0 mg/dl, que se a\u00f1ad\u00eda a una nefropat\u00eda cr\u00f3nica ya diagnosticada. El an\u00e1lisis de orina inicial fue positivo para sangre, con una proporci\u00f3n prote\u00edna/creatinina puntual de 3,9 g/g. Su creatinina s\u00e9rica basal, medida 6 meses antes de la primera consulta, era de 1,4 mg/dl. El an\u00e1lisis de orina de referencia antes de la primera consulta mostr\u00f3 prote\u00edna 2\u00fe, sin resultado disponible de la proporci\u00f3n prote\u00edna/creatinina puntual. Sus antecedentes inclu\u00edan diabetes mellitus de tipo 2, mal controlada, hipertensi\u00f3n esencial, dislipidemia y nefropat\u00eda cr\u00f3nica atribuida a la diabetes. Sus antecedentes quir\u00fargicos constaban de un parto por ces\u00e1rea y una colecistectom\u00eda. Nunca hab\u00eda fumado. Tambi\u00e9n neg\u00f3 haber consumido alcohol o drogas. A la exploraci\u00f3n f\u00edsica, la temperatura de la paciente era de 38,9 \u00b0C, la presi\u00f3n arterial de 140/90 mmHg, el pulso de 107 l.p.m. y la frecuencia respiratoria de 18 r.p.m. Ten\u00eda aspecto enfermizo pero estaba consciente y alerta. No se detect\u00f3 dolor a la palpaci\u00f3n sinusal, pero se observ\u00f3 un claro eritema far\u00edngeo, sin linfoadenopat\u00eda cervical. A la auscultaci\u00f3n, los pulmones se apreciaban normales. Los ruidos card\u00edacos eran normales, sin soplos. El abdomen era blando y depresible, con una pu\u00f1opercusi\u00f3n renal levemente dolorosa y ruidos intestinales. No hab\u00eda eritema, dolor a la palpaci\u00f3n ni derrame articular y no se observ\u00f3 exantema. El tiempo de llenado capilar era de dos segundos en todos los dedos. En las extremidades no se observaron edemas con f\u00f3vea. El estado de \u00e1nimo y el afecto eran estables y coherentes. La paciente presentaba anemia y alteraciones electrol\u00edticas. Adem\u00e1s, las pruebas serol\u00f3gicas para hepatitis B, hepatitis C y HIV fueron negativas. Las pruebas serol\u00f3gicas adicionales para C3 y C4 dieron resultado normal. Una radiograf\u00eda tor\u00e1cica mostr\u00f3 atelectasia subsegmentaria y un leve derrame pleural derecho. Una ecograf\u00eda renal mostr\u00f3 ri\u00f1ones de tama\u00f1o normal sin evidencias de uropat\u00eda obstructiva. El diagn\u00f3stico diferencial al ingreso fue s\u00edndrome s\u00e9ptico, pielonefritis y COVID-19. Se empez\u00f3 a administrarle l\u00edquidos por v\u00eda i.v., as\u00ed como ceftriaxona y vancomicina. Se orden\u00f3 un estudio completo de la lesi\u00f3n renal. La paciente fue trasladada a la planta de hospitalizaci\u00f3n para su tratamiento y gesti\u00f3n. En el curso de 5 d\u00edas, la paciente padeci\u00f3 desorientaci\u00f3n y malestar respiratorio, que oblig\u00f3 a aplicar oxigenoterapia. Pudo mantener la saturaci\u00f3n con 2 a 3 l/min con c\u00e1nula nasal. Una radiograf\u00eda tor\u00e1cica de seguimiento mostr\u00f3 primera aparici\u00f3n de opacidades parcheadas bilaterales difusas. El tratamiento antibi\u00f3tico se cambi\u00f3 de ceftriaxona a cefepima. La funci\u00f3n renal de la paciente se deterior\u00f3 durante el mismo per\u00edodo y se la puso en di\u00e1lisis el d\u00eda 8 de hospitalizaci\u00f3n, con una creatinina s\u00e9rica de 11,4 mg/dl, a pesar de una buena diuresis (> 1 l/d). La proporci\u00f3n prote\u00edna/creatinina puntual en el momento de la di\u00e1lisis era de 25 g/g. Un an\u00e1lisis completo autoinmunitario result\u00f3 positivo para el ant\u00edgeno A asociado al s\u00edndrome de Sj\u00f6gren y anticuerpos antinucleares. La evaluaci\u00f3n reumatol\u00f3gica no mostr\u00f3 signos cl\u00ednicos del s\u00edndrome de Sj\u00f6gren. Los anticuerpos citoplasm\u00e1ticos antineutrof\u00edlicos s\u00e9ricos resultaron negativos y las pruebas para C3 y C4 fueron normales. Todos los hemocultivos y urocultivos resultaron negativos, pendientes del ensayo mediante PCR para COVID-19. Se practic\u00f3 una biopsia renal para evaluar la etiolog\u00eda de la nefropat\u00eda de la paciente. Se lleg\u00f3 a un diagn\u00f3stico de glomerulopat\u00eda colapsante. Poco despu\u00e9s de la biopsia, las pruebas mediante PCR para COVID-19 dieron resultado positivo. El estado cl\u00ednico de la paciente mejor\u00f3 claramente con la di\u00e1lisis. Su desorientaci\u00f3n desapareci\u00f3 y ya no necesit\u00f3 oxigenoterapia. Continu\u00f3 con buena diuresis, aunque sin un buen aclaramiento, lo que exigi\u00f3 posterior hemodi\u00e1lisis ambulatoria."
    },
    {
        "file_name": "32352487.en.txt",
        "en": "A 48-year-old man with a history of hypertension presented to the emergency department in March 2020, during the COVID-19 outbreak in Madrid, Spain. He reported an onset of fever (up to 39 \u00b0C) several days before admission, along with pleuritic chest pain and shortness of breath. He noticed the abrupt appearance of slightly pruritic skin lesions 3 days after the onset of fever. He had not taken any new drugs during the year before this episode. Physical examination revealed confluent erythematous macules, papules, and petechiae in a symmetric periflexural distribution affecting the buttocks, popliteal fossae, proximal anterior thighs, and lower abdomen. A striking absence of lesions in the crural folds was noted. There were no acral or mucosal lesions. The exanthem consists of erythematous macules, papules, and petechiae affecting the popliteal fossae, buttocks and anterior thighsPosteroanterior and lateral chest radiographs showed ground-glass opacities in both lower pulmonary fields consistent with atypical pneumonia. A complete blood cell count revealed a lymphocyte count of 750/\u03bcL (reference range, 1000-4500/\u03bcL) (to convert to \u00d7109/L, multiply by 0.001), a C-reactive protein level of 1.7 mg/dL (reference range, 0-0.5 mg/L) (to convert to mg/L, multiply by 10), and a D-dimer level of 0.68 \u03bcg/mL (reference range, 0-0.5 \u03bcg/mL) (to convert to nmol/L, multiply by 5.476). The platelet count and coagulation parameters were normal. Serologic test results were negative for HIV, hepatitis B virus, hepatitis C virus, and parvovirus B19. Results of real-time reverse transcriptase\u2013polymerase chain reaction from a nasopharyngeal swab were positive for SARS-CoV-2. A 5-mm punch biopsy specimen from the left buttock revealed a superficial perivascular lymphocytic infiltrate with abundant red cell extravasation and focal papillary edema, along with focal parakeratosis and isolated dyskeratotic cells. No features of thrombotic vasculopathy were present. The patient was hospitalized and treated with hydroxychloroquine (200 mg twice a day), lopinavir-ritonavir (200 mg/50 mg twice a day), and azithromycin (250 mg/d). The patient continued to receive his regular hypertension medication, telmisartan. The rash was treated with 0.05% betamethasone dipropionate cream twice a day and loratadine (10 mg/d). The cutaneous lesions resolved after 5 days. The patient recovered from his respiratory illness and was released from the hospital after 12 days.",
        "es": "Un hombre de 48 a\u00f1os con antecedentes de hipertensi\u00f3n acudi\u00f3 al servicio de urgencias en marzo de 2020, durante el brote de COVID-19 en Madrid. Refiri\u00f3 aparici\u00f3n de fiebre (hasta 39 \u00b0C) varios d\u00edas antes del ingreso, junto con dolor tor\u00e1cico pleural y disnea. Not\u00f3 la s\u00fabita aparici\u00f3n de lesiones cut\u00e1neas ligeramente prur\u00edticas 3 d\u00edas despu\u00e9s de la aparici\u00f3n de la fiebre. No hab\u00eda tomado ninguna medicaci\u00f3n durante el a\u00f1o anterior a este episodio. A la exploraci\u00f3n f\u00edsica se observaron m\u00e1culas, p\u00e1pulas y petequias eritematosas confluyentes en una distribuci\u00f3n periflexural sim\u00e9trica con afecci\u00f3n en las nalgas, las fosas popl\u00edteas, la parte anteroproximal de los muslos y la parte inferior del abdomen. Cabe se\u00f1alar una notable ausencia de lesiones en los pliegues crurales. No hab\u00eda lesiones acras o mucosas. El exantema estaba formado por m\u00e1culas, p\u00e1pulas y petequias eritematosas que afectaban a las nalgas, las fosas popl\u00edteas y la parte anterior de los muslos. Un hemograma completo revel\u00f3 una cifra de linfocitos de 750/\u03bcL (intervalo de referencia, 1000-4500/\u03bcL) (para convertir a \u00d7109/L, multipl\u00edquese por 0,001), un valor de prote\u00edna C-reactiva de 1,7 mg/dL (intervalo de referencia, 0-0,5 mg/L) (para convertir a mg/L, multipl\u00edquese por 10) y un valor de d\u00edmero D de 0,68 \u03bcg/mL (intervalo de referencia, 0-0,5 \u03bcg/mL) (para convertir a nmol/L, multipl\u00edquese por 5,476). El recuento de trombocitos y los par\u00e1metros de coagulaci\u00f3n eran normales. Las pruebas serol\u00f3gicas fueron negativas para VIH, virus de la hepatitis B, virus de la hepatitis C y parvovirus B19. Los resultados de una RT-PCR en tiempo real a partir de un frotis nasofar\u00edngeo fueron positivos para SARS-CoV-2. Una muestra de biopsia en sacabocados de 5 mm de la nalga izquierda mostr\u00f3 un infiltrado linfoc\u00edtico perivascular superficial con abundante extravasaci\u00f3n de eritrocitos y edema papilar focal, junto con paraqueratosis focal y c\u00e9lulas disquerat\u00f3sicas aisladas. No se observaron caracter\u00edsticas de vasculopat\u00eda tromb\u00f3tica. El paciente fue hospitalizado y se le trat\u00f3 con hidroxicloroquina (200 mg dos veces al d\u00eda), lopinavir/ritonavir (200 mg/50 mg dos veces al d\u00eda) y azitromicina (250 mg/d). El paciente sigui\u00f3 recibiendo su medicaci\u00f3n regular para la hipertensi\u00f3n, telmisart\u00e1n. El exantema fue tratado con crema de betametasona dipropionato al 0,05% dos veces al d\u00eda y loratadina (10 mg/d). Las lesiones cut\u00e1neas remitieron tras 5 d\u00edas. El paciente se recuper\u00f3 de sus problemas respiratorios y fue dado de alta despu\u00e9s de 12 d\u00edas."
    },
    {
        "file_name": "32360384.en.txt",
        "en": "We report a case of a 59 years old Caucasian male with no evidence of cardiovascular risk factor and no medical therapy before hospitalization. He was admitted with a 10-days history of fever and dyspnoea unresponsive to paracetamol. Physical examination revealed a tachycardic hear rate (112 beats/minute), low blood pressure (90/50mmHg) and severe hypoxemia. Serial 12-leads electrocardiogram showed sinus tachycardia without ST segment elevation/depression or other electric pathways suggesting myocardial sufferance; chest x-ray showed signs of severe interstitial pneumonia with typical ground-glass changes suggesting SARS-CoV-2 infection. Echocardiography was within normal limits. Due to the severe ARDS unresponsive to assisted non-invasive ventilation the patient underwent ETI and was transferred to an isolation ward of the intensive care unit (ICU); the infection of SARS-CoV-2 virus was confirmed thereafter by an RT-PCR assay of a nasal swab. After few days of mechanical ventilation, the patient suddenly developed a cardiac arrest followed, after resuscitation, by acute hemodynamic deterioration. Urgent echocardiography showed a severe dysfunction of the right cardiac chambers highly suggestive for acute pulmonary embolism (PE). Due to rapid deterioration of the hemodynamic condition a CT-scan was not performed, and he was immediately transferred to our cardiac surgery room. Using a midline sternotomy with central aortic and bicaval venous cannulation a large thrombus was removed from the right atrium and from both left and right main pulmonary arteries. The complete clots removal resulted in a rapid improvement in pulmonary artery systolic pressure. The intervention was performed using 59 minutes of cardioplegic arrest with a mild hypothermia. Patient was under hydroxichloroquine sulfate and INNDarunavir plus Cobicistat as pharmacological therapy. At 32-days of follow-up he is in stable hemodynamic conditions without any inotropic support and has been transferred from ICU in regular ward in spontaneous ventilation. SARS-CoV-2 infection has been resolved as confirmed by two RT-PCR assays of nasal swab.",
        "es": "Hombre cauc\u00e1sico de 59 a\u00f1os sin evidencias de factores de riesgo cardiovascular ni tratamientos farmacol\u00f3gicos antes de la hospitalizaci\u00f3n. Fue ingresado con fiebre que no ced\u00eda con paracetamol y disnea de 10 d\u00edas de evoluci\u00f3n. La exploraci\u00f3n f\u00edsica revel\u00f3 taquicardia (pulso de 112 l.p.m. ), hipotensi\u00f3n (90/50 mmHg) e hipoxemia grave. Un electrocardiograma seriado de 12 derivaciones mostr\u00f3 taquicardia sinusal sin elevaci\u00f3n/depresi\u00f3n del segmento ST ni otras v\u00edas el\u00e9ctricas que sugirieran insuficiencia mioc\u00e1rdica; una radiograf\u00eda tor\u00e1cica mostr\u00f3 signos de neumon\u00eda intersticial grave, con alteraciones en vidrio esmerilado, que suger\u00edan infecci\u00f3n por SARS-CoV-2. El ecocardiograma dio resultados normales. A causa del SDRA grave, resistente a la ventilaci\u00f3n mec\u00e1nica no invasiva, el paciente se someti\u00f3 a una intubaci\u00f3n endotraqueal (IET) y se traslad\u00f3 a una sala de aislamiento de la unidad de cuidados intensivos (UCI); la infecci\u00f3n por virus SARS-CoV-2 fue confirmada posteriormente mediante una prueba RT-PCR a partir de un frotis nasal. Tras unos pocos d\u00edas de ventilaci\u00f3n mec\u00e1nica, el paciente sufri\u00f3 un paro card\u00edaco s\u00fabito seguido, tras reanimaci\u00f3n, por un empeoramiento hemodin\u00e1mico agudo. Un ecocardiograma de urgencia mostr\u00f3 una alteraci\u00f3n grave de las cavidades card\u00edacas derechas, indicadora de embolia pulmonar aguda. A causa del r\u00e1pido empeoramiento del estado hemodin\u00e1mico, no se realiz\u00f3 ninguna TAC tor\u00e1cica y el paciente se traslad\u00f3 inmediatamente a nuestro quir\u00f3fano card\u00edaco. Mediante una esternotom\u00eda media, con cateterismo venoso bicavo y a\u00f3rtico central se elimin\u00f3 un gran trombo de la aur\u00edcula derecha y de las arterias pulmonares principales izquierda y derecha. La completa eliminaci\u00f3n de los trombos llev\u00f3 a una r\u00e1pida mejora de la presi\u00f3n sist\u00f3lica de la arteria pulmonar. La intervenci\u00f3n se realiz\u00f3 con 59 minutos de paro cardiopl\u00e9gico con hipotermia leve. El paciente se trat\u00f3 con sulfato de hidroxicloroquina y darunavir y cobicistat como tratamiento farmacol\u00f3gico. A los 32 d\u00edas de seguimiento, se halla hemodin\u00e1micamente estable sin apoyo in\u00f3tropo y se ha trasladado de la UCI a la planta de hospitalizaci\u00f3n general, con ventilaci\u00f3n espont\u00e1nea. La infecci\u00f3n por SARS-CoV-2 se solucion\u00f3 tal como confirmaron dos pruebas de RT-PCR a partir de frotis nasales."
    },
    {
        "file_name": "32360439.en.txt",
        "en": "73-year-old male with a past medical history of hypertension, dyslipidemia, and carotid stenosis presented to the emergency department with fever, respiratory distress, and altered mental status. Review of systems was positive for dyspepsia, nausea, vomiting, reduced oral intake for two days, and negative for fevers or chills at home. He had a sick contact at home. Vital signs on presentation were fever of 38.3\u00b0 C, tachycardia with heart rate (HR) of 102, hypoxemia with saturation of 85% on 100% non-rebreather mask. The patient was intubated in the ED for hypoxemic respiratory failure. A computed tomography (CT) scan of the head was performed for altered mental status, which demonstrated loss of gray-white differentiation at the left occipital and parietal lobes, consistent with acute infarct. CT of the chest demonstrated bilateral peripheral patchy airspace opacities and diffuse ground-glass opacities, characteristic for atypical pneumonia/viral infection from COVID-19. Electrocardiogram(EKG) was within normal limits. Blood work was significant for leu-kocytosis with lymphopenia. Urine analysis was within normal limits. C-reactive protein was elevated to 26 mg/dl (0\u20130.4 mg/dl). D-Dimer was not checked during the hospital course. COVID-19 polymerase chain reaction (PCR) detected the virus. Blood and urine cultures did not yield any growth. A repeat CT of the head demonstrated progression toward a large acute infarct of the left MCA territory with hyperdense appearance of left MCA vessels consistent with an acute thrombus. The patient was deemed not a candidate for thrombolysis or neuro-intervention due to poor functional status. The patient was treated with aspirin and other supportive measures. No abnormal heart rhythm was noted on telemetry monitoring. The family eventually decided to pursue comfort measures and terminally extubated the patient.",
        "es": "Un hombre de 73 a\u00f1os con antecedentes de hipertensi\u00f3n, dislipidemia y estenosis carot\u00eddea acudi\u00f3 al servicio de urgencias con fiebre, dificultad respiratoria y alteraci\u00f3n del estado mental. La anamnesis sistem\u00e1tica revel\u00f3 dispepsia, n\u00e1useas, v\u00f3mitos y disminuci\u00f3n de la ingesta oral durante dos d\u00edas, pero no report\u00f3 fiebre ni escalofr\u00edos en el domicilio. Hab\u00eda tenido contacto con una persona enferma en su casa. Las constantes vitales en la primera consulta eran fiebre de 38,3 \u00b0C, taquicardia con un pulso de 102 l.p.m., hipoxemia con una saturaci\u00f3n de 85% en mascarilla con reservorio del 100%. Se intub\u00f3 al paciente en urgencias con diagn\u00f3stico de insuficiencia respiratoria hipox\u00e9mica. A causa de la alteraci\u00f3n del estado mental, se realiz\u00f3 una TAC craneal, que mostr\u00f3 p\u00e9rdida de diferenciaci\u00f3n entre sustancia gris y sustancia blanca en los l\u00f3bulos parietal y occipital izquierdo, coherente con un infarto agudo. Una TAC tor\u00e1cica mostr\u00f3 opacidades de vidrio esmerilado difusas y opacidades alveolares parcheadas perif\u00e9ricas bilaterales, caracter\u00edsticas de neumon\u00eda at\u00edpica o infecci\u00f3n v\u00edrica por COVID-19. El electrocardiograma (ECG) no mostr\u00f3 resultados fuera de lo normal. El an\u00e1lisis de sangre mostr\u00f3 leucocitopenia y linfocitopenia. El an\u00e1lisis de orina dio resultados dentro de los l\u00edmites normales. La prote\u00edna C-reactiva era elevada, con un valor de 26 mg/dl (0\u20130,4 mg/dl). No se comprob\u00f3 el d\u00edmero D durante el curso hospitalario. La reacci\u00f3n en cadena de la polimerasa (PCR) para COVID-19 detect\u00f3 la presencia del virus. Los hemocultivos y urocultivos no mostraron ning\u00fan crecimiento. Una nueva TAC craneal mostr\u00f3 evoluci\u00f3n hacia un gran infarto agudo de la zona de la ACM izquierda con aspecto hiperdenso de los vasos de la ACM izquierda, coherente con un trombo agudo. Se consider\u00f3 que el paciente no era un candidato adecuado para intervenci\u00f3n neuroquir\u00fargica ni tromb\u00f3lisis a causa de su estado. El paciente se trat\u00f3 con aspirina y otras medidas sintom\u00e1ticas. La telemetr\u00eda no apreci\u00f3 ning\u00fan ritmo card\u00edaco an\u00f3malo. Finalmente, la familia decidi\u00f3 asumir medidas paliativas y extubar al paciente."
    },
    {
        "file_name": "32363217.en.txt",
        "en": "The mother was aged 41 years and underwent an urgent caesarean section due to severe preeclampsia on week 38+4 of gestation. The pregnancy was achieved by in vitro fertilization, and the mother had a history of hypothyroidism for which she was receiving ongoing treatment. The newborn was a girl with low birth weight for gestational age (2500\u202fg), a 1-min Apgar score of 7 and a 5-min Apgar score of 9 who required resuscitation with oropharyngeal suctioning. She was transferred to the neonatal unit due to immediate respiratory distress under respiratory support with continuous positive airway pressure (CPAP) without supplemental oxygen. Respiratory support was discontinued at 2\u202fh post birth and the findings of the physical examination at 9\u202fh post birth were normal. These problems were attributed to stress during the transition to extrauterine life, and the patient was subsequently transferred to the maternity ward to stay with her mother. On day 3 from admission, the mother developed a low-grade fever, and obstetric complications were ruled out. Two days later the mother had peaks of fever and respiratory symptoms, and a chest X-ray revealed severe bilateral pneumonia. The mother reported a negative history of travel to coronavirus risk areas or contact with infected individuals, although her partner had exhibited fever associated with gastroenteritis since the day of the caesarean delivery. After common viral illnesses had been ruled out, a real-time reverse transcription polymerase chain reaction (RT-PCR) test for detection of coronavirus 2019 was ordered for the mother. The result was positive. Her partner was tested subsequently, and the result was also positive. Up to this point, the girl had remained asymptomatic as she stayed with her mother in the maternity ward and received mixed breastfeeding. Due to the clinical condition of the mother, which required care in a special unit, mother and child were separated and the newborn also underwent testing for COVID-19 by RT-PCR on a sample of nasopharyngeal aspirate (day 6 post birth). Despite the negative result, the girl was kept in isolation in the maternity ward in the care of the hospital staff until a second sample was obtained 36\u202fh later (nasopharyngeal swab) and testing turned out positive (day 8 post birth). The newborn was then transferred to the neonatal unit without performance of additional diagnostic tests, as she remained asymptomatic. She was closely monitored, and on day 9 post birth she exhibited intermittent hyperpnoea with mild intercostal retractions and 2 self-limited episodes of oxygen desaturation during deep sleep and feeding. A capillary sample was obtained for blood gas analysis, which revealed transient mild acidosis (pH, 7.27; pCO2, 49\u202fmmHg; bicarbonate, 22\u202fmEq/L; base excess -4; normal lactate), a chest radiograph detected ground glass opacities mainly in the right perihilar region and the serum level of C-reactive protein was normal (0.06\u202fmg/dL). After 24\u202fh, the symptoms resolved, and the patient has remained asymptomatic to date (day 13 post birth), when the COVID-19 RT-PCR has been repeated and continues to be positive. Her mother is in the intensive care unit under mechanical ventilation.",
        "es": "La madre ten\u00eda 41 a\u00f1os y se someti\u00f3 a una ces\u00e1rea de urgencia a causa de preeclampsia grave a la semana 38+4 de gestaci\u00f3n. El embarazo se logr\u00f3 mediante fertilizaci\u00f3n in vitro; la madre ten\u00eda antecedentes de hipotiroidismo, por el cual recib\u00eda tratamiento. El reci\u00e9n nacido era una ni\u00f1a de peso bajo para la edad gestacional (2500\u202fg), un \u00edndice de Apgar de 7 a 1 min y de 9 a los 5 min; se necesit\u00f3 reanimaci\u00f3n con succi\u00f3n orofar\u00edngea. Se traslad\u00f3 a la unidad neonatal debido a dificultad respiratoria inmediata, con respiraci\u00f3n asistida mediante ventilaci\u00f3n mec\u00e1nica positiva continua (PPC) sin administraci\u00f3n de ox\u00edgeno. La respiraci\u00f3n asistida se retir\u00f3 a las 2 h del nacimiento y los resultados de la exploraci\u00f3n f\u00edsica a las 9 h fueron normales. Los problemas se atribuyeron al estr\u00e9s durante el paso a la vida extrauterina; se llev\u00f3 a la paciente con su madre. El d\u00eda 3 tras el ingreso, la madre present\u00f3 febr\u00edcula y se descartaron complicaciones obst\u00e9tricas. Dos d\u00edas despu\u00e9s, la madre mostr\u00f3 picos de fiebre y s\u00edntomas respiratorios; una radiograf\u00eda tor\u00e1cica revel\u00f3 neumon\u00eda bilateral grave. La madre no ten\u00eda antecedentes de viajes a zonas de riesgo por coronavirus ni de contactos con individuos infectados, aunque su pareja hab\u00eda presentado fiebre asociada a una gastroenteritis desde el d\u00eda de la ces\u00e1rea. Tras descartar enfermedades v\u00edricas comunes, se orden\u00f3 una prueba mediante reacci\u00f3n en cadena de la polimerasa con retrotranscripci\u00f3n (RT-PCR) para detecci\u00f3n del coronavirus 2019; esta prueba detecta dos regiones del genoma v\u00edrico. El resultado fue positivo. Luego se hizo una prueba a su pareja, con resultado tambi\u00e9n positivo. Hasta este momento, la ni\u00f1a hab\u00eda permanecido asintom\u00e1tica mientras se hallaba con su madre y hab\u00eda recibido lactancia mixta. Debido al estado cl\u00ednico de la madre, que requer\u00eda cuidados en una unidad especial, se separ\u00f3 a la hija de la madre. Tambi\u00e9n se realiz\u00f3 una prueba a la reci\u00e9n nacida para la COVID-19, mediante RT-PCR en una muestra de aspirado nasofar\u00edngeo (d\u00eda 6 del nacimiento). A pesar del resultado negativo, se mantuvo a la ni\u00f1a en aislamiento en la sala de partos a cargo del personal del hospital, hasta la obtenci\u00f3n de una segunda muestra 36 h despu\u00e9s (frotis nasofar\u00edngeo), cuyo resultado fue positivo (8 d\u00edas despu\u00e9s del nacimiento). La reci\u00e9n nacida se transfiri\u00f3 a la planta de neonatolog\u00eda sin pruebas adicionales, pues continu\u00f3 asintom\u00e1tica. Se monitoriz\u00f3 de cerca y el d\u00eda 9 despu\u00e9s del nacimiento present\u00f3 hiperpnea con leve retracci\u00f3n intercostal y 2 episodios de desaturaci\u00f3n de ox\u00edgeno durante el sue\u00f1o profundo y la alimentaci\u00f3n, que remitieron espont\u00e1neamente. Se obtuvo una muestra capilar para una gasometr\u00eda, que revel\u00f3 una leve acidosis transitoria (pH 7,27; pCO2 49\u202fmmHg; bicarbonato 22\u202fmEq/L; exceso de base -4; lactato normal); una radiograf\u00eda tor\u00e1cica detect\u00f3 opacidades de vidrio esmerilado b\u00e1sicamente en la regi\u00f3n perihiliar derecha; el valor s\u00e9rico de la prote\u00edna C-reactiva era normal (0,06\u202fmg/dL). Tras 24 h, los s\u00edntomas remitieron y la paciente se ha mantenido asintom\u00e1tica hasta el momento (d\u00eda 13 tras el nacimiento), cuando se repiti\u00f3 la RT-PCR para la COVID-19 y sigue siendo positiva. Su madre se halla en la unidad de cuidados intensivos con ventilaci\u00f3n mec\u00e1nica."
    },
    {
        "file_name": "32363336.en.txt",
        "en": "A 45-year-old, gravida 4, para 2, African American at 39 weeks and 2 days of gestation presented with contractions and emesis on March 25, 2020. The patient had a history of 2 full-term vaginal deliveries and was a diet-controlled gestational diabetic (GDMA1). Her body mass index (BMI) was 44.6 kg/m2. Her medical history was significant just for obesity and advanced maternal age. Her only medication was a daily prenatal vitamin. The patient had no known contact with COVID-19 cases and had not traveled outside of the United States in the past month. She was found to have tachycardia with a heart rate (HR) of 120s beats/min, fetal tachycardia with baseline fetal heart rate of 170 beats/min, and initial temperature of 99.6\u00b0F. She was admitted for intravenous (IV) fluid hydration and prolonged monitoring. A fever of 100.8\u00b0F developed in the patient 2 hours after admission, and workup revealed a chest radiograph with pulmonary edema and a ground-glass appearance. Six hours after presentation, she developed severe range hypertension with blood pressure of 183/114 mm Hg, HR of 130 beats/min, respiratory rate (RR) of 26 breaths/min, temperature of 100.7\u00b0F, and oxygen saturation (SpO2) of 96%. Given the severe range blood pressures, a preeclampsia panel was sent that revealed proteinuria of 1+, platelets of 274,000 per mcL, aspartate aminotransferase (AST) of 32 IU/L, and alanine aminotransferase (ALT) of 24 IU/L. A diagnosis of preeclampsia was established, and magnesium sulfate was initiated for seizure prophylaxis. The patient\u2019s RR increased to 40 breaths/min and SpO2 dropped to 80% on oxygen via nasal cannula. After discussion with maternal-fetal medicine, anesthesia, general obstetrics and gynecology, and cardiology, the decision was made to deliver the fetus to aid maternal resuscitation. The patient underwent a primary cesarean delivery 7.5 hours after presentation on March 26, 2020. On postoperative day (POD) 0, maternal arterial blood gas (ABG) showed a pH of 7.27, pCO2 of 31 mm Hg, pO2 of 117 mm Hg, HCO3 of 16 mEq/L, and a base excess (BE) of\u00a0\u221211 mmol/L. A repeat chest radiograph revealed small peripheral bilateral opacities with differential diagnoses including atypical pneumonia, viral pneumonia, and congestive heart failure. Owing to suspicion of congestive heart failure, magnesium sulfate was discontinued and furosemide was administered intravenously. Cardiology was consulted to perform an echocardiogram, which showed a moderately reduced left ventricular ejection fraction (LVEF) of 40% with global hypokinesis, and she was diagnosed with acute heart failure with reduced EF. Given the clinical picture of fever, tachypnea, and chest radiograph findings amidst the background of a pandemic, a GeneXpert COVID-19 RNA polymerase chain reaction test was performed that returned positive. Further laboratory investigation found a normal troponin of 0.046 ng/mL, a brain natriuretic peptide (BNP) of 114 pg/mL (normal <100 pg/mL), and a procalcitonin of 0.13 ng/mL (normal <0.10 ng/mL). On POD 4, chest radiograph demonstrated worsening bilateral lung infiltrates, and despite oxygen therapy, SpO2 could not be maintained above 90%. An electrocardiogram (ECG) was performed with nonspecific T-wave abnormalities on an otherwise normal ECG, with a QT/QTc of 354/465 ms (both normal). Serum potassium was 3.7 mEq/L (normal). As the patient\u2019s condition failed to improve, she was started on 60-mg methylprednisolone IV every 3 hours and 400-mg hydroxychloroquine orally every 12 hours for 24 hours, followed by 400 mg orally daily. That evening, after the initial doses were administered, she began desaturating to 86% on 6 L of nasal cannula. An ABG revealed a pH of 7.07, pCO2 of 75 mm Hg, pO2 of 85 mm Hg, HCO3 of 21.7 mEq/L, and a BE of\u00a0\u22122 mmol/L. She was placed on a nonrebreather at 15 L, which initially improved SpO2 to 90%, and on POD 4, 100-mg methylprednisolone IV daily was started. On POD 5, the patient again desaturated to 80%. As our institutional COVID-19 protocol calls to avoid noninvasive mechanical ventilation that could aerosolize viral particles, the patient was intubated by anesthesia, but without improvement. HR decreased to the 30s, and the patient developed pulseless electrical activity. Cardiopulmonary resuscitation (CPR) was initiated, and return of spontaneous circulation was obtained after 5 minutes of CPR. After arrest, her troponin level peaked at 0.930 ng/mL (normal <0.4 ng/mL), with a BNP of 323 pg/mL. After CPR, the patient was started on a norepinephrine drip, initially at 8 mcg/min and titrated up to a maximum of 20 mcg/min. The patient was administered 1 dose of 800-mg tocilizumab IV, an interleukin-6 (IL-6) receptor antagonist. As of the writing of this article (April 2, 2020), the patient is currently at POD 7 and remains intubated and ventilated in the intensive care unit and is arousable and moving all 4 extremities, with SpO2 of 96%, continuance of norepinephrine drip at 20 mcg/min, 100-mg methylprednisolone IV daily, and 400-mg hydroxychloroquine orally daily. Her significant laboratory values are troponin 0.046 ng/mL and a markedly elevated procalcitonin of 48.21 ng/mL.",
        "es": "Una mujer afroamericana de 45 a\u00f1os, cuartigesta secund\u00edpara, de 39 semanas y 2 d\u00edas de gestaci\u00f3n acudi\u00f3 al servicio el 25 de marzo de 2020 con contracciones y v\u00f3mitos. La paciente ten\u00eda antecedentes de dos partos vaginales a t\u00e9rmino y de diabetes gestacional controlada mediante dieta (GDMA1). Su \u00edndice de masa corporal (IMC) era de 44,6 kg/m2. Sus antecedentes m\u00e9dicos solo eran relevantes por lo que respecta a obesidad y a una edad avanzada de embarazo. Su \u00fanica medicaci\u00f3n eran vitaminas prenatales diarias. La paciente no hab\u00eda tenido ning\u00fan contacto conocido con casos de COVID-19 y no hab\u00eda viajado fuera de Estados Unidos durante el \u00faltimo mes. Se le observ\u00f3 taquicardia con un pulso de 120 l.p.m., taquicardia fetal con un pulso fetal basal de 170 l.p.m. y una temperatura inicial de 37,5 \u00b0C. Se la ingres\u00f3 con hidrataci\u00f3n i.v. y monitorizaci\u00f3n prolongada. 2 horas despu\u00e9s del ingreso, la temperatura de la paciente subi\u00f3 a 38,2 \u00b0C y las pruebas radiol\u00f3gicas revelaron edema pulmonar y aspecto de vidrio esmerilado. Seis horas despu\u00e9s de la consulta inicial, la paciente present\u00f3 hipertensi\u00f3n grave en ambos l\u00edmites, con una presi\u00f3n de 183/114 mm Hg, pulso de 130 l.p.m., frecuencia respiratoria de 26 r.p.m., temperatura de 38,1 \u00b0C y saturaci\u00f3n de ox\u00edgeno (SpO2) de 96%. Teniendo en cuenta la presi\u00f3n arterial extrema, se hizo un perfil de preeclampsia que revel\u00f3 proteinuria de 1+, trombocitos de 274.000 por mcL, aspartato-aminotransferasa (AST) de 32 UI/L y alanina-aminotransferasa (ALT) de 24 IU/L. Se determin\u00f3 un diagn\u00f3stico de preeclampsia y se inici\u00f3 un tratamiento con sulfato de magnesio para prevenci\u00f3n de posibles crisis. Y la SpO2 baj\u00f3 a 80% con oxigenoterapia mediante c\u00e1nula nasal. Tras un an\u00e1lisis con los departamentos de medicina maternofetal, anestesia, obstetricia y ginecolog\u00eda general y cardiolog\u00eda, se decidi\u00f3 extraer el feto para permitir la reanimaci\u00f3n materna. Se llev\u00f3 a cabo una ces\u00e1rea 7,5 horas despu\u00e9s de la consulta inicial, el 26 de marzo de 2020. El d\u00eda 0 tras la operaci\u00f3n, la gasometr\u00eda arterial materna mostr\u00f3 un pH de 7,27, pCO2 de 31 mm Hg, pO2 de 117 mm Hg, HCO3 de 16 mEq/L y un exceso de base (EB) de\u221211 mmol/L. Una radiograf\u00eda tor\u00e1cica de seguimiento revel\u00f3 peque\u00f1as opacidades bilaterales perif\u00e9ricas, con un diagn\u00f3stico diferencial que inclu\u00eda neumon\u00eda at\u00edpica e insuficiencia card\u00edaca congestiva. A causa de la sospecha de insuficiencia card\u00edaca congestiva, se retir\u00f3 el sulfato de magnesio y se administr\u00f3 furosemida i.v. Se consult\u00f3 con cardiolog\u00eda para realizar un ecocardiograma, que mostr\u00f3 una fracci\u00f3n de expulsi\u00f3n del VI reducida, del 40%, con hipocinesia global; se diagnostic\u00f3 a la paciente con insuficiencia card\u00edaca aguda, con reducci\u00f3n de la fracci\u00f3n de expulsi\u00f3n. Teniendo en cuenta el cuadro cl\u00ednico de fiebre, taquipnea y los resultados de la radiograf\u00eda tor\u00e1cica, en el trasfondo de una pandemia, se realiz\u00f3 una prueba GeneXpert de PCR para el ARN de COVID-19, que dio resultado positivo. Con pruebas anal\u00edticas adicionales se hall\u00f3 un valor normal de troponina (0,046 ng/mL), p\u00e9ptido natriur\u00e9tico cerebral (114 pg/mL, normal < 100 pg/mL) y procalcitonina (0,13 ng/mL, normal < 0,10 ng/mL). El d\u00eda 4 tras la operaci\u00f3n, la radiograf\u00eda tor\u00e1cica mostr\u00f3 un empeoramiento de los infiltrados pulmonares bilaterales y, a pesar de la oxigenoterapia, no se pudo mantener la SpO2 por encima de 90%. Se realiz\u00f3 un electrocardiograma, que revel\u00f3 alteraciones inespec\u00edficas de la onda T en un ECG por lo dem\u00e1s normal, con un QT/QTc de 354/465 ms (ambos normales). El potasio s\u00e9rico era de 3,7 mEq/L (normal). El estado de la paciente no mejor\u00f3 y se inici\u00f3 un tratamiento con 60 mg de metilprednisolona i.v. cada 3 horas y 400 mg de hidroxicloroquina por v\u00eda oral cada 12 horas durante 24 horas, seguida de 400 mg por v\u00eda oral por d\u00eda. Esa misma tarde, tras la administraci\u00f3n de las dosis iniciales, empez\u00f3 a desaturar al 86% con 6 L por c\u00e1nula nasal. La gasometr\u00eda arterial materna mostr\u00f3 un pH de 7,07, pCO2 de 75 mm Hg, pO2 de 85 mm Hg, HCO3 de 21,7 mEq/L y un exceso de base de-2 mmol/L. Se le coloc\u00f3 una m\u00e1scara con reservorio a 15 L, que inicialmente mejor\u00f3 la SpO2 a 90% y el d\u00eda 4 tras la operaci\u00f3n se inici\u00f3 100 mg de metilprednisolona i.v. El d\u00eda 5 tras la operaci\u00f3n la paciente volvi\u00f3 a desaturar a 80%. Dado que nuestro protocolo institucional sobre la COVID-19 aconseja evitar ventilaci\u00f3n mec\u00e1nica no invasiva que pudiera aerosolizar part\u00edculas v\u00edricas, se intub\u00f3 a la paciente con anestesia, pero no se observ\u00f3 mejora. y la paciente present\u00f3 actividad el\u00e9ctrica sin pulso (AESP). Se inici\u00f3 reanimaci\u00f3n cardiopulmonar (RCP) y se logr\u00f3 el retorno de la circulaci\u00f3n espont\u00e1nea tras cinco minutos de RCP. Tras el paro, su valor de troponina lleg\u00f3 a 0,930 ng/mL (normal < 0,4 ng/mL), con un p\u00e9ptido natriur\u00e9tico cerebral de 323 pg/mL. Tras la RCP, se inici\u00f3 un tratamiento con norepinefrina i.v., inicialmente a 8 mcg/min, con un ajuste de dosis de hasta 20 mcg/min. Se le administr\u00f3 una dosis de 800 mg de tocilizumab i.v., un antagonista del receptor de la interleucina 6 (IL-6). En el momento de redactar este art\u00edculo (2 de abril de 2020), la paciente se halla en el d\u00eda 7 posoperatorio y sigue intubada y con ventilaci\u00f3n en la unidad de cuidados intensivos, se despierta y muestra movimiento en las 4 extremidades; la SpO2 es de 96% y se mantiene la infusi\u00f3n i.v. Los valores m\u00e1s relevantes de las pruebas anal\u00edticas son troponina a 0,046 ng/mL y un marcado aumento de procalcitonina a 48,21 ng/mL."
    },
    {
        "file_name": "32399449.en.txt",
        "en": "An 82-year-old woman was admitted to our emergency department (ED) for a 5-day history of fever and general malaise. The patient was on oral azithromycin and amoxicillin-clavulanate without any improvement. She was an ex-smoker and had a medical history of hypertension and chronic obstructive pulmonary disease. At admission she presented severe respiratory failure (PaO2/FiO2 55 mmHg, respiratory rate 26 breaths/min) with a need for high-flow oxygen therapy. A lung ultrasound (US) showed diffuse B lines with pleural thickening and small subpleural consolidations. A chest CT scan and nasopharyngeal swab confirmed the diagnosis of COVID-19 pneumonia. Antibiotics were discontinued, and darunavir/cobicistat, hydroxychloroquine and LMWH at a prophylactic dose were started. On day 12 after admission, the patient complained of an ache in her right leg and a sensation of warmth. She denied chest pain and dyspnoea (PaO2/FiO2>300 mmHg on nasal prong oxygen). Physical examination revealed oedema of the right leg and signs of dehydration. Compression ultrasound (CUS) of the right common femoral vein indicated venous thrombosis. Lung US showed multiple bibasal consolidations. Echocardiography documented normal ventricular function in the absence of indirect signs of PE. The inferior vena cava had completely collapsed, indicating hypovolemia. An electrocardiogram (ECG) revealed sinus tachycardia. Blood tests showed elevated D-dimer (24 131 mg/dl), fibrinogen (674 mg/dl), serum ferritin (765 ng/ml) and troponin I (57 ng/ml). As creatinine clearance was \u226430 ml/min, continuous intravenous infusion of unfractionated heparin was started with close monitoring of partial thromboplastin time (PTT). The patient underwent a CT scan of the chest that showed diffuse bilateral consolidations and a crazy-paving pattern (visual CT score 70%). Based on this finding, we introduced systemic corticosteroids. The patient is progressively improving with complete resolution of acute renal failure after infusion of crystalloid fluids. She needs only low-flow oxygen therapy. The heparin infusion was switched after 3 days to standard-dose LMWH (enoxaparin).",
        "es": "Una mujer de 82 a\u00f1os ingres\u00f3 en el servicio de urgencias con fiebre y malestar general de 5 d\u00edas de evoluci\u00f3n. La paciente tom\u00f3 azitromicina oral y amoxicilina/clavulanato sin ninguna mejora. Era exfumadora, con antecedentes de hipertensi\u00f3n y enfermedad pulmonar obstructiva cr\u00f3nica. Al ingreso mostr\u00f3 insuficiencia respiratoria grave (PaO2/FiO2 55 mmHg, frecuencia respiratoria 26 r.p.m.) y necesit\u00f3 oxigenoterapia de alto flujo. Una ecograf\u00eda pulmonar mostr\u00f3 l\u00edneas B difusas con engrosamiento pleural y peque\u00f1as consolidaciones subpleurales. Una TAC tor\u00e1cica y un frotis nasofar\u00edngeo confirmaron el diagn\u00f3stico de neumon\u00eda por COVID-19. Se retiraron los antibi\u00f3ticos y se inici\u00f3 un tratamiento con darunavir/cobicistat, hidroxicloroquina y HBPM a dosis preventiva. El d\u00eda 12 despu\u00e9s del ingreso, la paciente refiri\u00f3 dolor en su pierna derecha y una sensaci\u00f3n de calor. Afirm\u00f3 no tener dolor tor\u00e1cico ni disnea (PaO2/FiO2 > 300 mmHg con gafas nasales). La exploraci\u00f3n f\u00edsica revel\u00f3 edema en la pierna derecha y signos de deshidrataci\u00f3n. Una ecograf\u00eda compresiva de la porci\u00f3n proximal de la vena femoral derecha indic\u00f3 trombosis venosa. Una ecograf\u00eda pulmonar mostr\u00f3 varias consolidaciones bibasales. La ecocardiograf\u00eda revel\u00f3 una funci\u00f3n ventricular normal con ausencia de signos indirectos de embolia pulmonar. La vena cava inferior estaba totalmente colapsada, lo que indicaba hipovolemia. Un electrocardiograma (ECG) revel\u00f3 taquicardia sinusal. Los an\u00e1lisis de sangre dieron valores altos de d\u00edmero D (24.131 mg/dl), fibrin\u00f3geno (674 mg/dl), ferritina s\u00e9rica (765 ng/ml) y troponina I (57 ng/ml). Como la depuraci\u00f3n de la creatinina era \u2264 30 ml/min, se inici\u00f3 heparina no fraccionada i.v. con monitorizaci\u00f3n cercana del tiempo de tromboplastina parcial (TTP). La paciente se someti\u00f3 a una TAC tor\u00e1cica que mostr\u00f3 consolidaciones bilaterales difusas y patr\u00f3n en empedrado (\u00edndice visual TAC 70%). A partir de estos resultados, introdujimos corticosteroides sist\u00e9micos. La paciente mejor\u00f3 progresivamente con resoluci\u00f3n completa de la insuficiencia renal aguda tras infusi\u00f3n de soluci\u00f3n de cristaloides; solo necesit\u00f3 oxigenoterapia de bajo flujo. Despu\u00e9s de 3 d\u00edas, la infusi\u00f3n de heparina se cambi\u00f3 a una dosis est\u00e1ndar de HBPM (enoxaparina)."
    },
    {
        "file_name": "32414534.en.txt",
        "en": "A 69-year-old man with a 7-day history of fever and cough was admitted to the University Hospital of Guadeloupe (French indies) for confusion and severe headache. He had no medical history and reported having traveled to the Middle-East (cruise ship) with his wife 15 days before hospitalization. He did not report insect bites. A week after returning home, he presented fever, myalgia, cough, anosmia, ageusia, cervical pain, stiff neck, and diarrhea. At admission, he reported a worsening of his condition for 24 hours with painful and stiff neck and headache, confusion, walking disability with falls, and dyspnea. Noteworthy, his wife had also had isolated cough and ageusia for the past 10 days. On examination, the patient was febrile (38.5 8C) with diffuse headache, neck stiffness, altered consciousness(Glasgow Coma Scale 14), confusion, swallowing disorders, and right-sided hemiparesis. Respiratory rate was increased(36/min), pulse rate was 95/min, blood pressure 160/89 mmHg, and oxygen saturation was 91% in ambient air. Laboratory analyses showed increased C-reactive protein at 95 mg/L and creatine kinase level (655 U/L), raised transaminases (aspartate aminotransferase = 85 U/L, ala-nine aminotransferase = 94 U/L) and lactate dehydrogenase (442 U/L). Arterial partial pressure of oxygen was decreased at 64 mmHg with normal arterial partial pressure of carbon dioxide and pH. Chest computed tomographic scan was highly suggestive of COVID-19 (Fig. Cerebrospinal fluid was purely lymphocytic with no red blood cells, an increased protein level at 84 mg/dL and normal glucose level. Brain MRI with gadolinium was normal. Electro-encephalogram showed a bilateral slowed activity without seizures. The detection of SARS-CoV-2 by specific real-time reverse PCR (RT-PCR) was negative in nasopharyngeal swab and cerebrospinal fluid (CSF) on days 2 and 4 after admission but was positive in bronchoalveolar lavage on day 5. Using a similar biological tool, the search for Influenza virus was negative. RT-PCR for varicella-zoster virus, herpes simplex virus (HSV), and enterovirus in CSF were all negative. Other tests for endemic infections in our area were performed, but all negative. The patient received nasal oxygen therapy. Acyclovir infusions were performed for 3 days and stopped when RT-CR for HSV was found negative. We started hydroxychloroquine sulfate 200 mg, three times per day, and azithromycin 250 mg daily for 7 days. On hospital day 4, his neurological condition improved with normal consciousness and abatement of swallowing disorders. At discharged on day 10, mild neuropsychiatric features were still present with an alteration of executive functions. Montreal Cognitive Assessment was decreased to 26/30.",
        "es": "Un hombre de 69 a\u00f1os con fiebre y tos de 7 d\u00edas de evoluci\u00f3n ingres\u00f3 en el Hospital Universitario de Guadalupe (Indias francesas) con desorientaci\u00f3n y cefalea intensa. No ten\u00eda antecedentes y refiri\u00f3 haber viajado al Pr\u00f3ximo Oriente (crucero de vacaciones) con su esposa 15 d\u00edas antes de la hospitalizaci\u00f3n. No refiri\u00f3 picadas de insectos. Una semana despu\u00e9s de haber regresado a casa, tuvo fiebre, mialgia, tos, anosmia, ageusia, dolor cervical, rigidez de nuca y diarrea. Al ingreso, inform\u00f3 de un empeoramiento de su estado en las \u00faltimas 24 horas, con rigidez y dolor de nuca, cefalea intensa, desorientaci\u00f3n, incapacidad de andar, con ca\u00eddas, y disnea. Cabe se\u00f1alar que su esposa tambi\u00e9n hab\u00eda sufrido tos y ageusia durante los \u00faltimos 10 d\u00edas. A la exploraci\u00f3n, el paciente estaba febril (38,5 \u00b0C) con cefalea difusa, rigidez de nuca, alteraci\u00f3n de la conciencia (14 en la escala de coma de Glasgow), desorientaci\u00f3n, disfagia y hemiparesia derecha. La frecuencia respiratoria era alta (36 r.p.m. ), el pulso era de 95 l.p.m., la presi\u00f3n arterial era de 160/89 mmHg y la saturaci\u00f3n de ox\u00edgeno era de 91% en aire ambiental. Las pruebas anal\u00edticas mostraron aumento de proteina C-reactiva (95 mg/L) y de creatina-cinasa (655 U/L), aumento de transaminasas (aspartato-aminotransferasa = 85 U/L, alanina-aminotransferasa = 94 U/L) y de lactato-deshidrogenasa (442 U/L). La presi\u00f3n parcial arterial de ox\u00edgeno presentaba un valor bajo de 64 mmHg, con presi\u00f3n parcial arterial normal de di\u00f3xido de carbono y pH. Una TAC tor\u00e1cica fue muy indicativa de COVID-19. El l\u00edquido cefalorraqu\u00eddeo era \u00fanicamente linfoc\u00edtico, sin eritrocitos, y presentaba proteinorraquia elevada (84 mg/dL) y glucorraquia normal. Una RMN cerebral con gadolinio fue normal. El electroencefalograma mostr\u00f3 una disminuci\u00f3n bilateral de la actividad, sin crisis. La detecci\u00f3n de SARS-CoV-2 mediante RT-PCR en tiempo real fue negativa en frotis nasofar\u00edngeo y en l\u00edquido cefalorraqu\u00eddeo (LCR) los d\u00edas 2 y 4 tras el ingreso, pero positiva en lavado broncoalveolar el d\u00eda 5. Mediante recursos biol\u00f3gicos similares, los resultados para el virus de la gripe fueron negativos. Las RT-PCR para el virus de la varicela-z\u00f3ster, el virus del herpes simple (VHS) y enterovirus en LCR fueron todas negativas. Se realizaron otras pruebas para infecciones end\u00e9micas de nuestra zona, pero tambi\u00e9n fueron todas negativas. El paciente recibi\u00f3 oxigenoterapia nasal. durante 3 d\u00edas, y se retir\u00f3 cuando la RT-PCR para el VHS fue negativa. Se inici\u00f3 un tratamiento con sulfato de hidroxicloroquina 200 mg tres veces al d\u00eda y azitromicina 250 mg al d\u00eda durante 7 d\u00edas. El d\u00eda 4 de hospitalizaci\u00f3n su estado neurol\u00f3gico mejor\u00f3, con una conciencia normal y disminuci\u00f3n de la disfagia. Al recibir el alta, el d\u00eda 10 tras el ingreso, a\u00fan presentaba algunas manifestaciones leves neuropsiqui\u00e1tricas, con una cierta alteraci\u00f3n de las funciones ejecutivas. El \u00edndice seg\u00fan la escala MoCA disminuy\u00f3 a 26/30."
    },
    {
        "file_name": "32417987.en.txt",
        "en": "On February 28, 2020, a 54-year-old firefighter was admitted to our emergency room (ER) after a single seizure characterized by clonic movements in the right arm and loss of consciousness. His relatives reported a sudden onset of involuntary and rhythmic movements involving the right hand and arm lasting about 1 or 2 min; after that, it was reported that the patient appeared generally stiffened and he lost consciousness. When he awakened, he was confused for about 30 min. At the ER admission, he reported suffering from conjunctivitis in the last 10 days and mild fever in the past week. He had no remote medical or neurological history; he had been taking ophthalmic steroids during the previous days but he was not under regular medications; there was no history of drug use. Vital parameters, peripheral oxygen saturation, and EKG were normal (body temperature 36.5 \u00b0C); neurological examination showed no focal deficits. Serum laboratory tests revealed neutrophilia (85.5%, NR 40\u201375%), normal white blood cell count (6.38 \u00d7 1000/\u03bcL, NR 4.0\u201310.0), lymphopenia (0.69 \u00d7 1000/\u03bcL, NR 0.8\u20134.0), normal serum sodium (140.8 mmol/L, NR 132.0\u2013146.0), slightly elevated CRP (1.29 mg/dL, NR 0\u20130.5), and AST and ALT enzymes (57 and 59 UI/L respectively, NR 2\u201340 and 4\u201349). Head CT scan was unremarkable. Chest X-ray showed a single lingular disventilatory band. Urinalysis test, urine culture, and urinary antigen tests for Streptococcus pneumoniae and Legionella pneumophila were normal. The patient\u2019s electroencephalogram recorded the following day showed no abnormalities. In the suspicion of Mycoplasma pneumoniae infection, Azithromycin 500 mg QD for 3 days was prescribed. On February 29, the patient was discharged and a diagnosis of \u201cfirst focal motor seizure\u201d was made; no anti-epileptic medications were prescribed. After 4 days, on March 4, the patient was admitted to the ER again reporting cough, high fever, and shortness of breath; his daughter also had a high fever. His temperature was 38.5 \u00b0C, the heart rate was 100 bpm, and the peripheral oxygen saturation was 94%. Lab tests showed raised inflammatory markers; chest X-ray pointed out the appearance of mild bilateral perihilar consolidations; chest HR-CT scan showed bilateral ground-glass opacities. Based on epidemiological data and according to the government guidelines, two nasopharyngeal swabs were obtained and were found to be positive for SARS-CoV-2 on qRT-PCR. The patient was hospitalized in the Intermediate Care Unit and non-invasive ventilation (NIV) was undertaken. He completely recovered after 2 weeks of antiviral therapy (Lopinavir-Ritonavir); he remains seizure-free.",
        "es": "El 28 de febrero de 2020 ingres\u00f3 en urgencias un bombero de 54 a\u00f1os tras una crisis caracterizada por movimientos cl\u00f3nicos en el brazo derecho y p\u00e9rdida de conciencia. Sus parientes refirieron una aparici\u00f3n s\u00fabita de movimientos r\u00edtmicos e involuntarios en el brazo y la mano derecha, de 1 o 2 minutos de duraci\u00f3n; despu\u00e9s, el paciente mostr\u00f3 rigidez y se desmay\u00f3. Al despertar, se encontr\u00f3 desorientado durante unos 30 minutos. Al ingreso en urgencias, refiri\u00f3 tener conjuntivitis en los \u00faltimos 10 d\u00edas y febr\u00edcula durante la \u00faltima semana. No ten\u00eda antecedentes neurol\u00f3gicos, se hab\u00eda medicado con esteroides oft\u00e1lmicos durante los \u00faltimos d\u00edas, pero no tomaba ninguna medicaci\u00f3n regular; no hab\u00eda antecedentes t\u00f3xicos. Las constantes vitales, la saturaci\u00f3n de ox\u00edgeno en sangre perif\u00e9rica y el ECG eran normales (temperatura 36,5 \u00b0C); la exploraci\u00f3n neurol\u00f3gica no mostr\u00f3 carencias focales. Las pruebas anal\u00edticas revelaron neutrofilia (85,5%, valores de referencia 40\u201375%), cifra normal de leucocitos (6,38 \u00d7 1000/\u03bcL, valores de referencia 4,0\u201310,0), linfocitopenia (0,69 \u00d7 1000/\u03bcL, valores de referencia 0,8\u20134,0), sodio s\u00e9rico normal (140,8 mmol/L, valores de referencia 132,0\u2013146,0), prote\u00edna C-reactiva ligeramente alta (1,29 mg/dL, valores de referencia 0\u20130,5) y AST y ALT tambi\u00e9n altas (57 y 59 UI/L respectivamente, valores de referencia 2\u201340 y 4\u201349). La TAC craneal no dio resultados relevantes. Una radiograf\u00eda tor\u00e1cica mostr\u00f3 una \u00fanica banda disventilatoria lingular. Los urocultivos, los an\u00e1lisis de orina y las pruebas de uroant\u00edgenos para Streptococcus pneumoniae y Legionella pneumophila fueron normales. El electroencefalograma del paciente, obtenido el d\u00eda siguiente, no mostr\u00f3 ninguna anomal\u00eda. Al sospechar infecci\u00f3n por Mycoplasma pneumoniae, se recet\u00f3 azitromicina a una dosis de 500 mg al d\u00eda durante tres d\u00edas. El 29 de febrero, el paciente fue dado de alta con un diagn\u00f3stico de \u00abcrisis motora de primer foco\u00bb; no se recet\u00f3 medicaci\u00f3n antiepil\u00e9ptica. 4 d\u00edas despu\u00e9s, el 4 de marzo, el paciente fue ingresado de nuevo en urgencias con tos, fiebre alta y disnea; su hija tambi\u00e9n presentaba fiebre alta. Su temperatura era de 38,5 \u00b0C, el pulso era de 100 l.p.m. y la saturaci\u00f3n de ox\u00edgeno en sangre perif\u00e9rica era de 94%. Las pruebas anal\u00edticas mostraron un aumento de los marcadores de inflamaci\u00f3n; la radiograf\u00eda tor\u00e1cica evidenci\u00f3 la aparici\u00f3n de consolidaciones leves perihilares bilaterales; la TAC de alta resoluci\u00f3n mostr\u00f3 opacidades de vidrio esmerilado bilaterales. A partir de los datos epidemiol\u00f3gicos y siguiendo las directrices gubernamentales, se obtuvieron dos frotis nasofar\u00edngeos, que dieron resultado positivo para SARS-CoV-2 mediante qRT-PCR. El paciente fue hospitalizado en la unidad de cuidados intermedios y se le aplic\u00f3 ventilaci\u00f3n no invasiva. Tras dos semanas con terapia antiv\u00edrica (lopinavir/ritonavir), el paciente se recuper\u00f3 completamente; sigue sin evidencias de crisis."
    },
    {
        "file_name": "32426200.en.txt",
        "en": "A previously healthy 31-year-old female presented to the emergency department (ED) with symptoms of fever, congestion, rhinorrhea, cough, myalgias, vomiting, and abdominal cramping evolving over five days. She worked at a factory, but was not exposed to any symptomatic contacts and did not use tobacco products, alcohol, or illicit substances. On arrival, her vitals were blood pressure - 97/73 mm Hg, heart rate - 127 beats/minute, respiratory rate - 18\u00a0breaths/minute while saturating was at 95% on supplemental oxygen, along with persistent fevers despite acetaminophen administration. On exam, she appeared ill, uncomfortable, and in acute distress. Initial investigations were remarkable for hypernatremia, acute kidney injury (AKI), and bilateral infiltrates on chest radiograph indicative of pneumonia. Ceftriaxone and azithromycin were started empirically with intravenous hydration, while nasopharyngeal swab for COVID-19 was obtained. Her hypoxia and fevers continued to worsen with increasing oxygen requirements, evolving hypotension, and tachypnea, requiring intubation and sedation with transfer to the intensive care unit (ICU). A chest computed tomography (CT) was consistent with acute respiratory distress syndrome (ARDS) with partial pressure of oxygen (PaO2)/fraction of inspired oxygen (FiO2) ratio dropping as low as 77.5 consistent with severe ARDS. Testing to detect SARS-COV-2 came back positive. She was started on a course of hydroxychloroquine and optimized to lung-protective ventilation. Initial COVID-19 labs were indicative of cytokine release syndrome, while a high A-a gradient concerning for a V/Q mismatch was consistent with COVID-19 phenotype L.She was placed on a short course of therapeutic anticoagulation. She was proned with intermittent paralytics to improve oxygenation and synchronize her to the ventilator. On daily awakening trials, she displayed significant features of confusion and encephalopathy. During\u00a0saturation and weaning of her paralytic, new left-hand flaccidity was noted. The finding was subtle, and the National Institutes of Health Stroke Scale (NIHSS) could not be assessed due to her inability to follow commands. However, brainstem reflexes were preserved with pupillary and cough reflexes to stimuli, the ability to trigger spontaneous breaths, and response to pain. Delays in obtaining an emergent CT scan of her head ensued due to her positivity for COVID-19 and an equivocal stroke-like presentation. After appropriate precautions were set up, the final read of the CT was unrevealing for an acute or subacute infarct or haemorrhage. Atorvastatin and aspirin were started for secondary prevention, while COVID-19 labs were repeated to trend progression of the disease. A repeat CT scan revealed ischemic changes in the region supplied by the right middle cerebral artery (MCA) consistent with a cortical stroke. Follow up echocardiogram, and hypercoagulable workup was negative, including ultrasounds in the upper and lower extremities looking for deep vein thromboses (DVTs) to look for sources of thrombi. After remaining on mechanical ventilation and nasogastric (NG) feeding for a prolonged period, a tracheostomy and percutaneous endoscopic gastrostomy (PEG) tube were performed. Over the next few days, improvements in her mentation were noted with opening and tracking with her eyes, and the ability to start following commands. Physical therapy assessments recorded low mobility scores and severe disability while continuing to demonstrate periods of confusion. She was improving globally with the ability to tolerate breathing trials and follow commands. Conferred an overall poor prognosis, she was discharged to a rehabilitation facility.",
        "es": "Una mujer de 31 a\u00f1os, por lo dem\u00e1s sana, acudi\u00f3 al servicio de urgencias con s\u00edntomas de fiebre, congesti\u00f3n, rinorrea, tos, mialgia, v\u00f3mitos y c\u00f3licos, de cinco d\u00edas de evoluci\u00f3n. Trabajaba en una f\u00e1brica, pero no hab\u00eda estado expuesta a contactos sintom\u00e1ticos ni era fumadora, bebedora ni consum\u00eda sustancias ilegales. Al ingreso, sus constantes vitales eran: presi\u00f3n arterial 97/73 mmHg, pulso 127 l.p.m., frecuencia respiratoria 18 r.p.m. ; saturaba a 95% con oxigenoterapia y presentaba fiebre persistente a pesar de la administraci\u00f3n de acetaminofeno. A la exploraci\u00f3n, ten\u00eda aspecto enfermo, se mostraba inc\u00f3moda y con un malestar intenso. Las pruebas iniciales revelaron hipernatremia, lesi\u00f3n renal aguda e infiltrados bilaterales en radiograf\u00eda tor\u00e1cica, indicativos de neumon\u00eda. Se inici\u00f3 tratamiento sintom\u00e1tico con ceftriaxona y azitromicina e hidrataci\u00f3n i.v. y se obtuvo un frotis nasofar\u00edngeo para COVID-19. Su hipoxia y fiebre empeoraron, con una demanda creciente de ox\u00edgeno, que evolucion\u00f3 a hipotensi\u00f3n y taquipnea; la paciente requiri\u00f3 intubaci\u00f3n y sedaci\u00f3n y traslado a la unidad de cuidados intensivos (UCI). Una TAC tor\u00e1cica dio resultados coherentes con s\u00edndrome de dificultad respiratoria aguda (SDRA), con el cociente de presi\u00f3n parcial de ox\u00edgeno (PaO2) y fracci\u00f3n de ox\u00edgeno inspirado (FiO2) bajando hasta 77,5, coherente con SDRA grave. Se inici\u00f3 tratamiento con una pauta de hidroxicloroquina y se optimiz\u00f3 para respiraci\u00f3n asistida para protecci\u00f3n de los pulmones. Las pruebas iniciales de COVID-19 indicaban crisis de citocinas, mientras que un alto gradiente A-a que asociado a un desequilibrio V/Q era coherente con el fenotipo L de COVID-19. Se le administr\u00f3 una pauta breve de anticoagulantes. Se la coloc\u00f3 en dec\u00fabito prono con paralizaci\u00f3n intermitente para mejorar la oxigenaci\u00f3n y sincronizarla con el respirador. En pruebas diarias de vigilia, mostr\u00f3 caracter\u00edsticas evidentes de desorientaci\u00f3n y encefalopat\u00eda. Durante la saturaci\u00f3n y la retirada de la paralizaci\u00f3n, se apreci\u00f3 flacidez de la mano izquierda de nueva aparici\u00f3n. El resultado era sutil y no se pudo evaluar a la paciente de acuerdo con la escala de evaluaci\u00f3n neurol\u00f3gica de los NIH a causa de su incapacidad para seguir \u00f3rdenes. Sin embargo, los reflejos del tronco encef\u00e1lico se manten\u00edan, con reflejo fotomotor y tus\u00edgeno, capacidad de respiraci\u00f3n espont\u00e1nea y respuesta al dolor. Los retrasos para obtener una TAC craneal urgente fueron provocados por su COVID-19 positivo y un cuadro equ\u00edvoco de seudoictus. Tras establecer las precauciones adecuadas, el resultado de la TAC fue irrelevante para hemorragia o infarto agudo o subagudo. Se inici\u00f3 tratamiento con atorvastatina y aspirina para prevenci\u00f3n secundaria mientras se repet\u00edan las pruebas de COVID-19 para determinar la evoluci\u00f3n de la enfermedad. Una segunda TAC revel\u00f3 alteraciones isqu\u00e9micas en la regi\u00f3n irrigada por la arteria cerebral media derecha, consistentes con un ictus cortical. Un ecocardiograma de seguimiento y un an\u00e1lisis de hipercoagulabilidad dieron resultado negativo, as\u00ed como ecograf\u00edas en las extremidades superiores e inferiores para buscar fuentes de trombos para trombosis venosa profunda. Tras estar con respiraci\u00f3n asistida y alimentaci\u00f3n nasog\u00e1strica durante un tiempo prolongado, se le practic\u00f3 una traqueostom\u00eda y un tubo de gastroestom\u00eda endosc\u00f3pica percut\u00e1nea. Durante los d\u00edas siguientes se apreciaron mejoras en su actividad mental, con apertura y seguimiento de los ojos, y la capacidad de empezar a seguir \u00f3rdenes. Las evaluaciones de fisioterapia dieron bajas puntuaciones de movilidad y una incapacidad grave, adem\u00e1s de mostrar per\u00edodos de desorientaci\u00f3n. Globalmente, sigui\u00f3 mejorando, con capacidad para tolerar pruebas de respiraci\u00f3n y seguir \u00f3rdenes. Tras determinar un mal pron\u00f3stico, se la dio de alta para su traslado a un centro de rehabilitaci\u00f3n."
    },
    {
        "file_name": "32427774.en.txt",
        "en": "A 72-year-old male with a past medical history (PMH) of hypertension and hyperlipidemia presented to the emergency center with worsening dyspnea, fever, and chills of approximately one week\u2019s duration. He had been treated empirically with azithromycin on anoutpatient basis for a presumed upper respiratory infection and then subsequently tested positive for COVID-19. On admission, his vital signs were temperature (T) 36.7\u2103, heart rate (HR) 91bpm, respiratory rate (RR) 28, blood pressure (BP) 120/78mmHg. He was started on a hydroxychloroquine regimen. A chest X-ray showed minimal indistinct bibasilar opacities. The initial arterial blood gas (ABG) was significant for an arterial partial pressure of oxygen (PaO2) of 53mmHg and peripheral capillary oxygen saturation (SpO2) 88% on room air. There was minimal improvement with administration of supplemental oxygen by nasal cannula, and the patient was placed on a 50% venturi mask. On hospital day 2, the patient demonstrated increased work of breathing with oxygen saturations in the low 80s, so he was transitioned to high flow nasal cannula (HFNC) 60%/40L/min. Over the next few days, he failed to improve and had increasing oxygen requirements up to 100%/60L/min to maintain SpO2 in the low 90s. With increasing dyspnea and fatigue, and SpO2 in the mid 80s despite maximal support by HFNC, the decision was made to intubate on hospital day 8. Two days later, the patient\u2019s oxygenation had not improved despite max ventilator support with airway pressure release ventilation (APRV),proning, and paralytics. He had a PaO2/FiO2 (P/F) ratio ranging from 51-72. Due to his age, he was not eligible for extracorporeal membrane oxygenation (ECMO), and the decision to pursue tPA therapy was made. His pretreatment D-dimer and fibrinogen were 2.16ug/mL and 654mg/dL respectively. Approximately 24 hours following tPA infusion, his P/F ratio increased to 76 from the pretreatment 69 and his oxygenation requirements decreased to an FiO2 of 80%.He had an expected initial increase in D-dimer to 9.57ug/mL (Figure 2). His P/F ratio continued to increase daily with decreasing oxygen requirements and by post treatment day 5 reached 121,a 175% increase from pretreatment values. His D-dimer decreased to 1.99ug/mL. Ventilation was then deescalated from APRV to pressure controlled ventilation-volume guarantee (PCVVG)and paralytics were discontinued. By post-treatment day 8, pressure requirements werefurther decreased to 18 and his P/F ratio increased to 127. By post-treatment day 12, the patient successfully passed a CPAP trial and on the following day was able to be extubated to HFNC. He was subsequently transitioned to the floor on oxygen via nasal cannula.",
        "es": "Hombre de 72 a\u00f1os con antecedentes de hipertensi\u00f3n e hiperlipidemia acudi\u00f3 al servicio de urgencias con disnea, fiebre y escalofr\u00edos, de una semana de evoluci\u00f3n, aproximadamente. Hab\u00eda recibido un tratamiento sintom\u00e1tico ambulatorio con azitromicina por posible infecci\u00f3n de las v\u00edas respiratorias altas; luego dio positivo en una prueba de COVID-19. Al ingreso, sus constantes vitales eran temperatura (T) 36,7 \u2103, pulso 91 l.p.m., frecuencia respiratoria 28 r.p.m., presi\u00f3n arterial 120/78 mmHg. Se inici\u00f3 una pauta de hidroxicloroquina. Una radiograf\u00eda tor\u00e1cica mostr\u00f3 opacidades bibasales m\u00ednimas y mal definidas. La gasometr\u00eda arterial inicial fue relevante por una presi\u00f3n parcial de ox\u00edgeno arterial (PaO2) de 53 mmHg y saturaci\u00f3n de ox\u00edgeno capilar perif\u00e9rico (SpO2) de 88% en aire ambiental. Se observ\u00f3 una mejora m\u00ednima con oxigenoterapia mediante c\u00e1nula nasal; se aplic\u00f3 una mascarilla de Venturi al 50%. El d\u00eda 2 de hospitalizaci\u00f3n, el paciente mostr\u00f3 una dificultad creciente para respirar, con saturaci\u00f3n en el rango inferior de 80, de modo que se pas\u00f3 a c\u00e1nula nasal de alto flujo a 60% y 40 L/min. En los siguientes d\u00edas no mejor\u00f3 y necesit\u00f3 ox\u00edgeno al 100% y 60 L/min para mantener la SpO2 por encima de 90. Con una disnea y cansancio creciente y SpO2 alrededor de 85, a pesar de soporte m\u00e1ximo mediante c\u00e1nula de alto flujo, el d\u00eda 8 de hospitalizaci\u00f3n se decidi\u00f3 intubar al paciente. Dos d\u00edas despu\u00e9s, la oxigenaci\u00f3n no hab\u00eda mejorado, a pesar de respiraci\u00f3n asistida m\u00e1xima con ventilaci\u00f3n con liberaci\u00f3n de la presi\u00f3n, posici\u00f3n en dec\u00fabito prono y par\u00e1lisis. El cociente PaO2/FiO2 (P/F) estaba entre 51 y 72. A causa de su edad, no se le pod\u00eda aplicar oxigenaci\u00f3n por membrana extracorporal (OMEC) y se decidi\u00f3 iniciar tratamiento con APt. Sus valores de d\u00edmero D y fibrin\u00f3geno antes del tratamiento eran de 2,16 ug/mL y 654 mg/dL, respectivamente. Unas 24 horas despu\u00e9s de la infusi\u00f3n de APt, su cociente P/F aument\u00f3 a 76 (69 pretratamiento) y sus requisitos de oxigenaci\u00f3n bajaron a una FiO2 de 80%. El d\u00edmero D aument\u00f3 inicialmente a 9,57 ug/mL. Si cociente P/F sigui\u00f3 aumentando diariamente, con requisitos de ox\u00edgeno cada vez menores; el d\u00eda 5 postratamiento lleg\u00f3 a 121, un aumento del 175% respecto a los valores pretratamiento. El d\u00edmero D disminuy\u00f3 a 1,9 ug/mL. La respiraci\u00f3n asistida se rebaj\u00f3 de ventilaci\u00f3n con liberaci\u00f3n de la presi\u00f3n a ventilaci\u00f3n controlada presi\u00f3n con volumen garantizado y se elimin\u00f3 la paralizaci\u00f3n. El d\u00eda 8 postratamiento, los requisitos de presi\u00f3n disminuyeron a 18 y su cociente P/F aument\u00f3 a 127. El d\u00eda 12 postratamiento, el paciente super\u00f3 con \u00e9xito una prueba con PPC y el d\u00eda siguiente se pudo extubar y pasar a c\u00e1nula nasal de alto flujo. Posteriormente se le traslad\u00f3 a planta con oxigenoterapia mediante c\u00e1nula nasal."
    },
    {
        "file_name": "32554423.en.txt",
        "en": "A 72-year-old man with no relevant medical history presented with sudden left hemiparesis, altered mental status, and refractory status epilepticus. Retrospectively, the patient\u2019s family reported mild respiratory symptoms a few days earlier. The nasopharyngeal swab was positive for SARS-CoV-2 using the reverse transcriptase polymerase chain reaction (RT-PCR) and negative for influenza A and B viruses and adenoviruses. Cerebrospinal fluid (CSF) analysis showed an increased red blood cell count (500/mm3) due to traumatic lumbar puncture, and apleocytosis (30 white blood cells/mm3). The results of the RT-PCR including the SARS-CoV-2, herpes simplex viruses 1 and 2, varicella zoster virus, cytomegalovirus, and Epstein-Barr virus as well as the bacterial culture, were negative in the CSF. Noncontrast CT revealed a right deep hemispheric hypodensity with some hyperdense areas, involving the thalamus, basal ganglia, internal capsule and splenium of the corpus callosum, and the deep white matter. A subtle hypodensity within the left thalamus could also be seen. These abnormalities caused a moderate mass effect on the midline structures. Among the scattered areas of parenchymal hemorrhage, spontaneous hyperdensity was detected within the internal cerebral veins and the vein of Galen. A CT venogram showed no opacification of these veins, confirming the diagnosis of acute deep cerebral vein thrombosis complicated by hemorrhagic venous infarction.",
        "es": "Hombre de 72 a\u00f1os sin antecedentes relevantes present\u00f3 hemiparesia izquierda s\u00fabita, alteraci\u00f3n del estado mental y estado epil\u00e9ptico resistente. Retrospectivamente, la familia del paciente refiri\u00f3 s\u00edntomas respiratorios leves desde unos pocos d\u00edas antes. El frotis nasofar\u00edngeo dio positivo para SARS-CoV-2 mediante RT-PCR y negativo para virus de la gripe A y B y adenovirus. El an\u00e1lisis de l\u00edquido cefalorraqu\u00eddeo (LCR) mostr\u00f3 un aumento de la cifra de eritrocitos (500/mm3) a causa de una punci\u00f3n lumbar traum\u00e1tica y apleocitosis (30 leucocitos/mm3). Los resultados de RT-PCR para SARS-CoV-2, virus del herpes simple 1 y 2, virus de la varicela z\u00f3ster, citomegalovirus y virus de Epstein-Barr, as\u00ed como los cultivos bacterianos, fueron negativos en el LCR. Una TAC sin contraste mostr\u00f3 hipodensidad hemisf\u00e9rica intensa derecha con algunas \u00e1reas hiperdensas, afectando al t\u00e1lamo, ganglios basales, la c\u00e1psula interna y el esplenio del cuerpo calloso, as\u00ed como la sustancia blanca profunda. Tambi\u00e9n se pudo apreciar una ligera hipodensidad en el t\u00e1lamo izquierdo. Estas alteraciones provocaban un efecto de masa moderado en las estructuras mediales. Entre las \u00e1reas dispersas de hemorragia parenquimatosa, se detect\u00f3 hiperdensidad espont\u00e1nea en las venas cerebrales profundas y en la vena cerebral magna. Un flebograma por TAC no mostr\u00f3 opacificaci\u00f3n de estas venas, lo que confirmaba el diagn\u00f3stico de trombosis venosa profunda cerebral aguda, complicada por un infarto venoso hemorr\u00e1gico."
    },
    {
        "file_name": "32587121.en.txt",
        "en": "A 71-year-old man, who had a history of benign prostatic hyperplasia and of smoking 20 cigarettes a day for the past 30 years, presented to the emergency department with a 1-week history of dry coughing, mild dyspnoea and a fever of 38\u00b0C that did not resolve with paracetamol. Two weeks previously, he had returned to Mexico City from Miami. On the day of his admission, he felt greater dyspnoea and was suffering from severe myalgia and arthralgia, predominantly in his legs. At his initial evaluation, the patient reported generalised weakness and malaise. He did not report any nausea, vomiting, diarrhoea, urinary or neurological symptoms. He had not taken any medication except paracetamol (750\u2009mg) every 8\u2009hours to control the fever. He had no known allergies. A physical examination revealed a blood pressure of 120/68 mmHg, a pulse of 90 beats/min and a respiratory rate of 22 breaths/min. His temperature was 36.5\u00b0C and his oxygen saturation was 84% while breathing ambient air. He was alert and oriented, but his speech was slow and pausing. A cardiopulmonary examination revealed rales in both lung bases, but without signs of respiratory distress. Otherwise, his physical examination was unremarkable. Blood tests showed a normal leucocyte count with lymphopaenia (0.85 \u00d7109/L), haemoglobin level (161\u2009g/L) and mild thrombocytopaenia (118\u2009000\u00d7109/L). His creatinine level was increased, at 1.68\u2009mg/dL, and his C-reactive protein (CRP) and procalcitonin (PCT) were elevated, at 2.9\u2009mg/dL and 2.89\u2009ng/mL, respectively. His interleukin (IL)-6 was also increased (233\u2009pg/mL). His muscle enzymes were markedly elevated (creatine phosphokinase at 8720 U/L and myoglobin at 2079 ng/mL). His ferritin and lactic dehydrogenase levels were high as well (at 2603\u2009ng/mL and 541\u2009U/L, respectively). A urinalysis showed haemoglobin without erythrocytes in the sediment microscopy. A nasopharyngaeal swab for SARS-CoV2 was positive. Multiplex PCR for respiratory viruses and HIV test were negative. A lung CT scan showed bilateral infiltrates with areas of consolidation and extensive ground-glass opacities. The patient was admitted to the COVID-19 ward and administered oxygen by nasal cannula. We started aggressive fluid and bicarbonate therapy as well as enoxaparin, azithromycin and ceftriaxone. The patient agreed to the use of compassionate drug therapy, so we started him on hydroxychloroquine and lopinavir/ritonavir. His condition deteriorated on the third day of hospitalisation and he required invasive mechanical ventilation. Over the next 2\u2009days, his condition continued to deteriorate, with fever, hypotension and high ventilatory requirements. His CRP and IL-6 levels also increased (to 26.9\u2009mg/dL and 275\u2009pg/mL, respectively). His family agreed to the use of tocilizumab on a compassionate use scheme. Consequently, we gave him two doses of tocilizumab 400\u2009mg intravenous on the fifth and sixth day after admission. On the seventh day after admission, his condition started to improve and he showed a decrease in lactic dehydrogenase, ferritin, CRP and PCT levels. It was possible to extubate him on the 12th day after admission. His clinical condition continued to improve and after a negative SARS-CoV2 test, we were able to finally discharge him to his home on the 16th day after admission.",
        "es": "Hombre de 71 a\u00f1os, con antecedentes de hiperplasia prost\u00e1tica benigna y fumador desde hace 30 a\u00f1os (20 cigarrillos al d\u00eda), acudi\u00f3 al servicio de urgencias con tos seca, disnea leve y fiebre de 38 \u00b0C que no remit\u00eda con paracetamol, de una semana de evoluci\u00f3n. Dos semanas antes hab\u00eda regresado a Ciudad de M\u00e9xico procedente de Miami. El d\u00eda del ingreso, su disnea empeor\u00f3 y sufr\u00eda mialgia y artralgia intensa, sobre todo en las piernas. En la evaluaci\u00f3n inicial, el paciente refiri\u00f3 debilidad general y malestar. No refiri\u00f3 n\u00e1useas, v\u00f3mitos, diarrea ni s\u00edntomas urinarios o neurol\u00f3gicos. No hab\u00eda tomado medicaci\u00f3n excepto paracetamol (750 mg cada 8 horas para controlar la fiebre). No ten\u00eda alergias conocidas. La exploraci\u00f3n f\u00edsica mostr\u00f3 una presi\u00f3n arterial de 120/68 mmHg, pulso de 90 l.p.m. y frecuencia respiratoria de 22 r.p.m. La temperatura era de 36,5 \u00b0C y la saturaci\u00f3n de ox\u00edgeno era de 84% en aire ambiental. Estaba consciente y orientado, pero su habla era lenta y entrecortada. Una exploraci\u00f3n cardiopulmonar revel\u00f3 estertores en ambas bases pulmonares, pero sin signos de dificultad respiratoria. Por lo dem\u00e1s, la exploraci\u00f3n f\u00edsica fue normal. Los an\u00e1lisis de sangre mostraron una cifra normal de leucocitos con linfocitopenia (0,85 \u00d7 109/L), concentraci\u00f3n de hemoglobina de 161\u2009g/L y leve trombocitopenia (118\u2009000 \u00d7 109/L). Su valor de creatinina era alto, de 1,68 mg/dL, y los de prote\u00edna C-reactiva y procalcitonina tambi\u00e9n eran elevados, con 2,9\u2009 mg/dL y 2,89\u2009 ng/mL, respectivamente. Tambi\u00e9n se observ\u00f3 aumento de interleucina 6 (233 pg/mL). Las enzimas musculares eran claramente altas (creatina-fosfocinasa a 8720 U/L y mioglobina a 2079 ng/mL). Tambi\u00e9n eran altos los valores de ferritina y deshidrogenasa l\u00e1ctica (a 2603 ng/mL y 541 U/L, respectivamente). Un an\u00e1lisis de orina mostr\u00f3 hemoglobina sin eritrocitos en el sedimento. Un frotis nasofar\u00edngeo para SARS-CoV-2 result\u00f3 positivo. Una PCR m\u00faltiple para virus respiratorios y VIH dio resultados negativos. Una TAC pulmonar revel\u00f3 infiltrados bilaterales con zonas de consolidaci\u00f3n y opacidades de vidrio esmerilado extensas. El paciente fue ingresado en la planta de COVID-19 y se le administr\u00f3 ox\u00edgeno mediante c\u00e1nula nasal. Se inici\u00f3 una terapia agresiva de hidrataci\u00f3n y bicarbonato, as\u00ed como enoxaparina, azitromicina y ceftriaxona. El paciente accedi\u00f3 a una terapia compasiva, de modo que se inici\u00f3 terapia con hidroxicloroquina y lopinavir/ritonavir. Su estado empeor\u00f3 en el tercer d\u00eda de hospitalizaci\u00f3n y requiri\u00f3 ventilaci\u00f3n mec\u00e1nica invasiva. Durante los dos d\u00edas siguiente, su estado sigui\u00f3 empeorando, con fiebre, hipotensi\u00f3n y grandes requerimientos de ventilaci\u00f3n. Sus valores de prote\u00edna C-reactiva e interleucina 6 tambi\u00e9n aumentaron (a 26,9\u2009 mg/dL y 275 \u2009pg/mL, respectivamente). Su familia accedi\u00f3 a una pauta compasiva de tocilizumab. En consecuencia se le administraron dos dosis de 400 mg de tocilizumab i.v. El s\u00e9ptimo d\u00eda de ingreso su estado empez\u00f3 a mejorar y mostr\u00f3 una disminuci\u00f3n en los valores de deshidrogenasa l\u00e1ctica, ferritina, prote\u00edna C-reactiva y procalcitonina. Se le pudo extubar el d\u00eda 12 de ingreso. Su estado cl\u00ednico continu\u00f3 mejorado y, tras una prueba negativa de SARS-CoV-2, pudo ser dado de alta el d\u00eda 16 tras el ingreso."
    },
    {
        "file_name": "32589931.en.txt",
        "en": "\ufeffA slightly overweight, 67-year-old male patient with no past medical history accessed emergency room with fever (37.8\u00b0C) and mild respiratory symptoms. After thediagnosis of Covid-19, he was sent home on hydroxychloroquine and azithromycin. Five days later he was re-admitted to emergency room with worsening asthenia and fever. Atphysical examination, the patient presented anasarca, a respiratory rate of 32 breaths per minute, and bibasilar rales at auscultation, mainly on the right lung. Oxygen saturation in ambient air was 87%. Computed tomography chest scan revealed bilateral ground-glass opacity and crazy paving appearance of the right lung. C-reactive protein (114.1 mg/L, normal range <6 mg/L), fibrinogen (711 mg/dL, range 150-400 mg/dL) and D-dimer (1.83 \u03bcg/mL, range <0.77 \u03bcg/mL) were altered. Moreover, the association of hypoalbuminemia (33.2 g/L, 50.7% of total serum proteins) proteinuria 30 mg/dL, (normal range 0-15 mg/dL) and anasarca, was consistent with the diagnosis of nephrotic syndrome on top of Covid-19 pneumonia. The patient was admitted to Covid-19 ward and treated 100 with non-invasive ventilation, ceftriaxone, and enoxaparin 6,000 anti-Xa IU once a day as antithrombotic prophylaxis. During the first 48 hours, the patient did not show any further clinical deterioration. However, from the third day after the admission, there was a progressive increase of the platelet count (443 x109/L), D-dimer (3.73 \u03bcg/mL), C-reactive protein (229 mg/L) and worsening of the gas exchange. Consequently the patient was intubated and moved to Covid-19 Intensive Care Unit (ICU). On day 5, the patient suffered pain, numbness, and coldness of the right lower limb along with a massive augmentation of the D-dimer (> 20>g/ml). A Duplex ultrasound scan (DUS) showed complete occlusion of the right iliac and femoropopliteal arteries, for which it was performed an emergent revascularization of the lower limb under general anesthesia. A 20G catheter was inserted in the right radial artery to monitor the invasive blood pressure. To achieve an ACT above 250 seconds, three boluses of 1000 UI each of intravenous UFH were required after the administration of a loading dose of 5000 UI. To maintain the ACT target, further 6,000 IU of UFH were added. A right lower limb conventional thrombectomy was successfully performed with a Fogarty catheter using multiple accesses (femoral and below-the-knee popliteal). An intra-operative DUS control showed a biphasic flow pattern on the treated arteries. During the surgery, the sudden flattening of the arterial wave, the coldness and pallor of the right upper limb were highly suggestive of limb ischemia. The clinical suspicion was confirmed by the intra-operative DUS, which detected the thrombosis of the right brachial artery. Then, a right upper limb thrombectomy was successfully performed with restoring of radial artery patency. The patient was discharged from the operating theatre with a continuous infusion of 1,000 IU/h of UFH. Notably, an aPTT ratio of 1.92 was obtained only after the increase of the UHF infusion rate to 2,000 IU/h (more than35,000 IU/day). Nevertheless, the aPTT ratio dropped to 0.86 during  the first postoperative day leading to in further increase of the amount of UHF administered. The day after, the occurrence of a reactive thrombocytosis accounted for a reduction of the aPTT ratio from 2.54 to sub-optimal values. Since the anti-factor Xa assay was below the therapeutic range (0.34 IU/mL), the UFH was shifted to 8,000 of enoxaparin twice a day. Over the two following days, D-dimer decrease to 0.72 ig/mL and the anti-Xa activity ranged between 0.60 to 0.77 IU/mL. During this period, a high dosage (0.25 \u03bcg/kg/min) of norepinephrine was needed to treat hypotension. On the 6th post-op day, the patient presented a bilateral persistent acro-ischemia of the lower extremities, including finger/toe cyanosis, skin bulla, and dry gangrene with patency of lower limb arteries at the DUS. Therefore, prostaglandin E-1 infusion at the dosage of 60mcg twice a day was administered. Five days later the patient was discharged from the ICU to the medical Covid-19 ward and twenty days later from the hospital with oral anticoagulation. At 2 months follow-up no further thromboembolic events occurred. A slow reduction of D-dimer levels from 3.3 rg/mL to 1.6 /g/mL was observed. The acro-ischemic lesions are characterized by gradual improvement without the need of major amputation and the patient is coming to wound care service twice a week.",
        "es": "Un hombre de 67 a\u00f1os, con ligero sobrepeso y sin antecedentes relevantes, acudi\u00f3 al servicio de urgencias con fiebre (37,8 \u00b0C) y s\u00edntomas respiratorios leves. Tras un diagn\u00f3stico de COVID-19, se le envi\u00f3 a su domicilio con hidroxicloroquina y azitromicina. Cinco d\u00edas despu\u00e9s, reingres\u00f3 en urgencias con un empeoramiento de la astenia y fiebre. A laexploraci\u00f3n f\u00edsica, el paciente present\u00f3 anasarca, frecuencia respiratoria de 32 r.p.m. y estertores bibasales a la auscultaci\u00f3n, principalmente en el pulm\u00f3n derecho. La saturaci\u00f3n de ox\u00edgeno en aire ambiental era de 87%. Una TAC tor\u00e1cica revel\u00f3 opacidades de vidrio esmerilado bilaterales y patr\u00f3n en empedrado en el pulm\u00f3n derecho. Los valores de prote\u00edna C-reactiva (114,1 mg/L, intervalo normal < 6 mg/L), fibrin\u00f3geno (711 mg/dL, intervalo normal 150-400 mg/dL) y d\u00edmero D (1,83 \u03bcg/mL, intervalo normal < 0,77 \u03bcg/mL) eran elevados. Adem\u00e1s, la asociaci\u00f3n de hipoalbuminemia (33,2 g/L, 50,7% del total de prote\u00ednas s\u00e9ricas), proteinuria (30 mg/dL, intervalo normal 0-15 mg/dL) y anasarca era coherente con un diagn\u00f3stico de s\u00edndrome nefr\u00f3tico a\u00f1adido a neumon\u00eda por COVID-19. El paciente fue ingresado en una planta de COVID-19 y fue tratado con ventilaci\u00f3n no invasiva, ceftriaxona y enoxaparina 6000 UI anti-Xa una vez al d\u00eda como profilaxis antitromb\u00f3tica. Durante las primeras 48 horas, el paciente no mostr\u00f3 ning\u00fan empeoramiento adicional. Sin embargo, a partir del tercer d\u00eda de ingreso, se observ\u00f3 un progresivo aumento de la cifra de trombocitos (443 x 109/L), de d\u00edmero D (3,73 \u03bcg/mL) y de prote\u00edna C-reactiva (229 mg/L), as\u00ed como un empeoramiento del intercambio gaseoso. En consecuencia, el paciente fue intubado y trasladado a una UCI de COVID-19. El d\u00eda 5, el paciente present\u00f3 dolor, entumecimiento y fr\u00edo en la extremidad inferior derecha, as\u00ed como un gran aumento de d\u00edmero D (> 20 \u03bcg/mL). Una ecograf\u00eda doble mostr\u00f3 oclusi\u00f3n completa de las arterias il\u00edaca y popl\u00edtea derechas, para lo cual se llev\u00f3 a cabo una revascularizaci\u00f3n urgente de la extremidad inferior con anestesia general. Se insert\u00f3 un cat\u00e9ter 20G en la arteria radial derecha para monitorizar la presi\u00f3n arterial invasiva. Para lograr un TCA superior a 250 segundos, se requirieron tres bolos de 1000 UI de HNF i.v. tras una dosis inicial de 5000 UI. Para mantener el objetivo de TCA, se a\u00f1adieron 6000 UI m\u00e1s de HNF. Se realiz\u00f3 con \u00e9xito una trombectom\u00eda convencional en la extremidad inferior derecha, con un cat\u00e9ter de Fogarty en varios abordajes (femoral y popl\u00edteo subgenicular). Una ecograf\u00eda doble intraoperatoria de control mostr\u00f3 un patr\u00f3n de flujo bif\u00e1sico en las arterias tratadas. Durante la cirug\u00eda, el s\u00fabito aplanamiento de la onda arterial y la frigidez y palidez del miembro superior derecho eran indicativos de isquemia de extremidades. La sospecha cl\u00ednica qued\u00f3 confirmada mediante ecograf\u00eda intraoperatoria, que detect\u00f3 trombosis de la arteria humeral derecha. En consecuencia, se practic\u00f3 con \u00e9xito una trombectom\u00eda de la extremidad superior derecha, que restaur\u00f3 la permeabilidad de la arteria humeral. El paciente sali\u00f3 de quir\u00f3fano con una infusi\u00f3n continua de 1000 UI/h de HNF. Cabe destacar que se obtuvo un cociente TTPa de 1,92 solo con un aumento de la tasa de infusi\u00f3n de HNF a 2000 UI/h (m\u00e1s de 35.000 UI/d\u00eda). Sin embargo, el cociente TTPa cay\u00f3 a 0,86 durante el primer d\u00eda posoperatorio, lo que llev\u00f3 a un aumento adicional de HNF. El d\u00eda siguiente, la aparici\u00f3n de trombocitosis reactiva explic\u00f3 la reducci\u00f3n del cociente TTPa de 2,54 a valores sub\u00f3ptimos. Como la prueba de factor anti-Xa dio un valor por debajo del terap\u00e9utico (0,34 UI/mL), se pas\u00f3 a una pauta de HNF de 8000 UI dos veces al d\u00eda. Durante los dos d\u00edas siguientes, el d\u00edmero D disminuy\u00f3 a 0,72 \u03bcg/mL y la actividad anti-Xa estuvo entre 0,60 y 0,77 UI/mL. Durante este per\u00edodo, se necesit\u00f3 una dosis alta de norepinefrina (0,25 \u03bcg/kg/min) para tratar la hipotensi\u00f3n. El sexto d\u00eda de posoperatorio, el paciente present\u00f3 acroisquemia persistente bilateral de las extremidades inferiores, incluyendo cianosis en los dedos de las manos y los pies, ampollas cut\u00e1neas y gangrena seca con permeabilidad de las arterias de las extremidades inferiores en la ecograf\u00eda doble. En consecuencia, se administr\u00f3 prostaglandina E-1 a 60 mcg dos veces al d\u00eda. Cinco d\u00edas despu\u00e9s, el paciente sali\u00f3 de la UCI para pasar a la planta de COVID-19; veinte d\u00edas despu\u00e9s fue dado de alta del hospital con anticoagulantes orales. En el seguimiento a los dos meses, no se hab\u00edan producido episodios tromboemb\u00f3licos. Se observ\u00f3 una lenta reducci\u00f3n en los valores de d\u00edmero D, de 3,3 \u03bcg/mL a 1,6 \u03bcg/mL. Las lesiones acroisqu\u00e9micas mostraron una mejora gradual sin necesidad de amputaci\u00f3n y el paciente acude actualmente a una cura de heridas dos veces por semana."
    },
    {
        "file_name": "32590725.en.txt",
        "en": "\ufeffA 27-year-old woman, G2P1, with a short-interval pregnancy at 33 weeks of gestation age was admitted to a 166-bed community hospital with COVID-19. She was admitted to labor and delivery for continuous fetal monitoring, and the internal medicine service was consulted for comanagement. She became progressively ill and was transferred to the ICU, where she underwent intubation. The patient was noted to have worsening anemia and underwent transfusion with 1 unit of packed red blood cells and was started on prophylactic low-dose heparin. On hospital day 5, the patient was becoming more difficult to ventilate. The ICU team was considering the use of prone positioning or transfer to another facility for extracorporeal membrane oxygenation, which were complicated by her pregnancy. The decision was made to proceed with delivery to improve maternal oxygenation. The unoccupied room adjacent to the patient in the ICU was used to store supplies for both vaginal and cesarean birth. Thus, if there were a maternal or fetal indication for emergent delivery, this could be performed in the ICU. The patient was on prophylactic anticoagulation with low-dose subcutaneous heparin. This was not held during induction of labor. It was felt that the heparin would have minimal effect on bleeding but also could be reversed if necessary. Corticosteroids were not administered to the patient forfetal lung maturity. In the setting of viral pneumonia, the team decided the maternal risks outweighed the fetal benefits at 33 5/7 weeks of gestation. Evidence at the timeof this case stated that steroids were not recommended for a gestational age greater than 32 weeks. Although the patient\u2019s status was worsening, it was felt that she was an appropriate candidate for an induction of labor. This decision was based on the patient\u2019s history of an uncomplicated term vaginal delivery 11 months prior and the fact that she was contracting on her own and had had cervical change from 0 to 3 cm dilated. On the morning of induction, a vertex presentation was confirmed by ultrasound scan, and 25 micrograms of misoprostol was placed intravaginally. This was followed 5 hours later by dinoprostone because the patient had experienced tachysystole with the misoprostol without cervical change. The ability to remove the dinoprostone in the event of recurrent tachysystole or fetal intolerance of labor was considered a benefit. During the latent phase of labor, there was fetal tachycardia, with variable decelerations for 11 minutes. Fetal heart tones returned to baseline with accelerations with repositioning. During labor the patient was deeply sedated with propofol, midazolam, and fentanyl and did not require additional sedation. Seven hours after dinoprostone placement, amniotomy was performed when the patient was 5 cm dilated, 80% effaced, and 21 station. An internal pressure catheter was placed. A fetal scalp electrode was not placed because the fetus was easily monitored. The patient made progress without needing oxytocin augmentation, and 3.5 hours later was 9 cm dilated, 90% effaced, and 0 station with fetal variable decelerations. The fetus then had another variable, with a nadir of 60 beats per minute with a return to baseline over 90 seconds. With the next contraction, the variables persisted, with a nadir of 70 beats per minute. A cervical examination was performed that showed the cervix was completely dilated and effaced, with the occiput engaged between +1 and +2 station. The fetal heart rate tracing showed repetitive variable decelerations. The patient was placed in a frog leg position. An orthopedic wedge pillow was available in the room for delivery, but it was felt that there was adequate room for maneuvers due to maternal habitus. Anticipating the placement of forceps, thepatient received a bolus dose of fentanyl. The fetus was occiput anterior, and 12-inch Simpson forceps were easily applied. The neonate was easily delivered with a single pull over an intact perineum. The critical care and labor and delivery nurses attending the delivery noted that the patient responded to the forceps delivery by raising her hand and opening her eyes briefly. A tight nuchal cord was noted at delivery. The neonate was handed off to the waiting neonatal team. Apgar scores were 3 at 1 minute, 5 at 5 minutes, and 5 at 10 and 15 minutes; the fetal weight was 2,430 grams. Only a venous cord blood gas was able to be obtained, with a pH of 7.39. The total length of time from induction to delivery was 14.5 hours. The patient\u2019s husband was not permitted to attend the delivery in the ICU owing to hospital COVID-19 visitor restrictions. The neonate was intubated after birth for approximately 24 hours. Administration of surfactant was not required. Neonatal testing for severe acute respiratory syndromecoronavirus 2 (SARS-CoV-2) infection was negative at 24 and 48 hours of life. Findings of a chest X-ray were normal. Amniotic fluid, placental surface, and breast milk testednegative for SARS-CoV-2 infection. The patient\u2019s husband was able to visit the neonatal intensive care unit after he and the neonate both tested negative for SARS-CoV-2 infection. Our institution required the mother to have subsequent negative SARS-CoV-2 test results 24 hours apart before having contact with the newborn in the neonatalintensive care unit. This occurred 22 days after her initial positive test result. The neonate was discharged home at 36 2/7 weeks postmenstrual age. It is noted that the patient\u2019s ventilator support was stable throughout labor and delivery, varying from 45% to 50% FIO2. This improved within 1 hour after delivery, with anFIO2 of 35%. The patient had 4 more days of ventilator support, having completed 9 days of mechanical ventilation. She was discharged on hospital day 16 on enoxaparin prophylaxis for 4 weeks.",
        "es": "Una mujer de 27 a\u00f1os, G2P1, de 33 semanas de gestaci\u00f3n con per\u00edodo intergen\u00e9sico corto, ingres\u00f3 con COVID-19 en un hospital local de 166 camas. Fue ingresada en la sala de dilataci\u00f3n y partos para monitorizaci\u00f3n fetal continua; se consult\u00f3 al servicio de medicina interna para una atenci\u00f3n conjunta. El estado de la madre empeor\u00f3 progresivamente y fue trasladada a la UCI, donde se la intub\u00f3. La paciente presentaba un empeoramiento con anemia y se le hizo una transfusi\u00f3n, con 1 unidad de concentrado de eritrocitos, y se inici\u00f3 un tratamiento profil\u00e1ctico con dosis baja de heparina. El d\u00eda 5 de hospitalizaci\u00f3n, hubo que aumentar los requerimientos de ventilaci\u00f3n. El equipo de la UCI consider\u00f3 colocar a la paciente en dec\u00fabito prono o trasladarla a otro centro para oxigenaci\u00f3n por membrana extracorporal, complicada a causa de su embarazo. Se decidi\u00f3 proceder con el parto para mejorar la oxigenaci\u00f3n de la madre. La habitaci\u00f3n vac\u00eda adyacente a la paciente en la UCI se emple\u00f3 para almacenar material y equipos para un parto vaginal y un parto por ces\u00e1rea. De este modo, en caso de signos maternos o fetales de parto urgente, este se pod\u00eda realizar en la misma UCI. La paciente recib\u00eda anticoagulantes profil\u00e1cticos con una dosis baja de heparina subcut\u00e1nea, que se retir\u00f3 durante la inducci\u00f3n del parto. Se consider\u00f3 que la heparina tendr\u00eda un efecto m\u00ednimo sobre la hemorragia, que podr\u00eda revertirse en caso necesario. No se administraron corticoesteroides para la madurez pulmonar fetal. Con el cuadro de neumon\u00eda v\u00edrica, el equipo m\u00e9dico consider\u00f3 que los riesgos para la madre superaban los beneficios para el feto a 33 5/7 semanas de gestaci\u00f3n. Las pruebas en ese momento para este caso indicaban que los esteroides no est\u00e1n recomendados para una edad gestacional superior a 32 semanas. Aunque el estado de la paciente segu\u00eda empeorando, se consider\u00f3 que era un candidato aceptable para inducci\u00f3n del parto. La decisi\u00f3n se tom\u00f3 bas\u00e1ndose en el historial de la paciente de parto vaginal a t\u00e9rmino sin complicaciones 11 meses antes y en el hecho de que ten\u00eda contracciones y hab\u00eda dilatado de 0 a 3 cm. La ma\u00f1ana de la inducci\u00f3n, una ecograf\u00eda confirm\u00f3 presentaci\u00f3n cef\u00e1lica de v\u00e9rtice y se administraron 25 microgramos de misoprostol por v\u00eda intravaginal. 5 horas despu\u00e9s, se administr\u00f3 dinoprostona porque la paciente hab\u00eda presentado taquisistolia con el misoprostol sin cambios en el cuello uterino. La capacidad de retirar la dinoprostona en caso de taquisistolia recurrente o de intolerancia fetal al parto se consider\u00f3 una ventaja. Durante la fase latente del parto, se produjo taquicardia fetal, con desaceleraciones variables durante 11 minutos. Los tonos card\u00edacos fetales volvieron a la normalidad con aceleraciones con recolocaci\u00f3n. Durante el parto, la paciente estuvo profundamente sedada con propofol, midazolam y fentanilo y no requiri\u00f3 sedaci\u00f3n adicional. Siete horas tras la administraci\u00f3n de dinoprostona, se realiz\u00f3 una amniotom\u00eda cuando la paciente presentaba una dilataci\u00f3n de 5 cm y el borramiento era del 80%. Se coloc\u00f3 un cat\u00e9ter de presi\u00f3n interna. No fue necesario colocar ning\u00fan electrodo en el cuero cabelludo fetal porque se pudo monitorizar el feto con facilidad. La paciente progres\u00f3 sin necesidad de oxitocina; 3,5 horas despu\u00e9s presentaba 9 cm de dilataci\u00f3n, borramiento del 90% y estaci\u00f3n 0, con desaceleraciones variables fetales. El feto present\u00f3 otra variable, con un m\u00ednimo de 60 l.p.m. y retorno al valor basal despu\u00e9s de 90 segundos. Con la siguiente contracci\u00f3n, las variables persistieron, con un m\u00ednimo de 70 l.p.m. Una exploraci\u00f3n cervical revel\u00f3 que el cuello del \u00fatero estaba totalmente dilatado y borrado, con el occipucio entre la estaci\u00f3n +1 y +2. El pulso fetal mostr\u00f3 desaceleraciones variables repetitivas. Se coloc\u00f3 a la paciente en postura de piernas de rana. En la sala de partos se dispon\u00eda de una almohada en cu\u00f1a, pero se consider\u00f3 que hab\u00eda espacio suficiente para las maniobras debido a la posici\u00f3n materna. Antes de colocar el f\u00f3rceps, la paciente recibi\u00f3 un bolo de fentanilo. El feto estaba en occipucio anterior y se pudo aplicar f\u00e1cilmente un f\u00f3rceps de Simpson de 12 pulgadas. El ni\u00f1o naci\u00f3 con facilidad con un \u00fanico empuj\u00f3n y con el perineo intacto. El personal de neonatolog\u00eda y de cuidados intensivos que asisti\u00f3 al parto indic\u00f3 que la paciente respondi\u00f3 al alumbramiento con f\u00f3rceps levantando la mano y abriendo brevemente los ojos. En el parto se apreci\u00f3 una estrecha vuelta del cord\u00f3n umbilical. El reci\u00e9n nacido fue trasladado al equipo de neonatolog\u00eda que se hallaba en espera. Los \u00edndices de Apgar fueron de 3 al minuto 1, de 5 a los 5 minutos y de 5 a los 10 y 15 minutos; el peso del reci\u00e9n nacido era de 2.430 gramos. Solo se pudo obtener una gasometr\u00eda venosa del cord\u00f3n, con un pH de 7,39. El tiempo total entre la inducci\u00f3n y el parto fue de 14,5 horas. No se permiti\u00f3 que el marido de la paciente asistiera al parto en la UCI a causa de las restricciones hospitalarias por COVID-19. El reci\u00e9n nacido fue intubado tras el nacimiento durante unas 24 horas. No se necesit\u00f3 administraci\u00f3n de tensioactivos. Las pruebas neonatales para s\u00edndrome de dificultad respiratoria aguda por coronavirus 2(SARS-CoV-2) fueron negativas a las 24 y 48 horas de vida. Los resultados de una radiograf\u00eda tor\u00e1cica fueron normales. El l\u00edquido amni\u00f3tico, la superficie placentaria y la leche materna dieron resultado negativo para SARS-CoV-2. El esposo de la paciente pudo visitar la UCI neonatal despu\u00e9s de que tanto \u00e9l como el reci\u00e9n nacido dieran negativo para SARS-CoV-2. Nuestra instituci\u00f3n requer\u00eda que la madre diera negativo para SARS-CoV-2 en pruebas sucesivas separadas 24 horas antes de poder estar en contacto con el reci\u00e9n nacido en la UCI neonatal. Esta situaci\u00f3n se produjo 22 d\u00edas despu\u00e9s de su prueba inicial positiva. El reci\u00e9n nacido fue dado de alta a las 36 2/7 semanas de edad posmenstrual. Cabe se\u00f1alar que la respiraci\u00f3n asistida de la paciente fue estable durante la dilataci\u00f3n y el parto, con valores entre 45% y 50% de FIO2. El estado mejor\u00f3 en una hora despu\u00e9s del parto, con una FIO2 de 35%. La paciente estuvo 4 d\u00edas m\u00e1s con respiraci\u00f3n asistida, para un total de 9 d\u00edas de ventilaci\u00f3n mec\u00e1nica. Fue dada de alta el d\u00eda 16 de hospitalizaci\u00f3n, con profilaxis de enoxaparina durante 4 semanas."
    },
    {
        "file_name": "32592761.en.txt",
        "en": "\ufeffA 32-year-old previously healthy man developed acute, binocular, horizontal diplopia on waking after 3 days of progressive upper respiratory illness symptoms. He denied pain with eye movements or other neurologic symptoms, such as weakness, gait abnormality, paresthesias, or anosmia. Over the following week, his respiratory symptoms worsened, and he was hospitalized for acute hypoxemic respiratory failure after testing positive for COVID-19. He underwent a 5-day course of hydroxychloroquine and supplemental oxygen, and his respiratory symptoms subsequently resolved over the next 3 weeks. At the time of ophthalmic evaluation at the Bascom Palmer Eye Institute, 5 weeks after onset of diplopia, he reported no change in the double vision. On examination, his best-corrected visual acuity was 20/20 in each eye. Intraocular pressure was normal, and there was no afferent pupillary defect. Ocular motility examination revealed a left esotropia of 35\u0394 in primary gaze, 4\u0394 on right gaze, and 60\u0394 on left gaze. He had complete limitation to abduction in the left eye, consistent with a diagnosis of a complete left abducens nerve palsy. Optic nerve examination was unremarkable. There was no hypesthesia within the ophthalmic or maxillary divisions of the trigeminal nerve. Magnetic resonance imaging (MRI) was performed and revealed an atrophic left lateral rectus muscle, which was hyperintense on T2. The patient was instructed to perform monocular occlusion for alleviation of diplopia and scheduled for follow-up.",
        "es": "Un hombre de 32 a\u00f1os, por lo dem\u00e1s sano, present\u00f3 diplopia horizontal binocular aguda al despertarse, despu\u00e9s de 3 d\u00edas con s\u00edntomas respiratorios progresivos. No refiri\u00f3 dolor con el movimiento ocular ni otros s\u00edntomas neurol\u00f3gicos como debilidad, anomal\u00edas de la marcha, parestesia o anosmia. A lo largo de la siguiente semana, sus s\u00edntomas respiratorios empeoraron, y fue hospitalizado por insuficiencia respiratoria hipox\u00e9mica aguda, tras dar positivo en una prueba de COVID-19. Sigui\u00f3 una pauta de 5 d\u00edas de hidroxicloroquina y oxigenoterapia; los s\u00edntomas respiratorios remitieron a lo largo de las tres semanas siguientes. En el momento de la evaluaci\u00f3n oftalmol\u00f3gica en el Bascom Palmer Eye Institute, 5 semanas despu\u00e9s de la aparici\u00f3n de la diplopia, no refiri\u00f3 ning\u00fan cambio en la visi\u00f3n doble. A la exploraci\u00f3n, su agudeza visual con mejor correcci\u00f3n era de 20/20 en cada ojo. La presi\u00f3n intraocular era normal y no hab\u00eda defecto pupilar aferente. La exploraci\u00f3n de la motilidad ocular revel\u00f3 esotropia izquierda de 35\u0394 en mirada primaria, 4\u0394 en mirada derecha y 60\u0394 en mirada izquierda. Presentaba una limitaci\u00f3n completa de la abducci\u00f3n en el ojo izquierdo, coherente con un diagn\u00f3stico de par\u00e1lisis del nervio motor ocular izquierdo. La exploraci\u00f3n del nervio \u00f3ptico fue irrelevante. No hab\u00eda hipoestesia en las divisiones oft\u00e1lmicas o maxilares del nervio trig\u00e9mino. Se realiz\u00f3 una RMN que revel\u00f3 una atrofia del m\u00fasculo recto externo izquierdo, hiperintensa en T2. Se indic\u00f3 al paciente oclusi\u00f3n monocular para alivio de la diplopia y se le program\u00f3 una visita de seguimiento."
    },
    {
        "file_name": "32593478.en.txt",
        "en": "A, a 53-year-old man with no prior medical or psychiatric history presented to the emergency department after an apparent suicide attempt, having ingested an unknown quantity from a bottle of bleach. He was alert and oriented, although mostly uncooperative owing to epigastric pain on the initial examination. He refused to answer most of the primary team\u2019s questions. Examination of his mouth revealed a right lower lip abrasion with no oropharyngeal injuries or erosions.Per collateral information obtained from his wife who accompanied him, she was bewildered by his action. She reported that her husband had been \u201chealthy,normal, happy, never done anything like this before.\u201d She also stated that he had not complained of any fever, cough, or recent illness. She was unsure why he would have ingested bleach. He was not cooperative with the psychiatric interview because of his apparent cultural stigma. He reiterated,\u201cI don\u2019t need a shrink; I\u2019m not crazy.\u201dHis urine toxicology was negative. Our initial recommendation was psychiatric hospitalization after medical  clearance. While  still  in  the  emergency department, he developed fever (temperature: 101.7 F),tachycardia (heart rate: 120 beats/min), and elevated blood urea nitrogen and transaminases. Chest X-ray revealed an opacity in the upper lobe of the right lung, indicative of a possible COVID-19 pneumonia. He was admitted to the medical service for further workup and management. He was started on ceftriaxone 1000 mg intravenous (IV) daily, azithromycin 250 mg po daily,and hydroxychloroquine 200 mg po twice daily. During the next 5 days, he continued to be unco-operative. He refused his meals because of reported poor appetite and refused IV medications intermittently. He was observed by nursing staff to be \u201cchant-ing and singing to himself\u201dbut was able to be verbally redirected. He denied suicidal ideation, intent, or plan. Infection  with  severe  acute  respiratory  syndrome coronavirus  2  (SARS-CoV-2)  was  confirmed  byCOVID-19 real-time polymerase chain reaction from nasopharyngeal swab. There was no focal neurological deficit and no apparent cognitive impairment. Montreal Cognitive Assessment was performed on hospital day#6. He scored 26 out of 30, losing one point each for the modified trail making test, naming the rhinoceros, serial 7 subtractions, and delayed recall. He received a total of 3 doses of olanzapine 5 mg intramuscular injection intermittently to manage agitation on hospital day #3, 7, and 8. On hospital day #6, he developed worsening hypoxic respiratory failure due to COVID-19. He developed rigors and continued to have high-grade fevers. He began to improve on hospital day#10, requiring less supplemental oxygen and became more cooperative with examinations. Computed tomography of the head without contrast was performed on hospital day #12, and the findings were unremark-able. Lumbar puncture was not performed.On hospital day #12, he was able to discuss his auditory hallucinations in meaningful detail. He reported that his initial symptom was a repeated command auditory hallucination of an unrecognizable singular voice that started 1 day before him ingesting bleach. He was unsure about the gender of the voice but noted that it sounded \u201cdemonic\u201dand stated that he heard the voice externally. The voice initially told him,\u201cGo jump from the bridge\u201dand later told him,\u201cGo to the kitchen and drink bleach.\u201dHe reported feeling confused and terrified. He explained that he ultimately ingested bleach not because of suicidal intent but because\u201cthe voice got louder and more forceful.\u201dHe denied experiencing auditory hallucinations in the past and denied recurrence of hallucinations during his hospitalization. He also denied use of illicit substances,alcohol, or tobacco. He was goal-directed,affectively reactive, and future-oriented. He denied past or current symptoms of mood or anxiety disorders.Since  the  implementation  of  stay-at-home  directives, he reported that he had been able to continue his work remotely as an office clerk. His wife, a schoolteacher, and his 21-year-old web developer son were also working from home. Leading to his hospitalization,  he  noted  some  general  anxiety  about COVID-19 but stated that he felt fortunate to be at home and was trying to keep his\u201cspirit and body occupied.\u201dHe denied other acute stressors in his relationships, employment, or finances. Mr. A's account of history and absence of prior psychiatric illness was supported by collateral information obtained from his wife and his primary care provider. He was psychiatrically cleared for discharge to a subacute rehabilitation center. Discharge impression was psychotic disorder owing to another medicalcondition.",
        "es": "Un hombre de 53 a\u00f1os sin antecedentes m\u00e9dicos ni psiqui\u00e1tricos acudi\u00f3 al servicio de urgencias tras un aparente intento de suicidio, al ingerir una cantidad desconocida de lej\u00eda de una botella. Durante la exploraci\u00f3n inicial, estaba consciente y orientado, aunque poco colaborador a causa de dolor epig\u00e1strico. Se neg\u00f3 a responder a la mayor\u00eda de las preguntas del equipo de atenci\u00f3n primaria. La exploraci\u00f3n de la boca revel\u00f3 abrasi\u00f3n del labio inferior derecho, sin lesiones orofar\u00edngeas. La esposa, que lo acompa\u00f1aba, afirm\u00f3 estar desconcertada por la acci\u00f3n de su marido. Tambi\u00e9n afirm\u00f3 que no se hab\u00eda quejado de fiebre, tos ni ten\u00eda ninguna enfermedad reciente. No sab\u00eda por qu\u00e9 raz\u00f3n su marido podr\u00eda haber ingerido lej\u00eda. El paciente no colabor\u00f3 durante la entrevista psiqui\u00e1trica a causa de su estigma cultural aparente. Repet\u00eda que \u00abno necesito ning\u00fan loquero; no estoy loco\u00bb. Nuestra recomendaci\u00f3n inicial fue hospitalizaci\u00f3n psiqui\u00e1trica tras autorizaci\u00f3n m\u00e9dica. Mientras se hallaba en urgencias present\u00f3 fiebre (temperatura: 38,7 \u00baC), taquicardia (pulso: 120 l.p.m.) y aumento de transaminasas y nitr\u00f3geno ureico. La radiograf\u00eda tor\u00e1cica revel\u00f3 una opacidad en el l\u00f3bulo superior del pulm\u00f3n derecho, indicativo de posible neumon\u00eda por COVID-19. El paciente fue trasladado a la planta de hospitalizaci\u00f3n para su tratamiento. cada d\u00eda, 250 mg de azitromicina por v\u00eda oral cada d\u00eda y 200 mg de hidroxicloroquina por v\u00eda oral dos veces al d\u00eda. Durante los 5 d\u00edas siguientes continu\u00f3 no colaborativo, rechaz\u00f3 las comidas y refiri\u00f3 falta de apetito; tambi\u00e9n rechaz\u00f3 la medicaci\u00f3n i.v. en ocasiones. El personal de enfermer\u00eda observ\u00f3 que el paciente \u00abcantaba para s\u00ed mismo\u00bb pero se le pod\u00edan dar indicaciones verbales. Negaba haber planificado o intentado el suicidio. La infecci\u00f3n con s\u00edndrome de dificultad respiratoria aguda por coronavirus 2 (SARS-CoV-2) qued\u00f3 confirmada mediante una RT-PCR en tiempo real a partir de frotis nasofar\u00edngeo. No hab\u00eda carencias neurol\u00f3gicas focales ni afectaciones cognitivas aparentes. El d\u00eda 6 de hospitalizaci\u00f3n se realiz\u00f3 un Test de Evaluaci\u00f3n Cognitiva Montreal. El paciente obtuvo un resultado de 26 sobre 30; perdi\u00f3 un punto en la prueba visuoespacial, un punto por no nombrar el rinoceronte, un punto en la resta de 7 en 7 y un punto en el recuerdo diferido. Se le administr\u00f3 un total de 3 dosis de 5 mg de olanzapina intramuscular de manera intermitente, para gestionar el nerviosismo del paciente, en los d\u00edas 3, 7 y 8. El d\u00eda 6 de hospitalizaci\u00f3n, present\u00f3 insuficiencia respiratoria hipox\u00e9mica a causa de la COVID-19. Tambi\u00e9n present\u00f3 escalofr\u00edos y continu\u00f3 con hipertermia. Empez\u00f3 a mejorar el d\u00eda 10 de hospitalizaci\u00f3n, con menos requerimientos de oxigenoterapia, y fue m\u00e1s colaborador durante las exploraciones. El d\u00eda 12 de hospitalizaci\u00f3n se le realiz\u00f3 una TAC craneal sin contraste, con resultados irrelevantes. No se practic\u00f3 ninguna punci\u00f3n lumbar. El d\u00eda 12 de hospitalizaci\u00f3n pudo comentar sus alucinaciones auditivas en detalle. Refiri\u00f3 que su s\u00edntoma inicial fue una alucinaci\u00f3n auditiva en forma de orden repetida por una \u00fanica voz no reconocible, que empez\u00f3 un d\u00eda antes de su ingesti\u00f3n de lej\u00eda. No estaba seguro del sexo de la voz, pero se\u00f1al\u00f3 que sonaba \u00abdemon\u00edaca\u00bb y que la o\u00eda externamente. La voz inicialmente le dec\u00eda \u00abT\u00edrate del puente\u00bb y luego \u00abVe a la cocina y bebe lej\u00eda\u00bb. Refiri\u00f3 sentirse confuso y aterrado. Neg\u00f3 haber sufrido alucinaciones auditivas en el pasado, as\u00ed como la repetici\u00f3n de las alucinaciones durante la hospitalizaci\u00f3n. Tambi\u00e9n neg\u00f3 haber consumido drogas, alcohol o tabaco. Neg\u00f3 haber tenido ideas o intentos de suicidio, en la actualidad o en el pasado. Se mostraba consciente de objetivos y situaciones futuras y afectivamente reactivo. Neg\u00f3 s\u00edntomas pasados o actuales de alteraciones del estado de \u00e1nimo o ansiedad. Desde la aplicaci\u00f3n de las directivas de confinamiento, refiri\u00f3 que hab\u00eda podido proseguir su trabajo como oficinista; su esposa, una maestra de escuela, y su hijo de 21 a\u00f1os, desarrollador web, tambi\u00e9n trabajaban desde el hogar. Antes de la hospitalizaci\u00f3n, hab\u00eda experimentado cierta angustia sobre la COVID-19, pero afirm\u00f3 que se sent\u00eda afortunado de poder estar en casa e intentaba \u00abmantener ocupada su mente y su cuerpo\u00bb. La anamnesis del paciente y la ausencia de enfermedades psiqui\u00e1tricas anteriores fue confirmada mediante informaci\u00f3n obtenida a partir de su esposa y de su m\u00e9dico de cabecera. El equipo de psiquiatr\u00eda autoriz\u00f3 su alta para pasar a un centro de rehabilitaci\u00f3n subagudo. La impresi\u00f3n diagn\u00f3stica al alta fue de trastorno psic\u00f3tico asociado a otro proceso m\u00e9dico."
    },
    {
        "file_name": "32606105.en.txt",
        "en": "On 26 March 2020, a 4-month-old boy with a history of muscular ventricular septal defect and atopic dermatitis, presented via telemedicine, with decreased oral intake, loose stools, stuffy nose, mild cough and diaphoresis, but no fever. The patient was full-term, spontaneous vaginal delivery. The patient has no known allergies, no recent travel history and is up to date on all childhood vaccinations. Parents were advised to follow-up in acute care clinic the following day where the child was swabbed for COVID-19 and his mother advised to self-quarantine. To note, mother and maternal grandmother, who live with infant, both tested positive for COVID-19 on 26 March, after presenting with cough, and loss of taste and smell, but no fever. Mother states her symptoms started on 15 March. On 31 March, patient arrived at ED due to no improvement in symptoms. In the emergency deparment, patient was in acute distress with respiratory distress, nasal flaring and retractions. The patient was congested, had clear rhinorrhea and dry mucous membranes. He was afebrile, but tachycardic, tachypneic and saturating at 91% on room air. The patient was placed on 14 L of high flow nasal cannula at 30% FiO2 to achieve >98% oxygen saturation. There was marked improvement in his breathing. Complete blood counts and baseline comprehensive metabolic panel were normal as were the inflammatory markers: C-reactive protein (<5\u2009mg/dL), procalcitonin (<10\u2009ng/mL) and erythrocyte sedimentation rate (9\u2009mm/hour). Lactate dehydrogenase was mildly elevated at 387 U/L (110\u2013240\u2009U/L). Chest X-ray showed no evidence of pneumonia, with only mild bronchiolitis described. The RPP detects for influenza A and B, RSV A and B, parainfluenza 1\u20134, adenovirus, human metapneumovirus, rhinovirus/enterovirus, coronavirus, Chlamydia pneumoniae and Mycoplasma pneumoniae. The pre-admission COVID-19 test was still pending after 4 days. The patient was given a 20 cc/kg 0.9 normal saline intravenous fluid bolus and transferred to the paediatric intensive care unit. The results of the patient\u2019s RPP reported within 2\u2009hours and was positive for adenovirus. The next day, 5 days after collection, the COVID-19 test was positive, and, given the newly available rapid, in-house PCR test, a second COVID-19 test reported positive within 3\u2009hours of testing. The patient was treated with supportive care, intravenous fluids and oxygen. He was weaned off supplemental oxygen over the next 3 days, and discharged home on day 4. Given the relatively moderate course consistent with adenovirus bronchiolitis, only supportive care was given and no specific COVID-19 therapy was initiated. Blood cultures were negative and there was no indication of secondary bacterial infection. Three days after discharge, a virtual visit was performed from the child\u2019s home. The child was feeding well, producing normal number of wet diapers, having normal daily bowel movements and improvement in cough. On examination, patient had mild subcostal retractions improving since discharge. There were no additional concerns. To note, within a week of the child\u2019s discharge, his aunt and father tested positive for COVID-19.",
        "es": "El 26 de marzo de 2020, un ni\u00f1o de 4 meses con antecedentes de dermatitis at\u00f3pica y comunicaci\u00f3n interventricular, fue atendido mediante teleconferencia, con disminuci\u00f3n del apetito, heces semil\u00edquidas, congesti\u00f3n nasal, tos leve y sudoraci\u00f3n, pero sin fiebre. El paciente hab\u00eda nacido a t\u00e9rmino por parto vaginal espont\u00e1neo. No ten\u00eda alergias conocidas ni hab\u00eda viajado recientemente y su calendario de vacunaci\u00f3n estaba al d\u00eda. Se aconsej\u00f3 a los padres acudir a un servicio de urgencias al d\u00eda siguiente, donde se obtuvo un frotis del ni\u00f1o para COVID-19 y se aconsej\u00f3 a la madre el autoconfinamiento. Cabe se\u00f1alar que la madre y la abuela materna, que viven con el ni\u00f1o, dieron ambas positivo para COVID-19 el 26 de marzo, tras presentar tos, ageusia y anosmia, pero sin fiebre. La madre afirm\u00f3 que sus s\u00edntomas se hab\u00edan iniciado el 15 de marzo. El 31 de marzo, el paciente fue llevado a urgencias a causa de la falta de mejora de los s\u00edntomas. En urgencias, el paciente presentaba un malestar intenso, con insuficiencia respiratoria, aleteo nasal y retracciones; ten\u00eda congesti\u00f3n, rinorrea clara y mucosas secas. Estaba afebril, pero con taquicardia, taquipnea y saturaci\u00f3n de 91% en aire ambiental. Se le aplic\u00f3 c\u00e1nula nasal de alto flujo a 14 L y 30% FiO2 para lograr una saturaci\u00f3n > 98%. Su respiraci\u00f3n mejor\u00f3 considerablemente. Un hemograma completo y un panel metab\u00f3lico exhaustivo resultaron normales, as\u00ed como los marcadores de inflamaci\u00f3n: prote\u00edna C-reactiva (< 5\u2009mg/dL), procalcitonina (< 10\u2009ng/mL) y velocidad de sedimentaci\u00f3n globular (9\u2009mm/h). Se detect\u00f3 un ligero aumento de la lactato-deshidrogenasa, con 387 U/L (110-240 U/L). Una radiograf\u00eda tor\u00e1cica no aport\u00f3 evidencias de neumon\u00eda, pero s\u00ed de bronquiolitis leve. Se practic\u00f3 un panel de pat\u00f3genos respiratorios, que detecta gripe A y B, VRS A y B, virus paragripal 1-4, adenovirus, metaneumovirus humano, rinovirus/enterovirus, coronavirus, Chlamydia pneumoniae y Mycoplasma pneumoniae. A\u00fan no se dispon\u00eda de los resultados de la prueba de COVID-19 pre-ingreso, tras 4 d\u00edas. Se administr\u00f3 al paciente 20 cc/kg de bolo salino i.v. Normal 0,9 y se traslad\u00f3 a la UCI pedi\u00e1trica. En 2 horas, los resultados del panel de pat\u00f3genos dieron positivo para adenovirus. El siguiente d\u00eda, 5 d\u00edas despu\u00e9s de la obtenci\u00f3n, la prueba de COVID-19 fue positiva y, gracias al nuevo kit r\u00e1pido de PCR interno, se hizo una segunda prueba, que dio positivo 3 horas despu\u00e9s. El paciente fue tratado sintom\u00e1ticamente, con hidrataci\u00f3n i.v. y ox\u00edgeno. Se le fue reduciendo la oxigenoterapia durante los siguientes 3 d\u00edas y fue dado de alta el d\u00eda 4. Teniendo en cuenta el curso moderado, coherente con bronquiolitis adenov\u00edrica, solo se administr\u00f3 tratamiento sintom\u00e1tico y no se inici\u00f3 ninguna terapia espec\u00edfica para COVID-19. Los hemocultivos resultaron negativos y no hab\u00eda indicios de sobreinfecciones bacterianas. Tres d\u00edas despu\u00e9s del alta, se realiz\u00f3 una visita virtual desde el domicilio del ni\u00f1o. El paciente estaba bien alimentado, con una cantidad normal de orina y defecaciones y con una mejora de la tos. A la exploraci\u00f3n, el paciente presentaba una leve retracci\u00f3n subcostal, que hab\u00eda mejorado desde el alta. No se observaron problemas adicionales. Cabe se\u00f1alar que en una semana a partir del alta del ni\u00f1o, su t\u00eda y su padre dieron positivo para COVID-19."
    },
    {
        "file_name": "32607564.en.txt",
        "en": "On the 25th of April 2020, a 52-year-old gentleman presented at the emergency unit of a nearby hospital with fever of 40\u00b0C, cough, and shortness of breath. He deteriorated soon after, requiring endotracheal intubation. SARS-CoV-2 was detected from tracheal aspirate. In addition, bronchial aspirate samples grew with Staphylococcus aureus, Pseudomonas aeruginosa and Acinetobacter dijkshoorniae. Blood cultures grew Vancomycin-resistant Enterococcus faecium and Staphylococcus epidermidis. Hence, a broad antibiotic regimen containing meropenem and linezolid was initiated, yet the patient continued to have daily fevers up to 40\u00b0C without responding to antipyretics or antibiotics. He deteriorated further despite escalated pressure-controlled invasive ventilation and was finally transferred to our intensive care unit on 13th May, 2020, for possible initiation of extracorporeal membrane oxygenation (ECMO). For evaluation of pulmonary COVID-19 manifestation and in preparation for possible ECMO, computed tomography (CT) was performed on 13th and 14th May. Chest CT showed bilateral ground glass opacities, consolidations, and crazy-paving pattern typical for COVID-19. As a potential sign for subacute manifestation, airway changes, pleural changes, fibrosis, and nodules were present. Careful changes of ventilator settings finally made ECMO unnecessary. Differential cytology revealed a severe depletion of CD4+ cells (12 / \u03bcL, equaling 2%, CD4+/CD8+-ratio of 0.08). Lack of CD4+ cells in combination with the fact that the patient is MSM (men having sex with men) led us to the suspicion that he might be a HIV late presenter. RT-PCR for HIV-1 was indeed positive, measuring a viral load of 360,000 HIV-1 RNA copies / mL. The presence of fine reticular changes in his chest CT together with an elevated level of LDH prompted us to also consider Pneumocystis Jirovecii pneumonia (PJP) as a possible additional diagnosis. Broncho-alveolar lavage fluid was positive for P. jirovecii. and the patient was treated with intravenous trimethoprim-sulfamethoxazole (20 mg of trimethoprim component per kg body weight per day q.i.d.) together with 50 mg of prednisone daily to prevent adverse immune reactions in PCP and immune reconstitution inflammatory syndrome (IRIS). After the diagnosis of AIDS, rapid ART was initiated consisting of orally administered darunavir (600 mg bid), ritonavir (100 mg p.o. bid) and tenofovir/emtricitabine (450 / 400 mg 1x/d). Concomitant CMV infection (170,000 U/mL blood) was treated with ganciclovir at 5 mg/kg BW. Antibacterial treatment with meropenem and linezolid was continued for 7 days. Co-infection with Hepatitis B, C and syphilis was ruled out. On 15th, 18th and 20th May the patient tested negative for SARS-CoV-2 in bronchial aspirates. Cerebrospinal fluid testing showed 5,600 copies/mL HIV-1 but no evidence of JC-virus or bacterial meningitis or encephalitis. Over the next two weeks, his state improved significantly. Noradrenaline administration could be terminated three days after initiation of trimethoprim-sulfamethoxazole. Antiretroviral therapy had no apparent side effects, especially creatinine clearance and liver function remained stable over the following weeks. CMV-copies declined to <450 U/mL two weeks after Ganciclovir was started on 14th May. Under ART the viral load declined to 2,800 copies/mL (equaling 2.11 log units) on 25th May, 2020. HIV-1 genotyping revealed no relevant drug resistances. After convalescence and ability to swallow reliably, ART was switched to a single tablet regime to maintain patient\u2019s compliance and to reduce the pill burden. The patient is continuously improving. He is free from ventilator support and was discharged from ICU with 2 L/min of supplementary oxygen on June 4th.",
        "es": "El 25 de abril de 2020, un hombre de 52 a\u00f1os acudi\u00f3 al servicio de urgencias de un hospital cercano con fiebre de 40 \u00b0C, tos y disnea. Su estado empeor\u00f3 r\u00e1pidamente, y requiri\u00f3 intubaci\u00f3n endotraqueal. En aspirado traqueal se detect\u00f3 SARS-CoV-2. Adem\u00e1s, en las muestras de aspirado bronquial se observ\u00f3 crecimiento de Staphylococcus aureus, Pseudomonas aeruginosa y Acinetobacter dijkshoorniae. En los hemocultivos hubo crecimiento de Enterococcus faecium resistente a vancomicna y Staphylococcus epidermidis. En consecuencia, se inici\u00f3 un r\u00e9gimen antibi\u00f3tico de amplio espectro, con meropenem y linezolid, pero el paciente continu\u00f3 con fiebre diaria de hasta 40 \u00b0C, sin respuesta a los antipir\u00e9ticos o a los antibi\u00f3ticos. El estado cl\u00ednico del paciente empeor\u00f3 a\u00fan m\u00e1s, a pesar de un ajuste de ventilaci\u00f3n invasiva controlada por presi\u00f3n, de modo que se le traslad\u00f3 a nuestra UCI el d\u00eda 13 de mayo de 2020, por posible aplicaci\u00f3n de oxigenaci\u00f3n por membrana extracorporal (OMEC). Para evaluaci\u00f3n de manifestaciones pulmonares de COVID-19 y como preparaci\u00f3n de posible OMEC, se realiz\u00f3 una TAC los d\u00edas 13 y 14 de mayo. La TAC tor\u00e1cica mostr\u00f3 opacidades de vidrio esmerilado bilaterales, consolidaciones y patr\u00f3n en empedrado t\u00edpico de COVID-19. Como signo potencial de manifestaci\u00f3n subaguda, se observaron cambios en las v\u00edas respiratorias, cambios pleurales, fibrosis y n\u00f3dulos. Unas modificaciones cuidadosas en los ajustes de ventilaci\u00f3n hicieron innecesaria la OMEC. La citolog\u00eda diferencial revel\u00f3 una grave disminuci\u00f3n de c\u00e9lulas CD4+ (12 por \u03bcL, equivalente a 2%, cociente CD4+/CD8+ de 0,08). La falta de c\u00e9lulas CD4+ junto con el hecho de que el paciente es un var\u00f3n con relaciones homosexuales, llev\u00f3 a la sospecha de posible portador de VIH de aparici\u00f3n tard\u00eda. La RT-PCR para VIH-1 fue positiva, con una carga v\u00edrica de 360.000 copias de ARN de VIH-1 por mL. La presencia de cambios reticulares finos en su TAC tor\u00e1cica, junto con un aumento de la LDH, tambi\u00e9n plante\u00f3 la posibilidad de neumon\u00eda por Pneumocystis jirovecii como diagn\u00f3stico adicional. El lavado broncoalveolar fue positivo para P. jirovecii y el paciente fue tratado con trimetoprima/sulfametoxazol i.v. (20 mg de componente de trimetoprima por kg de peso por d\u00eda, cuatro veces al d\u00eda) junto con 50 mg de prednisona al d\u00eda para evitar reacciones inmunitarias adversas en la neumon\u00eda neumocist\u00f3sica y s\u00edndrome inflamatorio de reconstituci\u00f3n inmunitaria (SIRI). Tras el diagn\u00f3stico de sida, se inici\u00f3 r\u00e1pidamente TAR consistente en darunavir (600 mg dos veces al d\u00eda), ritonavir (100 mg dos veces al d\u00eda) y tenofovir/emtricitabine (450/400 mg una vez al d\u00eda), por v\u00eda oral. Una infecci\u00f3n concurrente por CMV (170.000 U/ml en sangre) se trat\u00f3 con ganciclovir a 5 mg/kg de peso. El tratamiento antibacteriano con meronepem y linezolid se mantuvo durante 7 d\u00edas. Se descartaron sobreinfecciones con hepatitis B, C y s\u00edfilis. Los d\u00edas 15, 18 y 20 de mayo, el paciente dio negativo en pruebas de SARS-CoV-2 a partir de aspirados bronquiales. Las pruebas de l\u00edquido cefalorraqu\u00eddeo mostraron 5.600 copias/mL de VIH-1, pero sin evidencia de virus JC, meningitis bacteriana o encefalitis. Durante las siguientes dos semanas, su estado mejor\u00f3 considerablemente. La administraci\u00f3n de noradrenalina se pudo finalizar tres d\u00edas despu\u00e9s del inicio del tratamiento con trimetoprima/sulfametoxazol. La terapia antiv\u00edrica no tuvo efectos secundarios aparentes; en concreto, la depuraci\u00f3n de creatinina y la actividad hep\u00e1tica permanecieron estables durante las semanas siguientes. Las copias de CMV disminuyeron por debajo de 450 U/mL dos semanas despu\u00e9s de iniciar el tratamiento con ganciclovir el 14 de mayo. Con el TAR, la carga v\u00edrica disminuy\u00f3 a 2.800 copias/mL (equivalente a una disminuci\u00f3n de 2,11 en escala logar\u00edtmica) el 25 de mayo de 2020. El genotipado de VIH-1 no mostr\u00f3 farmacorresistencias relevantes. Tras la convalecencia y con la capacidad de tragar adecuadamente, el TAR se pas\u00f3 a una pauta con un solo comprimido, para mantener el cumplimiento del paciente y reducir el n\u00famero diario de pastillas. El paciente sigue mejorando. Ya no necesita ventilaci\u00f3n mec\u00e1nica y fue dado de alta de la UCI con 2 L/min de oxigenoterapia en 4 de junio."
    },
    {
        "file_name": "32609542.en.txt",
        "en": "A 61 year old man with a history of Parkinson\u2019s disease presented with a history of 4 days cough and fever to an emergency department in New York City. He described acute high grade fever and cough with a background of 4 months of cough with occasional blood streaked sputum. He reported no known sick contacts or recent travel. Chest radiograph demonstrated a dense left basilar opacity and point of care ultrasound revealed a left pleural effusion with compressive atelectasis. Patient was placed in respiratory and contact isolation with concern for Coronavirus disease 2019 (COVID-19) as well as tuberculosis (TB). Initial work up included a nasal pharyngeal swab which tested positive by RT-PCR for SARS-CoV-2. Complete blood count revealed lymphopenia (absolute lymphocyte count 935 cells/ \u03bcL), other routine laboratory values were within normal limits. A thoracentesis was performed and 1.5 liters of bloody, lymphocyte predominant pleural fluid was removed. Sputum stained for acid fast bacilli revealed moderate mycobacteria and Gene-Xpert MT/RIF sputum assay confirmed M. tuberculosis (MTB). The patient was initiated on hydroxychloroquine for putative antiviral activity against SARS-CoV- 2, and started on standard isoniazid, rifampin, ethambutol, pyrazinamide for TB treatment. Initially he required nasal canula oxygen supplementation at 2 liters per minute to maintain a normal oxygen saturation. Over time the patient improved clinically: his supplemental oxygen requirements resolved, sputum acid fast stain for bacilli converted to negative x 3, repeat nasopharyngeal swab RT-PCR for SARS-COV-2 was negative, and he was successfully discharged to home to complete his TB treatment course.",
        "es": "Un hombre de 61 a\u00f1os con antecedentes de Parkinson se present\u00f3 en un servicio de urgencias de Nueva York con tos y fiebre de 4 d\u00edas de evoluci\u00f3n. Refiri\u00f3 hipertermia aguda y antecedentes de 4 meses de tos con ocasional expectoraci\u00f3n hemoptoica. No refiri\u00f3 haber tenido contacto con personas enfermas ni haber viajado recientemente. Una radiograf\u00eda tor\u00e1cica mostr\u00f3 una opacidad densa basal izquierda y una ecograf\u00eda a pie de cama revel\u00f3 derrame pleural izquierdo con atelectasia por compresi\u00f3n. Se estableci\u00f3 aislamiento respiratorio y de contacto para el paciente, teniendo en cuenta la enfermedad por coronavirus 2019 (COVID-19) y tuberculosis. Los an\u00e1lisis iniciales incluyeron un frotis far\u00edngeo que dio positivo para SARS-CoV-2 mediante RT-PCR. El hemograma completo revel\u00f3 linfocitopenia (cifra absoluta de linfocitos 935 c\u00e9lulas/\u03bcL); los dem\u00e1s valores anal\u00edticos habituales estaban dentro de los l\u00edmites normales. Se realiz\u00f3 una toracocentesis y se retiraron 1,5 litros de l\u00edquido pleural hemorr\u00e1gico predominantemente linfoc\u00edtico. El esputo te\u00f1ido para bacilos acidoalcoholorresistentes revel\u00f3 valores moderados de micobacterias, mientras que una prueba de esputo Gene-Xpert MT/RIF confirm\u00f3 M. tuberculosis. Se inici\u00f3 un tratamiento con hidroxicloroquina como posible antiv\u00edrico contra SARS-CoV-2; asimismo, se inici\u00f3 un tratamiento est\u00e1ndar con isoniazida, rifampicina, etambutol y pirazinamida para tuberculosis. Inicialmente, el paciente necesit\u00f3 oxigenoterapia con c\u00e1nula nasal a 2 litros por minuto para mantener una saturaci\u00f3n de ox\u00edgeno normal. El paciente mejor\u00f3 cl\u00ednicamente: ya no fue necesaria la oxigenoterapia, la prueba de bacilos acidoalcoholresistentes dio negativo x 3, un nuevo frotis nasofar\u00edngeo para SARS-CoV-2 mediante RT-PCR dio negativo y el paciente fue dado de alta para completar el tratamiento antituberculoso."
    },
    {
        "file_name": "32611659.en.txt",
        "en": "In April 2020, a 57-year-old Japanese man was admitted to our hospital with an 8-day history of fever and non-productive cough. Six days before admission, the patient presented first to general practitioners. The patient had a positive result for influenza A from a nasopharyngeal swab test. The patient was prescribed with laninamivir, but his symptoms did not improve. Two days before admission, the patient was referred to our hospital for a prolonged fever. Anteroposterior chest radiograph found ground-glass opacities (GGO) in the left lung and he was treated with garenoxacin. Later, real-time reverse transcription-polymerase chain reaction (rRT-PCR) of his nasopharyngeal swab returned positive for SARS-CoV-2. His medical history included vasospastic angina and diabetes mellitus. His medications were sitagliptin and miglitol. He worked as customer service in a restaurant. There was no history of smoking, travel or any contact with sick people. On admission, the patient reported of shortness of breath, anosmia and ageusia. Vital signs were as follows: temperature, 38.8\u00b0C; blood pressure 131/74, mm Hg; heart rate, 80 beats/min; respiratory rate, 20 breaths/min; and oxygen saturation, 91% on room air with desaturation on minimal exertion. Complete blood count revealed white blood cells, 8.3\u00d7109/L (neutrophils, 86%; lymphocytes, 8%; and monocytes, 6%); haemoglobin 144 g/L; mean corpuscular volume, 96 fL; and platelets, 199\u00d7109/L. Serum laboratory test results were as follows: total protein, 6.5 g/dL; albumin, 3.1 g/dL; total bilirubin, 0.6 mg/dL; aspartate aminotransferase, 103 IU/L; alanine transaminase, 161 IU/L; g-glutamyl transferase, 114 IU/L; lactate dehydrogenase, 416 IU/L; blood urea nitrogen, 11 mg/dL; creatinine, 0.8 mg/dL; sodium, 136 mmol/L; potassium, 4.6 mmol/L; chloride, 97 mmol/L; glucose, 231 mg/dL; haemoglobin A1c, 7.2%; ferritin, 1695 ng/mL; C-reactive protein, 15.7 mg/dL; and procalcitonin,<0.1 ng/mL. Hepatitis B surface antigen and anti-hepatitis C virus were negative. An ECG was normal. Anteroposterior chest radiography revealed consolidation in the left lung. Further evaluation with CT scanning of the chest found peripheral, bilateral, GGO with consolidation and visible intralobular lines (crazy-paving appearance). Sputum cultures for bacteria, fungus and acid-fast bacilli were all negative. Initial considerations for this patient who presented acutely with fever and cough include infection with a common virus (rhinoviruses, non-SARS-CoV-2 coronaviruses and influenza virus) and community-acquired pneumonia. The rapid antigen testing and his clinical course make influenza pneumonia likely. Owing to the SARS-CoV-2 outbreak in Japan, COVID-19 also needs to be considered. Ciclesonide inhaler (200 \u03bcg two times per day for 14 days), favipiravir (1800 mg two times per day at day 1, followed by 800 mg two times per day for a total duration of 14 days) and broad-spectrum antibiotics (meropenem and azithromycin) were initiated. Soon after hospitalisation, the patient developed progressive hypoxaemia (oxygen saturation of 91% on 2 L/min via nasal cannula). The fever continued for the first 4 days of hospitalisation, but subsequently abated. At day 7 of hospitalisation, the patient\u2019s dyspnoea and hypoxaemia improved. According to discharge criteria for confirmed COVID-19 cases in Japan (2 negative rRT-PCR tests from nasopharyngeal swabs at 24 hours interval and clinical improvement of signs and symptoms), he was discharged home 4 weeks after hospitalisation.",
        "es": "En abril de 2020, un hombre japon\u00e9s de 57 a\u00f1os ingres\u00f3 en nuestro hospital con fiebre y tos no productiva de 8 d\u00edas de evoluci\u00f3n. Seis d\u00edas antes del ingreso, el paciente acudi\u00f3 al m\u00e9dico de cabecera. El paciente hab\u00eda dado positivo para gripe A a partir de una prueba con frotis nasofar\u00edngeo. Se le recet\u00f3 laninamivir, pero sus s\u00edntomas no mejoraron. Dos d\u00edas antes del ingreso, el paciente fue derivado a nuestro hospital a causa de fiebre persistente. Una radiograf\u00eda tor\u00e1cica anteroposterior hall\u00f3 opacidades de vidrio esmerilado en el pulm\u00f3n izquierdo y fue tratado con garenoxacina. M\u00e1s tarde, los resultados de la RT-PCR en tiempo real a partir de su frotis nasofar\u00edngeo fueron positivos para SARS-CoV-2. Sus antecedentes m\u00e9dicos indicaban angina vasoesp\u00e1stica y diabetes mellitus. Su medicaci\u00f3n consist\u00eda en sitagliptina y miglitol. Trabajaba en el servicio de atenci\u00f3n al cliente de un restaurante. No ten\u00eda antecedentes de tabaquismo, viajes ni contactos con personas enfermas. Al ingreso, el paciente refiri\u00f3 disnea, anosmia y ageusia. Las constantes vitales eran las siguientes: temperatura 38,8 \u00b0C; presi\u00f3n arterial 131/74 mm Hg; pulso 80 l.p.m. ; frecuencia respiratoria 20 r.p.m. Un hemograma completo dio una cifra de leucocitos de 8,3\u00d7109/L (neutr\u00f3filos, 86%; linfocitos, 8%; monocitos, 6%); hemoglobina 144 g/L; volumen globular medio, 96 fL; trombocitos, 199\u00d7109/L. Los resultados serol\u00f3gicos fueron los siguientes: prote\u00ednas totales, 6,5 g/dL; alb\u00famina, 3,1 g/dL; bilirrubina toral, 0,6 mg/dL; aspartato-aminotransferasa, 103 UI/L; alanina-transaminasa, 161 UI/L; g-glutamil-transferasa, 114 UI/L; lactato-deshidrogenasa, 416 UI/L; nitr\u00f3geno ureico, 11 mg/dL; creatinina, 0,8 mg/dL; sodio, 136 mmol/L; potasio, 4,6 mmol/L; cloruro, 97 mmol/L; glucosa, 231 mg/dL; hemoglobina A1c, 7.2%; ferritina, 1695 ng/mL; prote\u00edna C-reactiva, 15,7 mg/dL; procalcitonina,< 0.1 ng/mL. El ant\u00edgeno de superficie de la hepatitis B y anticuerpos del virus de la hepatitis B fueron negativos. Un ECG fue normal. Una radiograf\u00eda tor\u00e1cica anteroposterior revel\u00f3 consolidaci\u00f3n en el pulm\u00f3n izquierdo. Una evoluci\u00f3n posterior mediante TAC tor\u00e1cica hall\u00f3 opacidades de vidrio esmerilado bilaterales perif\u00e9ricas con consolidaci\u00f3n y l\u00edneas intralobulares visibles (patr\u00f3n en empedrado). Los cultivos de esputo para bacterias, hongos y bacilos \u00e1cido alcohol resistentes fueron todos negativos. Las consideraciones iniciales para este paciente que presentaba un cuadro agudo con fiebre y tos fueron infecci\u00f3n con un virus com\u00fan (rinovirus, coronavirus no SARS-CoV-2 y gripe) as\u00ed como neumon\u00eda extrahospitalaria. La prueba r\u00e1pida de ant\u00edgenos y su evoluci\u00f3n cl\u00ednica daban peso a la posibilidad de neumon\u00eda. Debido al brote de SARS-CoV-2 en Jap\u00f3n, tambi\u00e9n era necesario considerar la posibilidad de COVID-19. Se inici\u00f3 un tratamiento con inhalador de ciclesonida (200 \u03bcg dos veces al d\u00eda durante 14 d\u00edas), favipiravir (1800 mg dos veces al d\u00eda el primer d\u00eda, seguido de 800 mg dos veces al d\u00eda durante un total de 14 d\u00edas) y antibi\u00f3ticos de amplio espectro (meropenem y azitromicina). Poco despu\u00e9s de la hospitalizaci\u00f3n, el paciente present\u00f3 hipoxemia progresiva (saturaci\u00f3n de ox\u00edgeno de 91% con c\u00e1nula nasal a 2 L/min). La fiebre continu\u00f3 durante los primeros 4 d\u00edas de hospitalizaci\u00f3n, pero luego remiti\u00f3. El d\u00eda 7 de hospitalizaci\u00f3n, la disnea y la hipoxemia mejoraron. Seg\u00fan los criterios de alta para casos confirmados de COVID en Jap\u00f3n (2 pruebas negativas de rRT-PCR a partir de frotis nasofar\u00edngeo con un intervalo de 24 horas y mejora cl\u00ednica de signos y s\u00edntomas), el paciente fue dado de alta 4 semanas despu\u00e9s del ingreso."
    },
    {
        "file_name": "32612435.en.txt",
        "en": "An 80-year-old man presented to our emergency department with complaints of poor general condition and fatigue for the last 18 h. The patient\u2019s relatives reported that the patient had not left his home for the past 15 days and had no contact with anyone suspected of having COVID- 19. However, his son was delivering groceries to his home once a week. Based on the statement given by his relatives, the patient had no known diseases and had undergone surgery in 2015 to repair an inguinal hernia. On physical examination, the patient\u2019s blood oxygen saturation was 86% at room temperature, respiratory rate was 38/min, blood pressure was 170/110 mmHg, and brachial/radial heart rate was 150 beats/min and regular. The patient exhibited disorientation to time and space, and the results of neurological evaluation indicated that he had delirium. Posterior lung auscultation revealed bilateral basal inspiratory rales. Laboratory tests results were as follows: white blood cells=16,760/\u03bcL, lymphocyte count=330/\u03bcL, neutrophils=15,870/\u03bcL, hemoglobin=20.4 g/dL, platelets=119,000/\u03bcL, lactate dehydrogenase=557 U/L, calcium=7.8 mg/dL, albumin=3.01 g/ dL, creatine=7.42 mg/dL, sodium=131 mmoL/L, blood-urea nitrogen=139.25 mg/dL, glomerular filtration rate=8.09 mL/min, troponin=88.1 ng/dL, D-dimer=3012 ng/mL, fibrinogen=890 mg/dL, prothrombin time=20.4 s, C-reactive protein=26.2 mg/dL, and ferritin=1124 ng/mL. On blood gas analysis, pH=7.23, SaO2=92.4%, PaO2=74 mmHg, PaCO2=28.1 mmHg, and HCO3=14.4 mEq/L. Posterior-anterior chest X-ray showed increased prominence of the bronchovascular structures with areas of pleural-based consolidation in the lower lobes of both lungs. Chest computed tomography revealed tubular and cystic bronchiectatic dilations in the bronchial structures in the upper lobe of the left lung, especially those leading to the anterior segment, with bronchial wall thickening at these levels. Areas of ground-glass opacity were noted adjacent to the areas of cystic bronchiectasis. The lower lobes of both lungs showed areas of ground-glass opacity and tree-in-bud appearance surrounding consolidation that contained air bronchograms, and the findings were reported as being primarily indicative of viral pneumonia. The diffusion MRI scan of the brain ordered due to delirium was reported as normal. The patient was admitted to the pulmonary diseases intensive care unit with acute renal failure and suspected COVID-19. PCR analysis of the nasopharyngeal swab sample was positive for COVID-19. In line with the Ministry of Health guidelines for management of adult patients, renal dose-adjusted treatment was initiated with hydroxychloroquine 200 mg every 12 h loading dose and 50 mg maintenance dose, favipiravir 1600 mg every 12 h loading dose and 600 mg maintenance dose, azithromycin 500 mg/day loading dose and 250 mg/day maintenance dose, and enoxaparin 0.5 mg/kg every 12 h. In light of the patient\u2019s laboratory parameters and clinical condition, 400 mg tocilizumab was also given to manage the cytokine storm. The patient\u2019s clinical symptoms improved after 24 h of treatment and follow-up is ongoing.",
        "es": "Un hombre de 80 a\u00f1os acudi\u00f3 a nuestro servicio de urgencias aquejado de malestar general y fatiga durante las \u00faltimas 18 horas. Los familiares del paciente informaron que no hab\u00eda abandonado su domicilio en los \u00faltimos 15 d\u00edas y no hab\u00eda tenido contacto con nadie sospechoso de COVID-19. Sin embargo, su hijo les entregaba la compra una vez por semana. Seg\u00fan lo afirmado por sus familiares, el paciente no ten\u00eda enfermedades conocidas y se hab\u00eda sometido a una operaci\u00f3n en 2015 para solucionar una hernia inguinal. A la exploraci\u00f3n f\u00edsica, la saturaci\u00f3n de ox\u00edgeno era de 86% en aire ambiental, la frecuencia respiratoria era de 38 r.p.m, la presi\u00f3n arterial era de 170/110 mmHg y el pulso humeral/radial era de 150 l.p.m. y regular. El paciente mostraba desorientaci\u00f3n espacial y temporal y los resultados de la evaluaci\u00f3n neurol\u00f3gica indicaban delirio. La auscultaci\u00f3n pulmonar posterior revel\u00f3 estertores inspiratorios basales bilaterales. Las pruebas anal\u00edticas dieron los resultados siguientes: leucocitos=16.760/\u03bcL, linfocitos=330/\u03bcL, neutr\u00f3filos=15.870/\u03bcL, hemoglobina=20,4 g/dL, trombocitos=119.000/\u03bcL, lactato-deshidrogenasa=557 U/L, calcio=7,8 mg/dL, alb\u00famina=3,01 g/dL, creatinina=7,42 mg/dL, sodio=131 mmol/L, nitr\u00f3geno ureico=139,25 mg/dL, velocidad de filtraci\u00f3n glomerular=8,09 mL/min, troponina=88,1 ng/dL, d\u00edmero D=3.012 ng/mL, fibrin\u00f3geno=890 mg/dL, tiempo de protrombina=20,4 s, prote\u00edna C-reactiva=26,2 mg/dL, ferritina=1.124 ng/mL. La gasometr\u00eda dio los resultados: pH=7,23, SaO2=92,4%, PaO2=74 mmHg, PaCO2=28,1 mmHg y HCO3=14,4 mEq/L. Una radiograf\u00eda tor\u00e1cica anteroposterior mostr\u00f3 un aumento de la prominencia de las estructuras broncovasculares, con zonas de consolidaci\u00f3n pleural en los l\u00f3bulos inferiores de ambos pulmones. La TAC tor\u00e1cica revel\u00f3 dilataciones bronquiect\u00e1sicas c\u00edsticas y tubulares en las estructuras bronquiales del l\u00f3bulo superior del pulm\u00f3n izquierdo, especialmente las que se dirigen al segmento anterior, con infiltrados peribronquiales. Se apreciaron zonas de opacidades de vidrio esmerilado adyacentes a las \u00e1reas de bronquiectasia c\u00edstica. Los l\u00f3bulos inferiores de ambos pulmones mostraron zonas de opacidades de vidrio esmerilado y patr\u00f3n en gemaci\u00f3n alrededor de las consolidaciones con broncograma a\u00e9reo; los resultados eran indicativos, primariamente, de neumon\u00eda v\u00edrica. La RMN cerebral ponderada por difusi\u00f3n, programada a causa del delirio, dio resultado normal. El paciente fue ingresado en la UCI de neumolog\u00eda con insuficiencia renal aguda y posible COVID-19. El an\u00e1lisis mediante PCR de una muestra de frotis nasofar\u00edngeo fue positivo para COVID-19. De acuerdo con las directrices del Ministerio de Sanidad para la gesti\u00f3n de pacientes adultos, se inici\u00f3 un tratamiento renal con ajuste de dosis, con una dosis inicial de hidroxicloroquina 200 mg cada 12 h y una dosis de mantenimiento de 50 mg, dosis inicial de favipiravir 1600 mg cada 12 h y dosis de mantenimiento de 600 mg, dosis inicial de azitromicina 500 mg/d\u00eda y dosis de mantenimiento de 250 mg/d\u00eda, as\u00ed como enoxaparina 0,5 mg/kg cada 12 h. Teniendo en cuenta los par\u00e1metros anal\u00edticos y el estado cl\u00ednico del paciente, tambi\u00e9n se administr\u00f3 400 mg de tocilizumab para gestionar la tormenta de citocinas. Los s\u00edntomas cl\u00ednicos mejoraron despu\u00e9s de 24 horas de tratamiento y, en estos momentos, el paciente se halla en seguimiento."
    },
    {
        "file_name": "32616174.en.txt",
        "en": "A 27-year-old male without medical history was admitted for respiratory distress, and COVID-19 was diagnosed. High-sensitivity troponin I and N-terminal pro\u2013B-type natriuretic peptide concentrations were elevated (100\u00a0ng/l and 9,300 pg/ml, respectively) suggesting myocardial involvement. In addition, echocardiography revealed an enlarged left ventricle with impaired left ventricle ejection fraction (LVEF) of 20%. The patient improved on a regimen of high-dose diuretic agents and noninvasive ventilation. He was discharged 9\u00a0days later with prescriptions for bisoprolol, furosemide, and spironolactone. One month later, his LVEF improved to 40% and showed normal filling pressure and cardiac output. Echocardiography revealed a 2-layered structure of the myocardium suggesting IVNC. CMR confirmed the IVNC diagnosis but also revealed acute myocarditis. Coronary computed tomography angiography results ruled out coronary artery disease. Management involved treating the patient\u2019s heart failure, and genetic screening of both the patient and family members was conducted.",
        "es": "Un hombre de 27 a\u00f1os sin antecedentes m\u00e9dicos ingres\u00f3 con insuficiencia respiratoria y se le diagnostic\u00f3 COVID-19. Las concentraciones de troponina I ultrasensible y de prohormona N-terminal del p\u00e9ptido natriur\u00e9tico cerebral eran altas (100 ng/l y 9.300 pg/ml, respectivamente), lo que suger\u00eda afectaci\u00f3n mioc\u00e1rdica. Adem\u00e1s, un ecocardiograma revel\u00f3 una dilataci\u00f3n del ventr\u00edculo izquierdo, con una baja fracci\u00f3n de expulsi\u00f3n del VI del 20%. El paciente mejor\u00f3 con una pauta de alta dosis de diur\u00e9ticos y ventilaci\u00f3n no invasiva. Fue dado de alta 9 d\u00edas despu\u00e9s con prescripci\u00f3n de bisoprolol, furosemida y espironolactona. Un mes despu\u00e9s, la fracci\u00f3n de expulsi\u00f3n del VI hab\u00eda mejorado a 40% y mostr\u00f3 un buen gasto card\u00edaco y una buena presi\u00f3n de llenado. Un ecocardiograma revel\u00f3 una estructura de dos capas del miocardio, indicativa de VINC. Una RMN card\u00edaca confirm\u00f3 el diagn\u00f3stico de VINC, pero tambi\u00e9n revel\u00f3 miocarditis aguda. Los resultados de una angiotomograf\u00eda computarizada coronaria descartaron arteriopat\u00eda coronaria. La gesti\u00f3n inclu\u00eda tratar la insuficiencia card\u00edaca del paciente y un cribaje gen\u00e9tico del paciente y los familiares."
    },
    {
        "file_name": "32619798.en.txt",
        "en": "A 68-year old man with no past medical history was admitted on the 22nd March, 2020 to a local hospital with an 8-day history of fever, cough and dyspnea. He had not recently travelled. His body temperature exceeded 40\u00a0\u00b0C, respiratory rate was 24 breaths/min and the oxygen saturation was 95% on ambient air. A chest X-ray was compatible with pneumonia. He received treatment with piperacillin/tazobactam. Real-time polymerase-chain-reaction assay (RT-PCR) of nasal swab returned positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). He deteriorated and was intubated two days after hospitalization, and treated in the ICU for 11\u00a0days. He failed a spontaneous-breathing trial and needed re-intubation within 48 h following extubation. He was moved to the ICU at Aarhus University Hospital because of weaning failure from mechanical ventilation, muscle weakness and multiple organ failure. Neuroimaging of the central nervous system and cerebrospinal fluid examinations excluded neuroinfection or structural lesion. On clinical examination he had severe symmetrical proximal and distal weakness (Medical Research Council-score, 2/5), diffuse muscle wasting, and absent deep tendon reflexes. On day 65 of hospitalization, nerve conduction studies (NCS) and quantitative electromyography were performed using conventional methods with the suspicion of Guillain-Barr\u00e9-Syndrome (GBS) or critical illness polyneuropathy (CIP). Abnormal findings on needle EMG were shortened motor unit potentials (MUPs) consistent with myopathy in biceps brachii and vastus medialis muscles with passive movements of the joints but there was no fibrillations or positive-sharp-waves whereas in the anterior tibial muscles bilaterally, profuse denervation activity was found. Left peroneal motor conduction velocity (CV) was decreased across the knee (27.8\u00a0m/s) and normal in lower leg segment (42.2\u00a0m/s), right motor response was absent as well as bilateral superficial peroneal sensory action potentials suggesting bilateral peroneal compression neuropathy. There were normal sensory NCS of median (CV:53.7\u00a0m/s, amplitude:10.2\u00a0\u00b5V), ulnar (CV:51.2\u00a0m/s, amplitude:6.9\u00a0\u00b5V) and right sural (CV:51.6\u00a0m/s, amplitude:2.7\u00a0\u00b5V) and left sural (CV:49.2\u00a0m/s, amplitude:2.8\u00a0\u00b5V) nerves. Furthermore, there were reduced compound muscle action potential (CMAP) amplitudes in median (2.3\u00a0mV), ulnar (1.6\u00a0mV) and tibial (right:0.8\u00a0mV, left:0.9\u00a0mV) nerves. CMAP duration was only increased in median nerve (8.5\u00a0ms) and normal in ulnar (6.9\u00a0ms) and tibial (right:7.2\u00a0ms, left:7.3\u00a0ms) nerves. F-waves were absent in all motor nerves. In the right median nerve, a 1-second burst of 20\u00a0Hz repetitive nerve stimulation (RNS) was performed and immediately after RNS, F-waves were easily obtained with normal minimum F-wave latencies and frequencies. There was no decrement with 3\u00a0Hz repetitive stimulation. In conclusion, the findings indicated critical illness myopathy (CIM) but not GBS or CIP.",
        "es": "Un hombre de 68 a\u00f1os sin antecedentes m\u00e9dicos ingres\u00f3 el d\u00eda 22 de marzo de 2020 en un hospital local con fiebre, tos y disnea de 8 d\u00edas de evoluci\u00f3n. No hab\u00eda viajado recientemente. Su temperatura superaba 40\u00b0C, la frecuencia respiratoria era de 24 r.p.m. y la saturaci\u00f3n de ox\u00edgeno era de 95% en aire ambiental. Una radiograf\u00eda tor\u00e1cica dio resultados compatibles con neumon\u00eda. Recibi\u00f3 tratamiento con piperacilina/tazobactam. Una prueba mediante RT-PCR de frotis nasofar\u00edngeo dio resultado positivo para s\u00edndrome de dificultad respiratoria aguda por coronavirus 2 (SARS-CoV-2). El paciente empeor\u00f3 y fue intubado dos d\u00edas despu\u00e9s de la hospitalizaci\u00f3n; fue tratado en la UCI durante 11 d\u00edas. No super\u00f3 una prueba de respiraci\u00f3n espont\u00e1nea y necesit\u00f3 reintubaci\u00f3n a las 48 horas de la extubaci\u00f3n. Se traslad\u00f3 a la UCI del hospital universitario de Aarhus, a causa de la imposibilidad de retirar la ventilaci\u00f3n mec\u00e1nica, de la debilidad muscular y de insuficiencia multiorg\u00e1nica. Las im\u00e1genes del sistema nervioso central y los an\u00e1lisis del l\u00edquido cefalorraqu\u00eddeo descartaron neuroinfecci\u00f3n o lesiones estructurales. A la exploraci\u00f3n cl\u00ednica, mostraba diversas debilidades sim\u00e9tricas distales y proximales graves (puntuaci\u00f3n en el \u00edndice del Medical Research Council: 2/5), atrofia muscular difusa y ausencia de reflejos osteotendinosos. El d\u00eda 65 de hospitalizaci\u00f3n, se realizaron estudios de conducci\u00f3n nerviosa y un electromiograma cuantitativo con m\u00e9todos convencionales, por sospecha de s\u00edndrome de Guillain-Barr\u00e9 (SGB) o de polineuropat\u00eda del paciente cr\u00edtico (PPC). Los resultados an\u00f3malos en el electromiograma fueron potenciales de unidad motora (PUM) reducidos, coherente con miopat\u00eda en el b\u00edceps braquial y el vasto medial con movimientos pasivos de las articulaciones, pero no se observaron fibrilaciones ni ondas positivas, mientras que en los tibiales anteriores se hall\u00f3 denervaci\u00f3n profusa bilateral. Se observ\u00f3 una disminuci\u00f3n de la velocidad de conducci\u00f3n motora peroneal izquierda en el tobillo (27,8 m/s) pero era normal en la pierna (42,2 m/s); la respuesta motora derecha estaba ausente, as\u00ed como los potenciales de acci\u00f3n sensorial peroneal superficial bilateral, lo que suger\u00eda neuropat\u00eda por compresi\u00f3n peroneal bilateral. Los estudios de conducci\u00f3n nerviosa sensorial eran normales en los nervios mediano (CV: 53,7m/s, amplitud: 10,2\u00b5V), cubital (CV: 51,2m/s, amplitud: 6,9\u00b5V) y safeno externo derecho (CV: 51,6m/s, amplitud: 2,7\u00b5V) e izquierdo (CV: 49,2m/s, amplitud: 2,8\u00b5V). Adem\u00e1s, se observaron amplitudes reducidas del potencial de acci\u00f3n muscular compuesto (PAMC) en los nervios mediano (2,3mV), cubital (1,6mV) y tibial (derecho: 0,8mV, izquierdo: 0,9mV). La duraci\u00f3n del PAMC solo estaba aumentada en el nervio mediano (8,5 ms) y era normal en los nervios cubital (6,9 ms) y tibial (derecho: 7,2 ms, izquierdo: 7,3 ms). Las ondas F estaban ausentes en todos los nervios motores. En el nervio mediano derecho, se realiz\u00f3 una estimulaci\u00f3n nerviosa repetitiva a 20 Hz con un pulso de 1 segundo; inmediatamente despu\u00e9s, se obtuvieron con facilidad ondas F con latencias y frecuencias m\u00ednimas normales. No hubo disminuci\u00f3n con una estimulaci\u00f3n repetitiva a 3 Hz. En conclusi\u00f3n, los resultados indicaban miopat\u00eda del paciente cr\u00edtico (MPC), pero no SGB ni PPC."
    },
    {
        "file_name": "32622823.en.txt",
        "en": "A 63-year-old male with a past medical history of systemic hypertension presented to our facility with symptoms of fevers, chills, nonproductive cough and epigastric pain for three days. Laboratory examination revealed a lactic acidosis of 4.9 mmol/L, serum creatinine of 2.34 mg/dl, hemoglobin of 21.6 g/dl, hematocrit of 65.6%, serum protein of 6.4 g/dl and albumin of 3.5 g/dl, and normal liver enzymes. Testing for SARS-COV-2 was positive. Despite volume crystalloid resuscitation, and broad spectrum antibiotics, he rapidly deteriorated and required initiation of vasopressors, intubation, and mechanical ventilation. Computed tomography scan of the chest and abdomen showed scant peripheral ground glass infiltrates but was unrevealing for a cause for his abdominal pain or source of septic shock. On echocardiogram, bilateral ventricular function was normal; there was a pericardial effusion without signs of tamponade. Over the next few hours, despite ongoing resuscitation, vasopressor requirement increased, lactic acid rose to >20 mmol/L, and serum protein and albumin dropped to <3.0 g/dl and <1.5 g/dL respectively. His vasopressor requirements were norepinephrine at 1 mcg/kg/min, vasopressin 0.03 units/min and epinephrine 0.15 mcg/kg/min. He developed tense anasarca, contractures of extremities and rising creatine kinase at over 20,000 U/L. Measured intracompartmental pressures in all compartments of his extremities revealed elevated pressures that ranged from 50 to 79 mmHg and were all within 30 mmHg of the diastolic blood pressure, consistent with compartment syndrome. The surgical team then performed fasciotomies of both arms and both lower legs. Up to this point, he had received 15 liters of balanced crystalloid and had been initiated on continuous renal replacement therapy. However, despite maximal supportive care the patient continued to decline. Family decided to withdraw care approximately 24 hours after admission.",
        "es": "Un hombre de 63 a\u00f1os con antecedentes de hipertensi\u00f3n sist\u00e9mica acudi\u00f3 a nuestro centro con s\u00edntomas de fiebre, escalofr\u00edos, tos no productiva y dolor epig\u00e1strico de tres d\u00edas de evoluci\u00f3n. Las pruebas anal\u00edticas revelaron acidosis l\u00e1ctica de 4,9 mmol/l, creatinina s\u00e9rica de 2,34 mg/dl, hemoglobina de 21,6 g/dl, hematocrito de 65,6%, prote\u00edna s\u00e9rica de 6,4 g/dl y alb\u00famina de 3,5 g/dl; las enzimas hep\u00e1ticas eran normales. La prueba de SARS-CoV-2 fue positiva. A pesar de reposici\u00f3n de l\u00edquidos con cristaloides y administraci\u00f3n de antibi\u00f3ticos de amplio espectro, el paciente empeor\u00f3 r\u00e1pidamente y necesit\u00f3 vasopresores, intubaci\u00f3n y ventilaci\u00f3n mec\u00e1nica. Una TAC tor\u00e1cica y abdominal mostr\u00f3 escasos infiltrados perif\u00e9ricos en vidrio esmerilado, pero no logr\u00f3 esclarecer la causa del dolor abdominal ni la fuente del choque s\u00e9ptico. En el ecocardiograma, la actividad ventricular bilateral era normal; hab\u00eda un derrame peric\u00e1rdico sin signos de taponamiento. Durante las horas siguientes, a pesar de la reposici\u00f3n de l\u00edquidos en curso, los requisitos de vasopresi\u00f3n aumentaron, el \u00e1cido l\u00e1ctico aument\u00f3 a > 20 mmol/l y la prote\u00edna s\u00e9rica y la alb\u00famina cayeron a < 3,0 g/dl y < 1,5 g/dl, respectivamente. Las exigencias de vasopresi\u00f3n eran: norepinefrina a 1 mcg/kg/min, vasopresina a 0,03 unidades/min y epinefrina a 0,15 mcg/kg/min. Present\u00f3 anasarca tensa, contracturas de las extremidades y aumento de la creatina-cinasa por encima de 20.000 U/l. Las presiones intracompartimentales medidas en todos los compartimentos de sus extremidades revelaron presiones elevadas, entre 50 y 79 mmHg, todas a menos de 30 mmHg de la presi\u00f3n arterial diast\u00f3lica, coherente con el s\u00edndrome compartimental. El equipo quir\u00fargico practic\u00f3 fasciotom\u00edas en ambos brazos y ambas piernas. Hasta ese momento, hab\u00eda recibido 15 litros de cristaloides equilibrados y se hab\u00eda iniciado tratamiento renal sustitutivo continuo. Sin embargo, a pesar del tratamiento sintom\u00e1tico m\u00e1ximo, el paciente continu\u00f3 empeorando. La familia decidi\u00f3 retirar los tratamientos unas 24 horas tras el ingreso."
    },
    {
        "file_name": "32633439.en.txt",
        "en": "\ufeffThe patient is a 6\u2010year\u2010old female with B\u2010lymphoblastic lymphoma in the maintenance phase of treatment, who was admitted to the hospital with fever and neutropenia per hospital standard of care. Her history was significant for symptomatic family household members who had tested positive for SARS\u2010CoV\u20102. The patient had a history of 1\u00a0day of cough, but was asymptomatic on admission, remained afebrile throughout her hospitalization, and denied symptoms of cough, shortness of breath, fatigue, abdominal pain, or diarrhea. Testing was positive for SARS\u2010CoV\u20102 by nasopharyngeal (NP) polymerase chain reaction (PCR). Infectious disease specialists were consulted and recommended a baseline chest X\u2010ray (CXR) and monitoring of inflammatory markers. D\u2010dimer, lactate dehydrogenase, and interleukin\u20106 were not elevated, and trended down during admission. Her ferritin was slightly elevated at 1098\u00a0ng/mL, and down\u2010trended to 983\u00a0ng/mL on repeat testing. Her CXR was normal, and as her clinical status remained stable, imaging was not repeated prior to discharge. Her oral chemotherapy was held while neutropenic as per Children's Oncology Group AALL1131 protocol guidelines and while actively infected with the virus. The patient was discharged home after 10\u00a0days of hospitalization. She had repeat SARS\u2010CoV\u20102 PCR testing of NP swab 3\u00a0weeks after her diagnosis and it was negative. Serum SARS\u2010CoV\u20102 IgG testing at 6\u00a0weeks after diagnosis was positive; demonstrating that she mounted an antibody response while immunocompromised.",
        "es": "Ni\u00f1a de 6 a\u00f1os con linfoma linfobl\u00e1stico B en fase de mantenimiento del tratamiento ingres\u00f3 en el hospital con fiebre y neutrocitopenia, seg\u00fan el procedimiento diagn\u00f3stico habitual. Sus antecedentes eran relevantes por familiares sintom\u00e1ticos en el mismo domicilio que hab\u00edan dado positivo en la prueba de SARS-CoV-2. La paciente ten\u00eda un d\u00eda de evoluci\u00f3n de tos, pero por lo dem\u00e1s era asintom\u00e1tica al ingreso, permaneci\u00f3 afebril durante toda la hospitalizaci\u00f3n y no refiri\u00f3 s\u00edntomas de tos, disnea, fatiga, dolor abdominal o diarrea. Dio positiva en una prueba para SARS-CoV-2 mediante PCR a partir de frotis nasofar\u00edngeo. Se consult\u00f3 con especialistas en enfermedades infecciosas y se recomend\u00f3 una radiograf\u00eda tor\u00e1cica inicial y la monitorizaci\u00f3n de marcadores de inflamaci\u00f3n. El d\u00edmero D, la lactato-deshidrogenasa y la interleucina 6 no eran altas y fueron disminuyendo durante el ingreso. La ferritina era algo elevada, a 1098 ng/mL, y baj\u00f3 a 983 ng/mL en una segunda prueba. Su radiograf\u00eda tor\u00e1cica era normal y su estado cl\u00ednico permaneci\u00f3 estable; no ser realiz\u00f3 ninguna radiograf\u00eda m\u00e1s antes del alta. Se mantuvo su quimioterapia oral mientras estaba neutrocitop\u00e9nica, de acuerdo con las directrices AALL1131 del Children's Oncology Group y mientras estaba infectada con el virus. La paciente fue dada de alta despu\u00e9s de 10 d\u00edas de hospitalizaci\u00f3n. Se le hizo una nueva prueba de SARS-CoV-2 a partir de frotis nasofar\u00edngeo mediante PCR tres semanas despu\u00e9s del diagn\u00f3stico y dio resultado negativo. Las pruebas serol\u00f3gicas de IgG de SARS-CoV-2 seis semanas tras el diagn\u00f3stico dieron resultado positivo, lo que demostraba que hab\u00eda generado una respuesta inmunitaria mientras se hallaba inmunodeprimida."
    },
    {
        "file_name": "32638890.en.txt",
        "en": "A 71-year-old male patient with prior history of hypertension, type II diabetes mellitus, and chronic kidney disease was admitted to the Hospital e Pronto-Socorro Delphina Rinaldi Abdel Aziz, a referral unit for the treatment of patients with COVID-19 in Manaus. The patient was transferred from another hospital, where he had already been diagnosed with COVID-19 by RT-qPCR. Upon admission into the ICU, he was placed under orotracheal intubation, received high-dose vasoactive drugs, was hemodynamically unstable, and presented cyanosis and cold extremities. He was administered high-flow norepinephrine (1.41 \u00b5g/kg/min) and placed on invasive mechanical ventilation under aspiration of an orotracheal tube with high parameters (positive end-expiratory pressure [PEEP] 8/FiO2 60%/respiratory rate 26; volume 360). The PaO2/FiO2 ratio was 86.6. The patient received oseltamivir (75 mg twice daily) and chloroquine (450 mg twice on the first day) via a nasoenteral tube, IV azithromycin (500 mg/day), IV ceftriaxone (2g/day), IV furosemide (20mg TID), and prophylactic subcutaneous enoxaparin (40 mg/day). No corticosteroid drugs were used. Laboratory parameters showed increased urea (360.7 mg/dL), creatinine (8.46 mg/dL), and C-reactive protein (12 mg/L). Normal values were seen for potassium and sodium (5.24 mmol/L; and 136.8 mmol/L, respectively). Leukocytes 6,530/\u00b5L, platelets 285x109/\u00b5L, hemoglobin 11.2 g/dL, hematocrit 34.5%, neutrophilia (84%), and lymphopenia (12,8%) were also observed. Chest x-rays showed infiltrate and nodular consolidation in the right lower lobe. No CT scan was performed. Blood culture was negative for bacterial growth. On day three, following admission, the patient progressed with hemodynamic worsening and refractory shock, with irreversible hypotension and bradycardia. He died the following day. Microscopic visualization of the lung showed the presence of clearly defined Aspergillus structures, including hyphae and fungal spores, and a well-defined Aspergillus head with phialides, conidia, and spores, as well as bronchopneumonia, fibrin thrombi occluding an artery, and squamous metaplasia.",
        "es": "Un hombre de 71 a\u00f1os, con antecedentes de hipertensi\u00f3n, diabetes mellitus de tipo 2 y nefropat\u00eda cr\u00f3nica, fue ingresado en el Hospital e Pronto-Socorro Delphina Rinaldi Abdel Aziz, de Manaus, un centro de referencia para el tratamiento de pacientes con COVID-19. El paciente proced\u00eda de otro hospital, donde hab\u00eda sido diagnosticado con COVID-19 mediante RT-qPCR. Al ingreso en una UCI, se le practic\u00f3 intubaci\u00f3n orotraqueal, recibi\u00f3 una dosis alta de vasoactivos, se hallaba inestable hemodin\u00e1micamente y presentaba cianosis y extremidades fr\u00edas. Se le administr\u00f3 norepinefrina a 1,41 \u00b5g/kg/min y se le aplic\u00f3 ventilaci\u00f3n mec\u00e1nica invasiva en aspiraci\u00f3n de c\u00e1nula orotraqueal con par\u00e1metros elevados (presi\u00f3n positiva telespiratoria 8/FiO2 60%/frecuencia respiratoria 26; volumen 360). El cociente PaO2/FiO2 era de 86,6. Se le administr\u00f3 oseltamivir (75 mg dos veces al d\u00eda) y cloroquina (450 mg dos veces el primer d\u00eda) mediante c\u00e1nula nasoenteral, azitromicina i.v. (500 mg/d\u00eda), ceftriaxona i.v. No se usaron corticoesteroides. Las pruebas anal\u00edticas mostraron hiperuremia (360,7 mg/dL) y aumento de creatinina (8,46 mg/dL) y prote\u00edna C-reactiva (12 mg/L). Se observaron valores normales de potasio y sodio (5,24 mmol/L y 136,8 mmol/L, respectivamente). Tambi\u00e9n se obtuvieron los resultados siguientes: leucocitos 6.530/\u00b5L, trombocitos 285x109/\u00b5L, hemoglobinemia 11,2 g/dL, hematocrito 34,5%, neutrofilia (84%) y linfocitopenia (12,8%). Las radiograf\u00edas tor\u00e1cicas mostraron consolidaci\u00f3n infiltrada y nodular en el l\u00f3bulo inferior derecho. No se hizo ninguna TAC. Los hemocultivos resultaron negativos para crecimiento bacteriano. El tercer d\u00eda tras el ingreso, el paciente empeor\u00f3 hemodin\u00e1micamente y present\u00f3 choque resistente, con hipotensi\u00f3n y bradicardia irreversibles. Muri\u00f3 al d\u00eda siguiente. El an\u00e1lisis microsc\u00f3pico del tejido pulmonar mostr\u00f3 la presencia, claramente definida, de estructuras de Aspergillus, incluyendo hifas y esporas f\u00fangicas, as\u00ed como una cabeza de Aspergillus bien definida, con fi\u00e1lides, conidios y esporas, adem\u00e1s de trombos de fibrina que taponaban una artera y metaplasia escamosa."
    },
    {
        "file_name": "32639089.en.txt",
        "en": "63-year-old  male,  with no previous psychiatric history, was first admitted in hospital presenting with bilateral pneumonia and positive PCR-COVID-19 test (March 30th 2020), being diagnosed with COVID-19. He also presented with a delirium during the hospitalization that improved in parallel to the respiratory disorder leading to patient\u2019s discharge (April 8th 2020). Ambulatory treatment with risperidone 2 mg per day was maintained, but bizarre delusions and incoherent thought and speech didn\u2019t disappear even after antipsychotic treatment adjustment, so the patient\u2019s was referred to hospital again (April 15th 2020). At  this second in-hospital admission a new PCR-COVID-19  test was performed with positive result. Respiratory evaluation was normal. An elevation of D-dimer level was detected in the blood test and a CT pulmonary angiography showed a low risk pulmonary thromboembolism (PTE), which was determined to be related to COVID-19 and treated with anticoagulants. In the first  psychiatric evaluation the  patient  referred thoughts  of changes occurred in his body, including the absence of anus, so he had decided not to eat anything to avoid exploding. At first fluctuant attention and orientation to time and place were observed, but no other common features of a delirium were present. A  cranial  MRI with contrast enhancement  showed no significant findings. Finally a diagnoses of Psychotic Disorder Due to Another Medical Condition (COVID-19) was made following DSM-5 criteria. During  the  case follow-up  by the Liaison Psychiatry department the delusions content  changed  -the patient related that  most of his relatives had died- and auditory verbal hallucinations appeared. Risperidone was titrated in the following days from 2.5 mg per day up to 6 mg per day. On April 30th 2020 the patient was mostly recovered, with absence of delusions and hallucinations and critical thought about the psychotic symptoms presented, so he was discharged and referred to his outpatient Mental Health Unit for further follow-up.",
        "es": "Hombre de 63 a\u00f1os, sin antecedentes psiqui\u00e1tricos, fue ingresado en el hospital con neumon\u00eda bilateral y prueba PCR positiva de COVID-19 (30 de marzo de 2020) y se le diagnostic\u00f3 COVID-19. Tambi\u00e9n presentaba delirio durante la hospitalizaci\u00f3n, que mejor\u00f3 en paralelo con el trastorno respiratorio, lo que llev\u00f3 al alta del paciente (8 de abril de 2020). Se mantuvo el tratamiento ambulatorio con risperidona 2mg al d\u00eda, pero el delirio extravagante y el habla y el pensamiento incoherente no remitieron, incluso despu\u00e9s de un ajuste del tratamiento antisic\u00f3tico, de modo que se envi\u00f3 al paciente de nuevo al hospital (15 de abril de 2020). En este segundo ingreso, se realiz\u00f3 una nueva prueba PCR de COVID-19, con resultado positivo. La exploraci\u00f3n respiratoria fue normal. Se detect\u00f3 un aumento de la concentraci\u00f3n de d\u00edmero D en los an\u00e1lisis de sangre; una angiograf\u00eda por TAC mostr\u00f3 un riesgo bajo de tromboembolia pulmonar, que se consider\u00f3 asociado a la COVID-19 y se trat\u00f3 con anticoagulantes. En la primera evaluaci\u00f3n psiqui\u00e1trica, el paciente refiri\u00f3 ideas de cambios en su cuerpo, como ausencia de ano, raz\u00f3n por la cual decidi\u00f3 no comer nada y as\u00ed evitar explotar. Al principio, se apreci\u00f3 atenci\u00f3n y orientaci\u00f3n respecto al tiempo y el espacio fluctuante, pero sin otros rasgos habituales de delirio. Una RMN craneal con contraste no revel\u00f3 resultados relevantes. Finalmente se hizo un diagn\u00f3stico de trastorno psic\u00f3tico causado por otro proceso patol\u00f3gico (COVID-19), seg\u00fan los criterios DSM-5. Durante el seguimiento del caso por parte del departamento de psiquiatr\u00eda, el contenido de los delirios cambi\u00f3 (el paciente explicaba que la mayor\u00eda de sus parientes hab\u00edan muerto) y aparecieron alucinaciones auditivas y verbales. Se ajust\u00f3 la dosis de risperidona durante los siguientes d\u00edas, de 2,5 mg por d\u00eda a hasta 6 mg por d\u00eda. El 30 de abril de 2020, el paciente se hab\u00eda recuperado casi por completo, sin delirios ni alucinaciones y se mostraba consciente acerca de los s\u00edntomas psic\u00f3ticos anteriores, de modo que fue dado de alta y derivado a su unidad de psiquiatr\u00eda ambulatoria para su seguimiento."
    },
    {
        "file_name": "32640066.en.txt",
        "en": "The patient was a 5\u2010year\u2010old girl who presented to paediatric urgent care with 5\u2009days of high\u2010grade fever, vomiting, diarrhoea and abdominal pain, which had been managed as an outpatient as a viral infection. On the third day, she developed conjunctivitis, blotchy rash and swelling of the hands. In the patient's history, she had experienced upper respiratory symptoms over the past 3\u2009weeks that had improved with supportive care. At the initial clinical examination, the patient was ill and had generalised erythematous skin rash, non\u2010purulent bilateral conjunctivitis, periorbital oedema and erythema, swelling and congestion of the lips, mild swelling of the hands and moderate dehydration due to vomiting and diarrhoea. There was no evidence of lymphadenopathy. Vital signs showed a temperature of 39.5\u00b0C, sinus tachycardia (165 beats/min), tachypnoea with normal breath sounds and an oxygen saturation of 98% and the blood pressure was 75/55. Laboratory tests revealed lymphopaenia, thrombocytopaenia, mildly elevated C\u2010reactive protein (CRP) of 23\u2009mg/L and erythrocyte sedimentation rate of 40\u2009mm/h. She had hyponatraemia (Na: 120\u2009mEq/L) and elevated liver function tests. About 4\u2009weeks before she was admitted to our hospital, she had a positive history of exposure to her uncle who was diagnosed with COVID\u201019. Owing to this history of exposure, reverse transcriptase\u2010polymerase chain reaction (RT\u2010PCR) and serology for SARS\u2010CoV\u20102 were requested. The PCR was negative on two occasions; however, IgG for SARS\u2010CoV\u20102 was positive (IgG: 10.3 times higher than reference standard; IgM: 0.2 times lower than reference standard; normal range was defined as lower than 1.1 ratio) suggesting previous SARS\u2010CoV\u20102 infection. Prompt treatment with fluid resuscitation was initiated due to the patient's dehydration and low blood pressure. After vital signs stabilised, the patient was evaluated for the possible diagnosis of KD. After establishing the diagnosis, standard treatment for KD was started according to guidelines. She was treated with a single dose of 2 g/kg intravenous immunoglobulin (IVIG) and high\u2010dose acetylsalicylic acid. The patient's fever subsided after the initiation of IVIG and she was without fever for about 24\u2009h. However, she developed high\u2010grade fever again as well as hypotension the next day. In serial laboratory tests, a markedly elevated CRP level along with high procalcitonin and d \u2010dimer were observed. There was evidence of shock and IVIG\u2010resistant KD. Inotropic management of the shock with epinephrine was started for the patient. According to advice from the infectious diseases team, broad\u2010spectrum antibiotics including meropenem, vancomycin and ciprofloxacin was also administered. After the shock resolved, a second dose of the IVIG was initiated. There were no significant findings on chest X\u2010ray and the echocardiogram was normal with no evidence of coronary artery dilation. Our patient suffered from severe generalised abdominal pain. On abdominal ultrasound scan, a fluid accumulation measuring 33\u2009\u00d7\u200934\u2009\u00d7\u200914\u2009mm was localised in the right lower quadrant and a volume of 9 mL was reported. After 48\u2009h, the abdominal ultrasound scan was repeated in which a mild free fluid collection was noted in the right paracolic area and pelvis. During this time, the patient had orthostatic hypotension and lower limb mottling while standing which was due to the presence of hyperinflammatory shock.The symptoms and fever were present for another 48\u2009h. All of our patient's signs and symptoms began to improve on the third day of hospitalisation after starting the second dose of IVIG and antibiotics. Antibiotic treatment was continued for 1\u2009week. The patient's blood culture and adenovirus\u2010specific PCR tests were negative. At the time of discharge, evidence of desquamation was observed on the patient's fingers. The patient was discharged with instructions to take low dose aspirin (3 mg/kg daily) and plans for repeating her follow\u2010up echocardiogram 1\u2009week after discharge.",
        "es": "Ni\u00f1a de 5 a\u00f1os que fue llevada a urgencias pedi\u00e1tricas con 5 d\u00edas de hipertermia, v\u00f3mitos, diarrea y dolor abdominal; hab\u00eda sido tratada ambulatoriamente por una infecci\u00f3n v\u00edrica. El tercer d\u00eda, present\u00f3 conjuntivitis, exantema e hinchaz\u00f3n en las manos. La paciente hab\u00eda tenido s\u00edntomas de las v\u00edas respiratorias altas durante las \u00faltimas 3 semanas, que hab\u00edan mejorado con tratamiento sintom\u00e1tico. En la exploraci\u00f3n cl\u00ednica inicial, la paciente se apreciaba enferma, con un exantema eritematoso generalizado, inflamaci\u00f3n y congesti\u00f3n labial, leve inflamaci\u00f3n de las manos y deshidrataci\u00f3n moderada a causa de los v\u00f3mitos y la diarrea. Las constantes vitales eran: temperatura de 39,5 \u00b0C, taquicardia sinusal con pulso de 165 l.p.m., taquipnea con ruidos respiratorios normales y saturaci\u00f3n de ox\u00edgeno de 98% y presi\u00f3n arterial de 75/55. Las pruebas anal\u00edticas revelaron linfocitopenia, valor ligeramente alto de prote\u00edna C-reactiva (23 mg/L) y velocidad de sedimentaci\u00f3n globular de 40 mm/h. Ten\u00eda hiponatremia (Na: 120\u2009mEq/L) y las pruebas funcionales hep\u00e1ticas eran elevadas. Unas 4 semanas antes del ingreso en nuestro hospital, tuvo antecedentes de exposici\u00f3n a su t\u00edo, que hab\u00eda sido diagnosticado con COVID-19. A causa de esta exposici\u00f3n, se solicit\u00f3 una prueba de reacci\u00f3n en cadena de la polimerasa con transcriptasa inversa (RT-PCR) y pruebas serol\u00f3gicas para SARS-CoV-2. La PCR fue negativa en dos ocasiones; sin embargo, la IgG para SARS-CoV-2 fue positiva (IgG: 10,3 veces superior al valor de referencia; IgM: 0,2 veces inferior al valor de referencia; el intervalo de referencia se defin\u00eda como inferior a un cociente 1,1), lo que suger\u00eda infecci\u00f3n previa por SARS-CoV-2. Se inici\u00f3 un tratamiento r\u00e1pido con rehidrataci\u00f3n a causa de la deshidrataci\u00f3n e hipotensi\u00f3n de la paciente. Una vez estabilizadas las constantes vitales, se la evalu\u00f3 para un posible diagn\u00f3stico de nefropat\u00eda. Tras establecer el diagn\u00f3stico, se inici\u00f3 un tratamiento est\u00e1ndar para nefropat\u00eda seg\u00fan las directrices. Se trat\u00f3 a la paciente con una dosis \u00fanica de 2 g/kg i.v. de inmunoglobulina y una dosis alta de \u00e1cido acetilsalic\u00edlico. La fiebre remiti\u00f3 tras la administraci\u00f3n de inmunoglobulina, y se mantuvo afebril durante unas 24 horas. Sin embargo, al d\u00eda siguiente present\u00f3 nuevamente hipertermia e hipotensi\u00f3n. En las pruebas anal\u00edticas sucesivas, se observ\u00f3 un claro aumento de prote\u00edna C-reactiva as\u00ed como valores altos de procalcitonina y de d\u00edmero D. Hab\u00eda pruebas de choque y de nefropat\u00eda resistente a inmunoglobulinas. Se inici\u00f3 un manejo in\u00f3tropo del choque con epinefrina. De acuerdo con las recomendaciones del equipo de enfermedades infecciosas, tambi\u00e9n se administraron antibi\u00f3ticos de amplio espectro: meropenem, vancomicina y ciprofloxacina. Tras la resoluci\u00f3n del choque, se inici\u00f3 una segunda dosis de inmunoglobulina i.v. No se hallaron resultados relevantes en la radiograf\u00eda tor\u00e1cica y el ecocardiograma era normal, sin pruebas de dilataci\u00f3n arterial coronaria. La paciente presentaba dolor abdominal intenso generalizado. En la ecograf\u00eda abdominal se hall\u00f3 una acumulaci\u00f3n de l\u00edquido de 33\u2009\u00d7\u200934\u2009\u00d7\u200914\u2009mm en el cuadrante inferior derecho, con un volumen de 9 mL. Tras 48 horas, se repiti\u00f3 la ecograf\u00eda abdominal, en la que se observ\u00f3 una ligera acumulaci\u00f3n de l\u00edquido libre en la zona parac\u00f3lica derecha y p\u00e9lvica. Durante este tiempo, la paciente tuvo hipotensi\u00f3n ortost\u00e1tica y present\u00f3 manchas en las extremidades inferiores en bipedestaci\u00f3n, a causa del choque hiperinflamatorio. Los s\u00edntomas y la fiebre persistieron durante 48 horas m\u00e1s. Todos los signos y s\u00edntomas de la paciente empezaron a mejorar al tercer d\u00eda de hospitalizaci\u00f3n tras iniciar la segunda pauta de inmunoglobulina y antibi\u00f3ticos. El tratamiento antibi\u00f3tico se mantuvo durante una semana. Un hemocultivo y pruebas PCR espec\u00edficas para adenovirus fueron negativos. En el momento del alta, se apreci\u00f3 descamaci\u00f3n en los dedos de la paciente. La paciente fue dada de alta con instrucciones para tomar una dosis baja de aspirina (3 mg/kg/ al d\u00eda) y repetici\u00f3n del ecocardiograma una semana tras el alta."
    }
]